stock here: I was curious about Hunter talking to “Pedo peter” and how that would refer to his Dad?

Here is the answer

stock here: After Fukushima destroyed the food chain, and 90% of the krill absorbed the radiation and went to Davy Jones locker….there were a rash of shark attacks in Hawaii, enough that they started hiding them and reclassifying them. So if a guy was spear fishing, they classified it as “instigated”.

So I was surprised to find 2019 had at least 6 attacks in Hawaii. There were 6 up to May 26th!!!!!! Surprised, because I heard nothing of them.

https://www.foxnews.com/us/hawaii-shark-attack-leaves-california-man-dead-witness-says-skin-just-torn-off

This article states that there were 14 attacks in Hawaii in 2020 when this fatal attack happened. Which is really odd, since that was COVID year, and there were near zero tourists.

Honolua Bay Maui Shark Attacks

Here is a 2021 Hawaii Shark Attack

https://www.foxnews.com/us/hawaii-shark-attack-woman-swimming-tourist-group

https://www.foxnews.com/us/shark-bites-new-york-teen-surfer-waters-long-island-beach

Odd, apparently ZERO in Hawaii this year?????

Video below show a Dec 2021 actual attack in Hawaii, with video of shark hitting the man, then pulling him under water!!!!

stock here– this transition has been going on a while.

They are plain making stuff up, like “the worst drought in 1200 years”, the Highest temperatures ever.

Damn them to hell. And remember this….when Fox starts telling the same lies as the MSM, then you know its a lie, but its an important lie to their strategy.

https://www.foxnews.com/opinion/climate-change-congress-must-act-cleaner-healthier-world

stock here: I think this is the only podcast I ever listened to twice. The field of Neuro-Biology as described by Andrew Huberman is fascinating.

I’ve said it before and I will say it again. The Jabs are very important to the CoC (Consortium of Cartels), and they completely attacked Rogan when he had the vxx truthspeakers on. They neutered him, he learned his lesson.

FC found it on Rumble so you don’t have to mess with Spotify, at bottom, Thanks Cuttlefish!

stock here: I think part of the abuse they want us to perform is jabbing the pregnant women and little kids, even babies.

We are at the level of “stockholm syndrome”

Last night we treated a 7 y/o little girl for multiple blood clots in her legs, then we found more in her lungs. Now in PICU, surgery later today. We’re very worried. Mom asked if it was because of the 💉💉. I was very transparent with her. Reporting in VAERS today. 7 years old!

— Emergency Room RN (@RnEmergency) July 20, 2022

stock here, what could possibly go wrong? Flying too close to the sun?

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3623694/

The development of three-dimensional (3D) synthetic biomaterials as structural and bioactive scaffolds is central to fields ranging from cellular biophysics to regenerative medicine. As of yet, these scaffolds cannot electrically probe the physicochemical and biological micro-environments throughout their 3D and macroporous interior, although this capability could have a marked impact in both electronics and biomaterials. Here, we address this challenge using macroporous, flexible and free-standing nanowire nanoelectronic scaffolds (nanoES), and their hybrids with synthetic or natural biomaterials. 3D macroporous nanoES mimic the structure of natural tissue scaffolds, and they were formed by self-organization of coplanar reticular networks with built-in strain and by manipulation of 2D mesh matrices. NanoES exhibited robust electronic properties and have been used alone or combined with other biomaterials as biocompatible extracellular scaffolds for 3D culture of neurons, cardiomyocytes and smooth muscle cells. Additionally, we show the integrated sensory capability of the nanoES by real-time monitoring of (i) the local electrical activity within 3D nanoES/cardiomyocyte constructs, (ii) the response of 3D nanoES based neural and cardiac tissue models to drugs, and (iii) distinct pH changes inside and outside tubular vascular smooth muscle constructs.

The design and functionalization of porous materials has been actively pursued to enable new material properties and applications^1–3. In particular, the development of synthetic 3D macroporous biomaterials as extracellular matrices (ECMs) represents a key area because (i) functionalized 3D biomaterials allow for studies of cell/tissue development in the presence of spatiotemporal biochemical stimulants

Submitted by Lot’s Wife:

We’ve been sold out by weak-kneed journalists who’ve capitulated to the upper-level management. When the truth is discovered, will they turn on their masters?

The Largest Unethical Medical Experiment in Human History

By Ronald N. Kostoff, PhD.

https://everydayconcerned.files.wordpress.com/2020/10/untitled.pdf

Dr. James Giordano, Professor of Neuroscience, Georgetown University, and DARPA/U.S. Army/EU Human Brain Project Consultant, in “Brain Science from Bench to Battlefield: The Realities – and Risks – of Neuroweapons” lecture, August 29, 2017

https://gangstalkingmindcontrolcults.com/dr-james-giordana-brain-science-from-bench-to-battlefield-the-realities-and-risks-of-neuroweapons/

Doubt the assertion? Read the documents. Curiously, the mass hypnosis via televised news programming is so profound that many people no longer care to examine facts that dispute it.

Upon examining the phenomenon in detail it’s seen that the trance is obdurate in those with advanced degrees. A wrinkle that begs scholarship

stock here, from WUWT. This climate site should be on your radar.

Case in point, In North America, how many people move north for the winter? How many move south to warm places, such as Florida ? We are a warm weather species after all. Makes for a hard sell that getting warmer is a bad thing. Just sayin ….

https://wattsupwiththat.com/2022/07/17/john-christy-debunks-climate-models-and-extreme-weather-hysteria-with-laura-ingraham-on-fox-news/

stock here: any ideas on how we can block this fossil Soros? He is so obvious, I know there is more going on hidden.

Soros donates $1 million to O’Rourke’s campaign for Texas governor

https://archive.ph/hY9i3#selection-953.3-953.70

And the below quote is exactly correct. It is exactly analogous to the Bay of Pigs. Capite?

stock here, this is from 1 Pfizer batch EP 1266

This format is not ideal. I have it as a Excel File in Box so will try to find. — Edit here it is

https://app.box.com/s/cp2i0r2wl1szcg5vskz3sd6spncn5we4

Here is another for Pfizer batch EM477 also a horrific Batch

https://app.box.com/s/vv8zd1voimcjnwpayglife92u3sf4hzq

Under reporting rate around 100 to 1. 73 deaths listed here, implying 7,300 deaths from this batch of 180,000 doses.

Impact on quality of life; Within few days of the first administration of the Pfizer COVID vaccine, the subject began to show signs of mental confusion and dizziness resulting in cerebral hemorrhage.; Within few days of the first administration of the Pfizer COVID vaccine, the subject began to show signs of mental confusion and dizziness resulting in cerebral hemorrhage.; Within few days of the first administration of the Pfizer COVID vaccine, the subject began to show signs of mental confusion and dizziness resulting in cerebral hemorrhage.; Within few days of the first administration of the Pfizer COVID vaccine, the subject began to show signs of mental confusion and dizziness resulting in cerebral hemorrhage.; This is a spontaneous report from a contactable consumer or other non hcp downloaded from the Regulatory Authority-WEB regulatory authority number IT-MINISAL02-745788.  A 86-years-old male patient received first dose of BNT162b2 (COMIRNATY, solution for injection, Lot Number: EP2166), via an intramuscular route on 03Mar2021 as dose 1, 0.3 ml single in the right arm for covid-19 immunisation. The patient medical history included hypertension (intake of 2 tablets per day for high blood pressure) and walking difficulty, which worsened after vaccination. The patient concomitant medications included bisoprolol fumarate (CONGESCOR) for hypertension from an unknown date and unknown if ongoing. On 08Mar2021, the patient experienced Within few days of the first administration of the Pfizer COVID vaccine, the subject began to show signs of mental confusion and dizziness resulting in cerebral hemorrhage.On 10Mar2021 first access to the emergency room, family members report that the patient in a confusional state may had accidentally ingested some mouthwash. On 11Mar2021 second access to the emergency room following which he is hospitalized in neurology and had Impact on quality of life (10/10). Reporter stated that there were no other pathologies. the patient was in good health confirmed by blood tests carried out in the recent period prior to vaccination.The patient died on unspecified date and autopsy results was unknown. The outcome of the events was fatal.   Sender”s comments:requested clinical documentation of hospitalization  No follow-up attempts are needed. No further information is expected.  Health Authority comment:The patient suffered from hypertension resulting in a daily intake of 2 tablets per day for high blood pressure and 1 tablet per day for the heart (CONGESCOR). There were no other pathologies. The patient was in good health confirmed by blood tests carried out in the recent period prior to vaccination. the patient had walking problems, which worsened after vaccination.; Reported Cause(s) of Death: Dizziness; Cerebral haemorrhage; Mental confusion; Head revolving around; Impact on quality of life Cerebrovascular accident; This is as spontaneous report received from a contactable physician downloaded from the regulatory authority-WEB. The regulatory authority report number is FR-AFSSAPS-BX20213039, Safety report unique identifier FR-AFSSAPS-2021037432.   A 75-year-old male patient received 1st dose of BNT162B2 (COMIRNATY, lot number: EP2166) intramuscular in the left arm on 09Mar2021 as single dose for COVID-19 vaccination. Medical history included glaucoma and hypertension. Concomitant medications were unknown. The patient experienced cerebrovascular accident (AVC) and died on 23Mar2021. The patient had stroke on 23Mar2021without further details on D16 of a 1st dose of Comirnaty vaccine. The patient did not have COVID. Description of the effect: On D5 after vaccination, balance disorders with memory disorders, without medical consultation. On D16 at 4 am, malaise with disturbance of balance, then disturbance of consciousness, clonies of the upper limbs and jet vomiting. Home medical assistance, upon arrival, comatose patient, Glasgow at 3 with coiling, isocore but reactive pupils. No fever. Normal blood sugar. orotracheal intubation in rapid sequence in front of neurological failure. Switch to thrombolysis alert. CT angiography then MRI: stroke with occlusion of the proximal third of the basilar trunk with recent left occipital infarction associated with several old disseminated parenchymal infarctions of embologenic origin, fatal outcome. No autopsy was performed. Outcome of the event was fatal.   No follow-up attempts possible. No further information expected.; Reported Cause(s) of Death: AVC dyspnoea; dry cough; COVID positive / fluctuating saturation after COVID-19; Lung complication, suspected pneumonia; Type 2 infarction due to hypoxia; Type 2 infarction due to hypoxia; This is a spontaneous report from a contactable physician downloaded from a regulatory authority-WEB, regulatory authority number SE-MPA-2021-037898. Additional reference number includes SE-VISMA-1620722650778.  An 83-year-old female patient received BNT162B2 (COMIRNATY, solution for injection), dose 2 via an unspecified route of administration on Mar2021 (Lot Number: EP2166) as second dose, single dose for COVID-19 immunisation; covid-19 vaccine nrvv ad (chadox1 ncov-19) (VAXZEVRIA), via an unspecified route of administration on Mar2021 (Lot number was not reported), at unspecified dose for an unspecified indication. Medical history included COVID-19 from Feb2021 to an unknown date, ongoing myalgia, ongoing mitral insufficiency, angina pectoris from an unknown date and unknown if ongoing and macular degeneration from an unknown date and unknown if ongoing. The patient”s concomitant medications were not reported.   The patient received dose 1 of VAXZEVRIA (pending clarification) at the end of January 2021. The next day, the patient had a debut of pain between the shoulder blades that radiated between, against the sternum, started when she was resting and it lasted for a week, the medical record lists costosternal-type chest pain, suspected angiogenesis, she also states that she was very tired and went straight in to deep sleep. Arrived at hospital 12 days after vaccination. The patient stated that she had been heavy-breathing and had a fever in recent days. The form states that the dyspnoea started the day after the vaccination, the medical record states that the dyspnoea began 4 days later when the patient developed increasing dyspnoea. Saturated at 80%, get 5 liters of oxygen and saturation rose to 97-100%. Positive D-dimer, PCR positive. The patient thought the complications were due to the vaccine, she had not had it like this before, she stated. Initially, tinzaparin (INNOHEP) was given 14,000 units, DT thorax was negative for pulmonary embolism, but showed groundglass changes, which supported the suspicion that she had had COVID for several days before arriving at the hospital, she received treatment with dexamethasone, oxygen (mask and OPTIFLOW) and INNOHEP 4,500 units as thrombosis prophylaxis. Substantially complication-free care time, the patient was clear and oriented and could be discharged after 11 days of hospital care with a saturation of $g 95% on air. The patient was prescribed apixaban (ELIQUIS) 2.5 mg x2 to take to the follow-up visit. In the journal entry, the assessment is stated as an oxygen-demanding COVID-19 infection.  The patient received dose 2 of VAXZEVRIA (pending clarification) was given in early March, 37 days after dose 1. The day after onset of effort dyspnoea with minimal exertion and discomfort / pain in the center of the chest without radiance, not aggravated by activity, she took nitro puffs which helped temporarily, but quickly needed to take more, the patient stated that she has not taken that much in several years, she also had a dry cough, but no fever / chills. The patient arrived at the health center 3 days later and then had saturation 75%, ECG (electrocardiogram)with widespread t-wave negativities, however, she had had it before, CRP M (C-reactive protein)$g 200, the patient was sent to hospital by ambulance. Patient was affected by breathing, but completely clear in the head and alert at rest with oxygen and afebrile. Saturation dropped rapidly during transfer to 65% without oxygen. Quick test showed COVID positive. Got 9 L oxygen and 2 g cefotaxime. Regular thin pulse, frequency 80, blood pressure 162/93, lactate 6.2, pH 7.245, LPK 15.5 ECG dynamics and chest pain may well be secondary to hypoxia. The patient was loaded with acetylsalicylic acid (BAMYL), transition to acetylsalicylic acid (THROMBYL). Cefotaxime 1gx3, ipratropium / salbutamol (COMBIVENT), sodium chloride inhalations and Nasal high flow oxygen (OPTIFLOW) were given as needed, thrombosis prophylaxis 4,500 units tinzaparin (INNOHEP). DT aortic angio showed no pulmonary embolism, but widespread densifications in both lungs of the ground-glass nature. Mediastinal lymphadenopathy, Cefotaxime were switched to piperacillin / tazobactam and moxifloxacin (AVELOX), methylprednisolone (SOLU-MEDROL) 500 mg to try to reduce inflammation. Palliative drugs were added the next day. Change to prednisolone after 4 days. New troponin increase and heart failure, received furosemide (FURIX) intravenously and KAD (catheter a demeur), 0 CPR, was admitted to IVA, hypoxic and insufficiency probably part of type 2 infarction. Lung X-rays six days after admission to the hospital generally showed reduced air content, severe failure. Type 2 infarction due to hypoxia. Got rising infection parameters and fever, they switched from piperacillin / tazobactam (TAZOCIN) to meropenem (MERONEM) + Anidulafungin (ECALTA). The patient deteriorated sharply, OPTIFLOW was withdrawn and the patient died shortly afterwards, 14 days after receiving dose 2 of VAXZEVRIA. The medical record states Lung complication, suspected pneumonia, fluctuating saturation after COVID-19. Type 2 infarction due to hypoxia. CRP 254 on income, 322 the day after, then down to 66 210312. 210314 CRP 163, drops to 66 210318. LPK 15-8-19-17,8-20. Sodium 132 on income, rises nicely to normal value, 134 210318. Potassium 3.1 210314, normalizes. LD 13.7. Trop 210308 249-205. ProBNP 9519 (as reported). The patient died on 2021.  It was not reported if an autopsy was performed. Outcome was reported as Fatal. Report assessed as serious, death.   No follow-up attempts are possible. No further information is expected.; Reported Cause(s) of Death: dyspnoea; dry cough; COVID positive / fluctuating saturation after COVID-19; Lung complication, suspected pneumonia; Type 2 infarction due to hypoxia; Type 2 infarction due to hypoxia fall incident; had embolization to truncus coeliacus; duodenal ulcers; Duodenal bleeding; embolization to truncus coeliacus with splenic infarction/Splenic infarction; Pulmonary embolism; This is a spontaneous report from a contactable physician downloaded from the Agency Regulatory Authority-WEB, regulatory authority number SE-MPA-2021-042995.   An 87-year-old female patient received the first dose of bnt162b2 (COMIRNATY, Batch/Lot Number: EP2166), via an unspecified route of administration on 23Mar2021 as single dose for covid-19 immunisation. Medical history included cardiac assistance device (artificial cardiac pacemaker user) due to sick sinus syndrome, chronic obstructive pulmonary disease, hypertension, which were ongoing. Concomitant medications were budesonide (GIONA), olodaterol hydrochloride, tiotropium bromide monohydrate (SPIOLTO RESPIMAT), acetylcysteine, allopurinol, bisoprolol, losartan/hydrochlortiazide, mirtazapine, simvastatin. Reported suspect adverse events were pulmonary embolism, duodenal bleeding and splenic infarction occurred in April 2021. The physician has also reported that the woman arrived at the emergency clinic on 19th of April 2021 due to fall incident. On trauma CT was found that that woman had embolization to truncus coeliacus with splenic infarction. The woman received a high dose of tinzaparin sodium (INNOHEP). The woman died a few days later (in Apr2021), the death was probably caused by bleeding from duodenal ulcers. In addition to the splenic infarction, according to postmortem examination the patient had pulmonary embolism, which has caused or contributed to the death. Report assessed as serious, death. Outcome was fatal for events pulmonary embolism, duodenal bleeding and splenic infarction, for fall, duodenal ulcers and embolization to truncus coeliacus was unknown.   No follow-up attempts are possible. No further information expected.; Reported Cause(s) of Death: Pulmonary embolism; Duodenal bleeding; Splenic infarction; Autopsy-determined Cause(s) of Death: pulmonary embolism; splenic infarction Subcutaneous emphysema; acute bilateral pulmonary edema; Pain in arm; Oedema/hard edema of the limb; Necrotising fasciitis; ecchymotic streaks; replaced by water blisters; This is a spontaneous report from a contactable physician downloaded from a regulatory authority-WEB, regulatory authority number IT-MINISAL02-716695.     An 81-year-old patient of an unspecified gender received first dose of BNT162B2 (COMIRNATY), intramuscular, administered in deltoid right on 05Mar2021 at 11:37 (Batch/Lot Number: EP2166; Expiration Date: 31May2021) as single dose for COVID-19 immunisation.  Medical history included ongoing pancreatitis chronic, laparotomy, arteriosclerosis (coronary and aortic), ongoing benign prostatic hyperplasia and ongoing hyperplasia adrenal cortex. Concomitant medications included allopurinol (ZYLORIC, formulation: tablet, strength: 300 mg); lercanidipine (LERCADIP, formulation: film-coated tablet, strength: 20 mg); ferrous sulfate (TARDYFER, formulation: prolonged-release tablet, strength: 80 mg); pantoprazole sodium sesquihydrate (PANTORC, formulation: gastro-resistant tablet, strength: 20 mg); apixaban (ELIQUIS, formulation: film-coated tablet, strength: 5 mg); atenolol (formulation: film-coated tablet, strength: 100 mg); atorvastatin calcium (TOTALIP, formulation: film-coated tablet, strength: 20 mg); ascorbic acid/cupric oxide/tocopheryl acid succinate/xantofyl/zeaxanthin/zinc oxide (MACULAR) and serenoa repens (PROSTAMOL), all concomitants were taken for an unspecified indication, start and stop date were not reported. On 07Mar2021, the patient experienced subcutaneous emphysema, acute bilateral pulmonary edema, pain in arm, oedema and necrotising fasciitis. The evets were serious (fatal). Clinical course was reported as follows: on 07Mar2021 appearance of pain in the right arm. As the hours passed, the pain extended to the whole limb and was accompanied by the appearance of ecchymotic streaks then replaced by water blisters some of which opened upon arrival in the Emergency Department. Physical examination: adverse reactions except for the presence of water blisters dorsal surface elbows and third inferomedial arm, some already de-epithelialized with hard edema of the limb, poorly assessable arterial pulses. The patient underwent lab tests and procedures which included ALT/GPT, alpha amylase, enzyme natriuretic, total and fractionated bilirubin, total calcium, serum CPK, serum creatinine, functional fibrinogen, serum potassium, c-reactive protein, glycemia, ECG, complete blood count, Gamma-Glutamyl Transferase, lipasemia, procalcitonin, serum protein, prothrombin time, troponin and arterial or venous limb/district ultrasound, all on an unspecified date and unknown results, SARS-COV-2 test (rapid swab): negative on an unspecified date; APTT: 39,3, SGOT:149, azotaemia (10-50): 59 mg, Creatine kinase MM: 65.52 ng, Fibrin D dimer: unknown results, myoglobin blood (25-72): 17.358 ng, all on 07Mar2021. Therapeutic measures were taken as a result of the events and included treatment with sodium chloride 0.9%, PANTORC IV 40 mg (1FL in drip), arthrosylene 160 mg/2ml (1fl in drip), URBASON IV 40 mg (1fl in 100 cc of physiological solution), trimeton 10 mg/1 ml (1 fl intramuscular), MERREM 1000 mg (1 fl in 500 cc), VANCOTEX 1 g (1 fl IV), BENTELAN 4mg/2ml (1 fl IV). The patient died on 07Mar2021. An autopsy was performed, and the results were reported as follows: Anatomo-pathological report dated 09Mar2021, acute bilateral pulmonary edema in patients with morphological signs compatible with necrotizing fasciitis and vast subcutaneous emphysema of the upper limb and right hemithorax. Diffluent spleen and kidney as in initial shock stage. Hepatomegaly (liver weight 2400g), and chronic liver stasis in the second stage. Chronic pancreatitis. Non-stenosing calcific atherosclerosis of the coronary vessels and complicated aortic atherosclerosis in the abdominal area. Benign prostatic hyperplasia. Column hypertrophy of the bladder, adrenal cortical hyperplasia. Outcomes of laparotomy surgery. Multiple samples were taken for histological investigation.  No follow-up attempts are needed. No further information is expected.; Reported Cause(s) of Death: Subcutaneous emphysema; Pain in arm; Necrotising fasciitis; Autopsy-determined Cause(s) of Death: Acute pulmonary oedema Death/the adverse event as related to the patient”s primary diseases (cancer with metastases); This is as spontaneous report received from a contactable physician downloaded from the Agency Regulatory Authority-WEB. The regulatory authority report number is HU-OGYI-345421.  A 78-year-old female patient received BNT162b2 (COMIRNATY), intramuscular, administered in left arm, on 18Mar2021 (Batch/Lot Number: EP2166) as 2nd single dose, at 0.3 ml, for COVID-19 immunisation. Medical history included cecal, liver and endometrial adenocarcinoma, hypertension, meningioma, hysterectomy and hiatus hernia. Concomitant medications included octreotide acetate (SANDOSTATIN LAR) from 25Mar2021, and temozolomide (TEMOZOLOMIDE ACCORD) from 24Feb2021. The first dose of BNT162b2 was administered on 25Feb2021. This case concerns the occurrence of death after BNT162b2 second injection. The patient was hospitalized on 29Mar2021 because of severe agranulocytosis and bleeding. The patient received antibiotics, GSF and thrombocyte transfusion. Her condition temporarily got better, but then it started to deteriorate. Later, pulmonary edema occurred. On 04Apr2021 at 9:00 the patient passed away. An autopsy was not performed. The event reported was ”death” with no cause of death specified. Further information is not expected.  Sender”s Comments: The reporter physician assessed the adverse event as related to the patient”s primary diseases (cancer with metastases), therefore the causal relationship is unlikely between the suspected drug and the event of death. The case is considered serious because the outcome was fatal. Further information is not expected.  No follow-up attempts possible. No further information expected.; Reported Cause(s) of Death: Death/the adverse event as related to the patient”s primary diseases (cancer with metastases) impaired general condition; confusion; diarrhea; suspected meningioma; multi organ failure; THROMBOCYTOPENIA; This is a spontaneous report from a contactable physician downloaded from the Agency Regulatory Authority-WEB SE-MPA-2021-041737.   A 92-year-old female patient received bnt162b2 (COMIRNATY), dose 2 via an unspecified route of administration in Mar2021 (Batch/Lot Number: EP2166) as single dose at the age of 92-year-old for COVID-19 immunisation.  Medical history included ongoing hypertension, pneumonia in Mar2021, radius fracture in 2012. The patient”s concomitant medications were not reported. The patient received bnt162b2 (COMIRNATY), dose 1 in Feb2021 (Batch/Lot Number: Ej6790) as single dose at the age of 92-year-old for COVID-19 immunisation.  In Apr2021 7 weeks after 2nd vaccination, the patient experienced thrombocytopenia, impaired general condition, confusion, diarrhea, suspected meningioma and multi organ failure on Apr2021. The patient underwent lab tests and procedures which included. The patient died on an unspecified date.  The outcome of the events was fatal.  It was not reported if an autopsy was performed.  The course of events was as follows: Reported suspect adverse event was thrombocytopenia with start date 7 weeks after vaccination with dose two.  She was essentially a healthy woman with the exception of hypertension. Admitted to the hospital ward due to impaired general condition, confusion and diarrhea. TPC (platelet) 29. Also Hb (hemoglobin) 105, SR (Sedimentation rate) 42, LD (lactate dehydrogenase) 22, Ferritin 1877, Transferrin 1, Homocystein 54 and LPK (prealbumin) 3.9. The latest previous TPC value 19 days earlier was 255. CT (computed tomogram) abdomen with diffuse heterogeneous spleen, possibly artifact, was recommended by radiologist to order additional survey. CT brain with newly discovered suspected meningioma. Assessed in consultation with a haematologist as suspected haematological malignancy. Not considered treatable with regard to the patient”s age, status and suspected meningioma. Thus no further investigation. Transfers to palliative care and the patient later dies calmly and quietly. Sampling was taken before this in view of the sudden onset of thrombocytopenia and vaccination administration. The patient has not received Heparin, Fragmin or similar preparations according to the medical record. P-HIT Antibodies IgG Positive. HPF4 Antibodies IgG Negative.  The reporting physician discussed the case with a hematologist consultant and coagulation consultant. In summary, this is interpreted as a primarily probable hematological malignancy. There is a low degree of suspected vaccine side effect.   Cause of death stated in the report as multi organ failure.   No follow-up attempts possible. No further information expected. Information about batch number already obtained.; Reported Cause(s) of Death: Multi organ failure COVID-19 pneumonia; COVID positive; COVID-19 infection; This is a spontaneous report from a contactable physician downloaded from the Agency Regulatory Authority-WEB, regulatory authority number HU-OGYI-345321. A 68-year-old male patient received first dose of bnt162b2 (COMIRNATY; Lot Number: EP2166), intramuscular, administered in arm left on 24Feb2021 as 1st dose, 0.3 ml single for COVID-19 immunisation.  Medical history included COVID-19 pneumonia, varicosity, tonsillectomy, COVID-19, lymphoma (non-Hodgkin”s) from 2020 (low-grade B cell lymphoma progressed) and hypertension. The patient”s concomitant medications were not reported. On 08Mar2021 thee patient experienced COVID-19 pneumonia , COVID positive and COVID-19 infection. It was reported that on 08Mar2021 COVID-19 infection was confirmed and the patient was hospitalized. Chest X-ray also showed bilateral pneumonia. The patient received COVID therapy but his condition did not get better and passed away on 24Mar2021 at 07:00. The patient was diagnosed with incurable low-grade B cell lymphoma in 2020 which progressed, therefore the patient”s general condition was not adequate enough to recover from the COVID-19 infection. The patient underwent lab tests and procedures which included chest x-ray: bilateral pneumonia on 08Mar2021, chest x-ray: positive (confirmed pneumonia) on 16Mar2021, COVID-19 antigen test: positive on 08Mar2021. The patient died on 24Mar2021 due to COVID-19. An autopsy was not performed.  Sender comments: As the patient got infected with COVID-19 after the first dose, the causal relationship is unlikely between the suspected drug and the adverse events. The case is considered serious because the outcome was fatal. Further information is not expected.     No follow-up attempts possible. No further information expected.; Reported Cause(s) of Death: COVID-19 fell; rib fracture; weak state; confused state; condition deteriorated; Death; This is a spontaneous report from a contactable other health professional downloaded from the Agency Regulatory Authority-WEB, regulatory authority number HU-OGYI-345221.     An 86-year-old female patient received second dose of BNT162B2 (COMIRNATY), intramuscular, administered in arm left on 10Mar2021 (Batch/Lot Number: EP2166) as 0.3 mL single dose for COVID-19 immunisation.  Medical history included cataract operation, vascular dementia, urinary infection, osteoporosis, reflux esophagitis, asthma bronchial and pyelonephritis chronic, all from an unknown date and unknown if ongoing. Concomitant medications included glyceryl trinitrate (NITROMINT, formulation: transdermal patch) transdermal; theophylline (RETAFYLLIN); budesonide/formoterol fumarate (SYMBICORT) and spironolactone (VEROSPIRON) oral daily, all concomitants were taken for an unspecified indication, start and stop date were not reported. The patient previously received first dose of BNT162B2 (COMIRNATY), intramuscular on 17Feb2021 (Batch/Lot Number: EL0725) as 0.3 mL single dose for COVID-19 immunisation. On 23Mar2021 the patient was hospitalized after she was found lying on the ground in her home. The old patient possibly fell because she had a rib fracture. The patient was in a weak, confused state the whole time. Despite the therapy (which also included parenteral antibiotics), the patient”s condition deteriorated and passed away on 04Apr2021. The patient underwent lab tests and procedures which included inflammatory parameters: laboratory results showed elevated inflammatory parameters and implied urinary infection, COVID-19 antigen test and COVID-19 PCR test: both negative on 22Mar2021.  The patient died on 04Apr2021. The patient outcome of the events was unknown.  An autopsy was not performed. Sender Comment: the reporter assessed the events as related to the patient”s primary diseases; therefore the causal relationship is unlikely between the suspected drug and the adverse event. The case is considered serious because the outcome was fatal.   No follow-up attempts are needed. No further information is expected.; Reported Cause(s) of Death: Death massive pulmonary embolism; This is a spontaneous report from a contactable physician downloaded from the Regulatory Authority NL-LRB-00535901.  An 86-year-old female patient received second dose bnt162b2 (COMIRNATY), via an unspecified route of administration on 09Mar2021 (Batch/Lot Number: EP2166) at single dose for COVID-19 immunisation.  The patient medical history and concomitant medications were not reported. The patient received first dose bnt162b2 (COMIRNATY), via an unspecified route of administration on 02Feb2021 at single dose for COVID-19 immunisation and experienced no adverse event.  The patient experienced massive pulmonary embolism on 14Mar2021. Targeted heart / vci emergency ultrasound (ER): wide right system, D-shape septum, Mc cullen sign +, empty left ventricle with moderate Left ventricular failure (LVF), VCI wide, does not collapse. No pericardial fluid. Conclusion: clear signs of legal tax with positive mc cullen sign, strong suspicion of obstructive shock due to massive pulmonary embolism. Electrocardiogram (ECG): SR 80 / min, normal cardiac axis, normal conductances, minimum segment (ST) depressions in I, V5-V6, no segment (ST) elevations, normal T-waves. After one-time filling (started from ambulance) no improvement, hemodynamics. With clear signs of legal tax on targeted emergency ultrasound with high suspicion of obstructive shock pulmonary embolism now no longer filled (due to worsening of circulatory situation in case of obstruction of the right system). Considering that it is too unstable for Computed tomography (CT) hemodynamically, consult IC about yes / no thrombolysis given deep shock and clear desire not to resuscitate want to become. Decided after assessment by intensivis. The patient did not have previous COVID-19 infection. The patient died on 15Mar2021 due to lung embolism.  It was not reported if an autopsy was performed.  No follow-up attempts possible. No further information expected. ; Reported Cause(s) of Death: massive pulmonary embolism Vaccination failure; COVID-19; COVID-19 pneumonia; This is a spontaneous report from a contactable physician downloaded from the Regulatory Authority.  An 89-year-old male patient received bnt162b2 (COMIRNATY), first dose via an unspecified route of administration on 27Feb2021 at single dose, second dose intramuscularly administered in left arm on 20Mar2021 (Batch/Lot Number: EP2166) at 0.3 ml single, for COVID-19 immunisation. Medical history included atrial fibrillation, hypertension, congestive heart failure, COVID-19 pneumonia, COVID-19, all unknown if ongoing. Concomitant drugs included amoxicillin trihydrate, clavulanate potassium (AUGMENTIN DUO); alprazolam (FRONTIN); lacidipine (LACIPIL); furosemide; allopurinol (MILURIT); solifenacin succinate (VESICARE); troxerutin (VENORUTON); perindopril erbumine (PRENESSA); spironolactone (VEROSPIRON); potassium chloride (KALIUM-R); apixaban (ELIQUIS); tamsulosin hydrochloride (PROSOLIN); dexamethasone; pantoprazole. The patient experienced vaccination failure (death, hospitalization) on 28Mar2021, covid-19 (death, hospitalization) on 28Mar2021, covid-19 pneumonia (death, hospitalization) on 28Mar2021. The patient was hospitalized from 01Apr2021. The patient died on 09Apr2021. Clinical course: On 01Apr2021 the patient was hospitalized with a positive Covid-19 antigen test result and dyspnea. His oxygen saturation was 70% and laboratory tests also implied abnormalities in association with Covid-19. Chest X-ray confirmed bilateral Covid-19 pneumonia. The patient received covid treatment but his respiratory insufficiency intensified and passed away on 09Apr2021 at 8:20. An autopsy was not performed. The outcome of the events was fatal.   Health Authority Comment: According to the SmPC of Comirnaty, immunity usually develops 14 days after the second dose of the vaccine. Vaccination failure can be considered possible as the patient died of Covid-19, 19 days after the second dose. The case is considered serious because the outcome was fatal. Further information is not expected.   No follow-up attempts are needed. No further information is expected.; Reported Cause(s) of Death: Vaccination failure; COVID-19; COVID-19 pneumonia Cardio-respiratory failure; Status epilepticus; congestive hepatopathy; Covid-like symptoms; possible white brain matter damage; This is a spontaneous report from a contactable physician downloaded from a regulatory authority-WEB, regulatory authority number HU-OGYI-289021. This is a report received from a regulatory authority. A 72-year-old female patient received first dose of bnt162b2 (COMIRNATY, solution for injection, Batch/Lot Number: EP2166, expiry date: unknown), intramuscularly on 18Mar2021 (at the age of 72-year-old) at 0.3 ml, single for active immunization to prevent COVID-19. Medical history included epilepsy, vascular encephalopathy, meningioma and Incontinence of urine, all from an unknown date and unknown if ongoing. Concomitant medication included carbamazepine (NEUROTOP) taken for epilepsy. The patient previously took carbamazepine (TIMONIL). The patient experienced cardio-respiratory failure and status epilepticus on 07Apr2021. This serious, medically confirmed report concerned the occurrence of status epilepticus and cardiorespiratory failure resulting in death after bnt162b2 injection. At the time of this report the patient was under care due to epilepsy. On 07Apr2021 the patient had a grand mal seizure which lasted for 30 minutes. After the seizure the patient was somnolent, had difficulty in breathing and her oxygen saturation was low on 07Apr2021. The patient was transferred to the hospital on 07Apr2021. Cranial CT scan on 07Apr2021 showed abnormalities including edema and possible white brain matter damage. The patient had Covid-like symptoms on 07Apr2021, but both antigen and PCR tests were negative on 08Apr2021. Examinations also implied congestive hepatopathy and circulatory decompensation caused by cardiac insufficiency on 07Apr2021. On 08Apr2021 at 15:15 the patient suddenly passed away due to cardiorespiratory failure. The outcome of events cardio-respiratory failure and status epilepticus was fatal, outcome of the other events was unknown. The patient died on 08Apr2021 at 15:15. It was not reported if an autopsy was performed.  Sender Comment: The causal relationship cannot be assessed between the suspected drug and the adverse events because the patient passed away before additional examinations. TTO was 20 days. The case is considered serious because the outcome was fatal. Further information is not expected.  No follow-up attempts are possible. No further information is expected.; Reported Cause(s) of Death: Cardio-respiratory failure; Status epilepticus Intracerebral haemorrhage; Refractory hydrocephalus; Ischemic stroke – obstructive/lesion; Cardiorespiratory arrest due to vascular ischemia of the mid brain and vertebral arteries; atrial fibrillation; This is a spontaneous report from a contactable physician downloaded from the Agency Regulatory Authority-WEB, regulatory authority number GR-GREOF-20213319. An 85-year-old female patient received second dose of bnt162b2 (COMIRNATY), intramuscular on 05Mar2021 (Lot Number: EP2166) as single dose for covid-19 immunisation. Medical history included hypertension from 2016, ischaemic stroke (transient ischemic stroke) from 2016. Concomitant medications included irbesartan (APROVEL), clopidogrel bisulfate (PLAVIX) from 13May2017 to an unspecified stop date, omeprazole (LOSEC [OMEPRAZOLE]), omeprazole (OMEPRAZOLE), irbesartan (APROVEL). On 19Apr2021 patient experienced intracerebral haemorrhage, refractory hydrocephalus, Ischemic stroke – obstructive/lesion. Patient was admitted on 19Apr2021, admittance cause reported as follows: Ischemic stroke -refractory hydrocephalus – intracerebral haemorrhage. The patient was admitted to clinic on 19Apr2021 due to right hemiparesis (climax: Glasgow Coma Scale (GCS) E3V4M6 13/15). Computerised tomogram (CT) Scan revealed extensive ischemic lesion of right cerebellum hemisphere with edema and pressure of brain stem on 4th ventricle. Medication in her admittage (in the clinic): MANNITOL  150 for 3 intravenous (iv), SALOSPIR 325 MG 1X1 per oral solution (os). It was followed atrial fibrillation and they administered 2 amp ANGORON in 100 D/W 5% in a 2 hours infusion and 6 amp ANGORON in 500 cc D/W %. On 20Apr2021 due to relapse neurologically signs she underwent a new CT Scan due to hydrocephalus and it was decided to underwent neurosurgeon procedure (external ventricular drainage). On unknown date in Apr2021 (reported by the regulatory authority as 24Apr2021) the neurological examination remains the same (serious). New CT Scan was performed which revealed intracerebral hemorrhage. Respiratory problems appeared so she was incubated. Finally, the patient died due to cardiac arrest following ischemia of brain stem – rear circulation. On 23Apr2021 patient died due to cardiorespiratory arrest due to vascular ischemia of the mid brain and vertebral arteries, intracerebral haemorrhage, hydrocephalus, ischemic stroke, it was reported that an autopsy was done, no results provided. Outcome of the other mentioned event was unknown.  No follow-up attempts possible. No further information expected. Lot/Batch number already obtained.; Reported Cause(s) of Death: Cardiorespiratory arrest due to vascular ischemia of the mid brain and vertebral arteries; Intracerebral haemorrhage; Hydrocephalus; Ischemic stroke Respiratory distress; Vaccination failure; COVID-19 positivity; This is a spontaneous report from a consumer or other non HCP downloaded from the regulatory authority. Regulatory Authority Report Number: FR-AFSSAPS-DJ20211054. Safety Report Unique Identifier: FR-AFSSAPS-2021048085. Declaration from an EHPAD director via the reporting portal of the Agency and registered under the number 2021.0503124559648. This consumer reported similar events for two patients. This is the first of two reports.  A 69-year-old female patient received bnt162b2 (COMIRNATY), dose 1 via intramuscular on 11Feb2021 (Lot Number: EJ6789) as single dose, dose 2 via intramuscular on 04Mar2021 (Lot Number: EP2166) as single dose for COVID-19 immunisation. Patient age at vaccination was reported as 69 years old. The patient medical history included ongoing diabetes, ongoing hypertension arterial, ongoing obesity, ongoing insufficiency renal, coronary arteritis. The patient had no history of COVID-19 disease. The patient”s concomitant medication included potassium chloride (DIFFU K), etifoxine hydrochloride (STRESAM), furosemide, insulin aspart (NOVORAPID), insulin glargine (LANTUS), clopidogrel bisulfate (PLAVIX), allopurinol (ZYLORIC), esomeprazole, nicorandil (IKOREL), bisoprolol. The patient experienced vaccine failure with a fatal outcome. The registrant reported on 26Apr2021, or 53 days after the injection of the second dose of vaccine, the occurrence of COVID-19 positivity. Before 26Apr2021 no variant has been identified. On 02May2021 the patient presented with respiratory distress requiring hospitalization. The patient died on 06May2021. The cause of death was reported as COVID infection following vaccination failure. Autopsy was not done. Hospitalization report pending. Several cases in the same AFDEP (Accommodation facility for dependent elderly people), in particular another death (DJ20211042).   No follow-up attempts possible. No further information expected.; Sender”s Comments: Linked Report(s) : FR-PFIZER INC-2021546915 Different patient/ same AE and suspect product.; Reported Cause(s) of Death: COVID infection following vaccination failure; respiratory distress; COVID infection following vaccination failure Oedema started at legs, spreads to whole legs, hands; oedema in the legs which spread throughout the legs into the buttocks, lower back; Little concentration so she falls asleep after a page of reading and can”t follow TV programs/Concentration loss; Sleepy: She is very sleepy so she falls asleep after a page of reading and can”t follow TV programs/Somnolence; Heart failure; This is a spontaneous report from a contactable consumer (patient”s daughter) downloaded from a regulatory authority-WEB NL-LRB-00513409, received from Regulatory Authority.   A 90-year-old female patient received bnt162b2 (COMIRNATY, Batch/Lot Number: EP2166), via an unspecified route of administration on 03Mar2021 as 2nd dose, 0.3 ml single for COVID-19 immunisation. The patient”s medical history was not reported. Concomitant medications included fluvoxamine maleate (FEVARIN) and diazepam, both taken for an unspecified indication, start and stop date were not reported. The patient previously received the first dose of COMIRNATY on 27Jan2021 for COVID-19 immunisation and experienced no adverse reaction. The patient experienced oedema started at legs, spreads to whole legs, hands and oedema in the legs which spread throughout the legs into the buttocks, lower back on an unspecified date, little concentration so she falls asleep after a page of reading and can”t follow tv programs/concentration loss and sleepy: she is very sleepy so she falls asleep after a page of reading and can”t follow tv programs/somnolence on an unspecified date; heart failure on 28Apr2021. Treatment: Oedema is treated with diuretics; however, that treatment is stopped in consultation with the GP because it caused more harm than good. Two weeks after the second vaccination, the patient developed oedema in the legs which spread throughout the legs into the buttocks, lower back and hands. It has affected the quality of life because it used to be a healthy woman who is now no longer able to move as smoothly as before and who can no longer dress herself. She has to pant often, but her heart appears to be fine. She does not experience dyspnoea. She has been to the GP who investigated her blood and urine but was unable to find any abnormalities. The internist too was not able to find abnormalities. The GP had given her diuretics, but they caused more harm than good, so the treatment was stopped. They made the patient anxious. Up until now, the patient can barely walk. The GP does not know what to do. Latency: oedema: 2 weeks after start, somnolence and concentration loss: latency unknown. The patient was a healthy woman who is no longer herself since the oedema. She can hardly walk anymore. Must pant then (heart is okay, not stuffy). She is very sleepy, little concentration so she falls asleep after a page of reading and can”t follow TV programs. The oedema breaks her skin. She can no longer dress herself, the reporter”s father (94) has to help her, she is awake at night (while she was always a good sleeper), she then gets out of bed but is physically difficult to get back in. The doctor has done extensive blood and urine tests. All values are normal. Subsequently, her mother went to the internist for an examination, he also concluded that everything is fine. She has now been given water pills from the doctor, but they have not helped, and the remedy was worse than the disease, because she became anxious. She can barely walk now, and her parents are desperate. The patient”s mother died today (28Apr2021) in the hospital, this week the cardiologist diagnosed heart failure. They don”t know if this started with Pfizer, only that the edema started 2 weeks after the 2nd vaccine and that she gained 25 kilos of fluid in a few weeks, from 53 to 80 kilos. She was leading a healthy life. The patient underwent lab tests and procedures which included blood test: no abnormalities and urine analysis normal: no abnormalities on an unspecified date. The outcome of concentration loss and somnolence is unknown, while of the rest was fatal. The patient died on 28Apr2021. It was unknown if an autopsy was performed. Oedema and oedema peripheral were reported as fatal, medically significant and serious per hospitalization by the regulatory authority.  Case Summary and Reporter”s Comments Text:  28Apr2021 Follow-up received: Dear people, my mother died today in the hospital, this week the cardiologist diagnosed heart failure. We don”t know if this started with Pfizer, only that the edema started 2 weeks after the 2nd vaccine and that she gained 25 kilos  of fluid in a few weeks, from 53 to 80 kilos . She was leading a healthy life. Hopefully this will be sufficient for you Kind regards.   No follow-up attempts are possible. No further information is expected.; Reporter”s Comments: 28Apr2021 Follow-up received: Dear people, my mother died today in the hospital, this week the cardiologist diagnosed heart failure. We don”t know if this started with Pfizer, only that the edema started 2 weeks after the 2nd vaccine and that she gained 25 kilos  of fluid in a few weeks, from 53 to 80 kilos . She was leading a healthy life. Hopefully this will be sufficient for you Kind regards.; Reported Cause(s) of Death: Heart failure; Oedema started at legs, spreads to whole legs, hands; oedema in the legs which spread throughout the legs into the buttocks, lower back Death/ died due to her long persisting heart disease; This is a spontaneous report from a contactable physician downloaded from the regulatory authority, regulatory authority number HU-OGYI-255021.     A 76-year-old female patient received BNT162B2 (COMIRNATY), intramuscular, administered in Arm Left on 20Mar2021 (Batch/Lot Number: EP2166) as 1st dose, 0.3 ml single for COVID-19 immunization. Medical history included mitral stenosis with insufficiency, ischemic heart disease, hypertension, decompensation cardiac and atrial fibrillation. The patient”s concomitant medications were not reported. On 13Apr2021 at 13:35 the patient passed away. The cause of death was due to her long persisting heart disease. It was not reported if an autopsy was performed.  Sender Comment: The causal relationship is unlikely between the suspected drug and the adverse event as the reporter physician assessed the adverse event as related to the patient”s primary diseases. The case is considered serious because the outcome was fatal. Further information is not expected.  Follow-up attempts are completed. No further information is expected.; Reported Cause(s) of Death: cause of death was due to her long persisting heart disease Dyspnea; Coughing; Cardiac failure left; Drug ineffective; COVID-19/COVID-19 PCR test positive; This is a spontaneous report from a contactable physician downloaded from the Agency Regulatory Authority-WEB, regulatory authority number HU-OGYI-254821 reported on 19Apr2021. An 81-year-old male patient received bnt162b2 (COMIRNATY, tozinameran, concentrate for dispersion for injection, COVID-19 mRNA Vaccine embedded in lipid nanoparticles), dose 1 intramuscular, administered in left arm on 19Mar2021 (Batch/Lot Number: EP2166) as first dose, 0.3 mL single, for COVID-19 immunization/for active immunization to prevent COVID-19. Relevant medical history includes myocardial infarction acute, ischemic heart disease, COVID-19 and hypertension from unspecified dates and unknown if ongoing. The patient”s concomitant medications were not reported. On 08Apr2021, the patient”s COVID PCR test was positive. On 15Apr2021 the patient was admitted in the hospital because of coughing and dyspnea which started the day before (14Apr2021). The patient received oxygen therapy as his oxygen saturation was 85% and had severe dyspnea. On 17Apr2021 at 17:45 the patient died. The cause of death were COVID-19 infection and cardiac failure left. The patient underwent lab tests and procedures which included COVID-19 PCR test: positive on 08Apr2021, and oxygen saturation: 85 % on an unspecified date. The patient died on 17Apr2021.  It was not reported if an autopsy was performed. Case was reported as serious, medically confirmed.  Sender Comment: According to the SmPC of Comirnaty, immunity usually develops 14 days after the second dose of the vaccine. The patient received the first dose of Comirnaty on 19Mar2021 and got infected with the virus 20 days after, therefore immunity may not have developed yet without the second dose. Based on the above, the causal relationship is unlikely between the suspected drug and the adverse events. The case is considered serious because the outcome was fatal. Further information is not expected.; Reported Cause(s) of Death: Drug ineffective; Dyspnea; Coughing; COVID-19/COVID-19 PCR test positive; Cardiac failure left Cardiac insufficiency; This is a spontaneous report from a contactable physician downloaded from the Agency Regulatory Authority-WEB, regulatory authority number HU-OGYI-255121.     A 80-years-old female patient received the first dose of BNT162b2 (COMIRNATY), intramuscular, administered in arm left on 25Feb2021 (Lot Number: EP2166) as 0.3 ml single for covid-19 immunisation. Medical history included hyperlipidaemia unknown if ongoing, hypertension unknown if ongoing, peripheral arterial occlusive disease unknown if ongoing, pulmonary embolism from 05Feb2020 to 15Feb2020 (in chronic anticoagulant program). The patient”s concomitant medications were not reported. The patient experienced cardiac insufficiency on 16Mar2021. The patient died on 16Mar2021 at 11:50. The cause of death was cardiac insufficiency. It was not reported if an autopsy was performed. On 16Mar2021 at 11:50 the patient passed away.   Sender Comment: The causal relationship is unlikely between the suspected drug and the adverse event as the reporter physician assessed the adverse event as related to the patient”s primary diseases. The case is considered serious because the outcome was fatal. Further information is not expected.  Follow-up attempts are completed. No further information is expected.; Sender”s Comments: Based on the information available the event cardiac insufficiency is attributed to patient”s multiple underlying medical conditions and assessed unrelated to BNT162b2 (COMIRNATY) vaccine.; Reported Cause(s) of Death: Cardiac insufficiency Vaccination failure; possibility of vaccination failure; cardiac arrest; This is a spontaneous report from a contactable physician downloaded from the Agency-WEB, regulatory authority number HU-OGYI-254921.     An 85-year-old male patient received BNT162B2 (COMIRNATY), intramuscular, administered in Arm Left on 26Feb2021 (Batch/Lot Number: EP2166) as 2nd dose, 0.3 ml single for COVID-19 immunization. Medical history included epilepsy, benign meningioma, stomach cancer, stroke and cholecystectomy. The patient”s concomitant medications were not reported. The patient previously took first dose of BNT162B2 (COMIRNATY) on 04Feb2021 (batch number: EP0725) for COVID-19 immunization. On 13Mar2021 at 13:45, the patient passed away. The cause of death was cardiac arrest. It was not reported if an autopsy was performed. The patient died 15 days after the booster shot, therefore there”s a possibility of vaccination failure, however the reporter physician assessed the adverse event as related to the patient”s primary diseases. The events were assessed as serious-fatal.  Sender Comment: According to the guidelines of Comirnaty, immunity usually develops 14 days after the second dose of the vaccine. The patient died 15 days after the booster shot, therefore there”s a possibility of vaccination failure, however the reporter physician assessed the adverse event as related to the patient”s primary diseases. Based on the above, the causal relationship cannot be excluded between the suspected drug and the adverse event. The case is considered serious because the outcome was fatal. Further information is not expected.  Follow-up attempts are completed. No further information is expected.; Reported Cause(s) of Death: Cardiac arrest Cardiopulmonary insufficiency; This is a spontaneous report from a contactable physician downloaded from the Agency Regulatory Authority-WEB. The regulatory authority number HU-OGYI-253221.     An 81-year-old male patient received BNT162B2 (COMIRNATY; Lot Number: EP2166), intramuscular into the left arm on 18Mar2021 as 0.3 mL, single for covid-19 immunisation.  Medical history included dementia Alzheimer”s type, hypertension and paranoia from an unknown date. Concomitant medications included perindopril arginine (COVEREX AS) taken for hypertension from 07Apr2021 to 13Apr2021; clonazepam (RIVOTRIL) taken for agitation from 07Apr2021 to 13Apr2021; haloperidol (MANUFACTURER UNKNOWN) taken for dementia from 07Apr2021 to 13Apr2021; nebivolol (MANUFACTURER UNKNOWN) taken for hypertension from 07Apr2021 to 13Apr2021; enoxaparin sodium (CLEXANE) taken for thrombosis prophylaxis from 07Apr2021 to 13Apr2021.  On 13Apr2021, the patient experienced cardiopulmonary insufficiency, which was serious as it lead to death. The patient was hospitalized from 07Apr2021 till 13Apr2021. It was reported that the patient did not require hospitalization due to sequelae of the vaccination but rather because of his worsening condition due to his severe Alzheimer”s type dementia. On 13Apr2021 at 23:15,  the patient passed away. According to the patients death certificate, the cause of death was circulatory and respiratory insufficiency.  While hospitalized, the patient received nebivolol, perindopril arginine for hypertension, clonazepam for agitation, haloperidol for dementia and enoxaparin sodim for thrombosis prophylaxis. The patient died on 13Apr2021.  An autopsy was performed and results were not provided.  Sender Comment: The patient received the first dose of Comirnaty on 18Mar2021 and passed away on 13Apr2021 therefore immunity may have not developed yet. The reporter physician also assessed the fatal outcome as not related to the vaccine. Based on the above, the causal relationship is not related between the suspected drug and the adverse event. The case is considered serious because the patient passed away. Further information is not expected.  Follow-up attempts are completed. No further information is expected.; Reported Cause(s) of Death: circulatory and respiratory insufficiency; circulatory and respiratory insufficiency death; This is a spontaneous report from a contactable physician downloaded from the regulatory authority-WEB. The regulatory authority number is HU-OGYI-228821.     An 86-year-old male patient received BNT162B2 (COMIRNATY; Lot Number: EP2166), intramuscular in the left arm on 19Mar2021 as 0.3 mL, single for covid-19 immunisation.  Medical history included ongoing myocardial infarction and ongoing aortic valve stenosis from unknown dates. Concomitant medication included acetylsalicylic acid (MANUFACTURER UNKNOWN) taken for an unspecified indication, start and stop date were not reported.  The patient experienced death on 10Apr2021. The patient died on 10Apr2021.  An autopsy was performed and results were not provided. An autopsy was performed and results were not provided. In the opinion of the patients physician, the death was not related to the vaccination.  Sender Comment: The patient died 22 days after vaccination. Death is not expected adverse event of COMIRNATY. It might be related to the patient”s chronic cardiovascular diseases. Based on the above, and in lack of detailed medical information, relationship between death and COMIRNATY is not assessable. The case is serious because the patient died. No further information is expected.  Follow-up attempts are completed. No further information is expected.; Reported Cause(s) of Death: unknown cause of death Stroke 10 days after of receiving the second dose of the pfizer covid-19 vaccine; This is a spontaneous report from a contactable consumer downloaded from the Agency Regulatory Authority-WEB, regulatory authority number IT-MINISAL02-719979.    An 81-year-old female patient received bnt162b2 (COMIRNATY), dose 2 intramuscular on 26Mar2021 15:44 (Lot Number: EP2166; Expiration Date: 31May2021) as 30 ug, single for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient previously took the first dose of bnt162b2 on 05Mar2021 administered at 16:58 for COVID-19 vaccination. The patient experienced stroke 10 days after of receiving the second dose of the Pfizer covid-19 vaccine on 05Apr2021 15:44. The patient died on an unspecified date due to stroke. It was unknown if an autopsy was performed. The outcome of the event was fatal.  No follow up attempts are possible. No further information is expected.; Reported Cause(s) of Death: stroke suspected COVID-19; suspected COVID-19; weakness; confusion; dyspnoea; This is a spontaneous report from a contactable physician downloaded from the Agency Regulatory Authority-WEB (HU-OGYI-229421).  A 93-year-old male patient received BNT162B2 (COMIRNATY), intramuscularly, on 17Mar2021 (Lot number: EP2166) as 0.3 mL, single for COVID-19 immunisation. The patient”s medical history and concomitant medications were not reported. The patient experienced weakness, confusion, and dyspnoea on 19Mar2021, which were reported as fatal. The patient also experienced suspected COVID-19 on 19Mar2021. Therapeutic measures were taken as a result of the events, which included favipiravir (MANUFACTURER UNKNOWN) from 03Apr2021. The patient died at home on 10Apr2021. The cause of death was assessed as suspected COVID-19 (reported as: unknown cause of death). It was not reported if an autopsy was performed.  Sender”s Comment: Weakness is expected adverse event of COMIRNATY. Confusion and dyspnoea are not expected adverse events. The symptoms started two days after vaccination. They might have been already the symptoms of the patient”s suspected COVID-19. Based on the above, and in lack of detailed medical information, relationship between death and COMIRNATY is not assessable. The case is serious because the patient died. No further information is expected.  No follow-up attempts are possible. No further information is expected.; Reported Cause(s) of Death: suspected COVID-19; suspected COVID-19 Dizziness; Fatigability; Appetite lost; Breathing difficult; diagnosed with SARS-CoV-2 virus infection confirmed by a test on March 16, 2021; This is a spontaneous report from a contactable consumer who is also the patient”s daughter downloaded from the regulatory authority-WEB, regulatory authority number RO-NMA-2021-SPCOV6833-FU1.  A 63-year-old female patient received bnt162b2 (COMIRNATY), dose 1 intramuscular on 07Mar2021 (Batch/Lot Number: EP2166) as SINGLE DOSE (1 DF) for covid-19 immunisation. Medical history included Cancer of head of pancreas (The patient had surgery for a pancreatic head cancer in December 2016). The patient”s concomitant medications were not reported. On 12Mar2021 the patient experienced fatigue/ Fatigability, dizziness, lack of appetite/ Appetite lost, difficult breathing/ Breathing difficult. The events were assessed as serious (hospitalization, fatal). The patient needed hospitalization where she was diagnosed with SARS-CoV-2 virus infection confirmed by a test on March 16, 2021. The patient underwent lab tests and procedures which included sars-cov-2 test: diagnosed with sars-cov-2 virus infection on 16Mar2021 (diagnosed with SARS-CoV-2 virus infection confirmed by a test on March 16, 2021). The patient died on 20Mar2021.  It was not reported if an autopsy was performed.  Sender Comment: Follow up information added on 26-Apr-2021: following investigation of the case, on 22-Apr-2021 it was concluded: it is denied that the death was caused by the post-vaccination reaction; the person was confirmed with COVID-19 infection on 16-Mar-2021 and died on 20-Mar-2021 at the Hospital.  Routine follow-up is not conducted for HA-web reports. No follow-up attempts are needed. No further information is expected. The information about lot number was provided within the initial report. The case was closed for follow-up activities.; Reported Cause(s) of Death: Dizziness; Fatigability; Appetite lost; Breathing difficult On 19Mar2021 she experienced respiratory failure for one day. Oxygen therapy administered. Death followed; This is a spontaneous report from a contactable healthcare professional downloaded from the Agency Regulatory Authority-WEB, regulatory authority number IT-MINISAL02-719569. A 99-year-old female patient received bnt162b2 (COMIRNATY), via an unspecified route of administration on 12Mar2021 (Lot Number: EP2166) as single dose for covid-19 immunisation. The first dose was received in 19Feb2021. Medical history included diabetes mellitus. Concomitant medications included furosemide (LASIX), omeprazole; metformin hydrochloride (METFORMINA ACTAVIS), glyceryl trinitrate (DEPONIT), acetylsalicylic acid (CARDIOASPIRIN), allopurinol (ZYLORIC); all taken for an unspecified indication, start and stop date were not reported. On 19Mar2021 the patient experienced respiratory failure for one day. Oxygen therapy administered. Death followed. The patient died on an unspecified date. It was not reported if an autopsy was performed. Clinical course, therapeutic measures, outcome and additional relevant information: the patient was vaccinated with 1st dose of Pfizer vaccine on 19Feb2021 and with the 2nd dose of Pfizer vaccine on 13Mar2021. On 19Mar2021 she experienced respiratory failure for one day, she was treated with oxygen therapy, then she died. The reporter did not indicate the date of death, therefore further information has been requested in this regard.; Reported Cause(s) of Death: On 19Mar2021 she experienced respiratory failure for one day. Oxygen therapy administered. Death followed Respiratory insufficiency; This is a spontaneous report received from a contactable Other Health Professional downloaded from the Agency Regulatory Authority WEB. The regulatory authority report number is IT-MINISAL02-718863. A 97-year-old female patient received second dose of bnt162b2 (COMIRNATY; Lot Number: EP2166), intramuscularly on 12Mar2021 as single dose for COVID-19 immunisation. The patient”s medical history was not reported. Concomitant medications included atorvastatin calcium (TOTALIP) and clopidogrel bisulfate (PLAVIX). Historical vaccine includes first dose of bnt162b2 (COMIRNATY; Lot Number: EJ6790) on 19Feb2021 for COVID-19 immunization and experienced no adverse effect. The patient experienced respiratory insufficiency on 29Mar2021 for 8 days. It was also reported that the patient was hospitalized on an unspecified date and died due to respiratory insufficiency on an unspecified date.  It was not reported if an autopsy was performed.; Reported Cause(s) of Death: Respiratory insufficiency cardiac arrest (duration of 30 minutes); This is as spontaneous report received from a contactable healthcare professional downloaded from the Regulatory Authority (RA)-WEB. The regulatory authority report number is IT-MINISAL02-718853. A 92-year-old male patient received bnt162b2 (COMIRNATY), dose 2 intramuscular on 13Mar2021 (Lot Number: EP2166) as single dose for covid-19 immunisation. The patient received the 1st dose of bnt162b2 (COMIRNATY; lot number EJ6790) on 19Feb2021 for covid-19 immunization with no adverse reaction reported. The patient medical history was not reported. Concomitant medication included escitalopram oxalate (ESCITALOPRAM ALTER). On 25Mar2021, the patient experienced cardiac arrest (duration of 30 minutes), causing death on 25Mar2021. It was not reported if an autopsy was performed.; Reported Cause(s) of Death: Cardiac arrest Sudden death; Vomited; This is as spontaneous report received from a contactable pharmacist downloaded from the Regulatory Authority-WEB. The regulatory authority report number is ES-AEMPS-836497.  A 92-year-old female patient received the first dose of bnt162b2 (COMIRNATY), intramuscular, administered in the arm on 01Mar2021 (Lot Number: EP2166) as single dose for COVID-19 immunisation. Medical history included allergies to beta-lactam antibiotics, non-smoker, hypertension arterial (HTA) of 10-15 years of evolution, no DM, dyslipidaemia, no known heart disease, no surgical interventions, diverticulosis in colon, iron deficiency anaemia, hiatus hernia, osteoporosis, admission in December 2018 for acute pancreatitis of biliary origin (mild), AF: Not remarkable, Nephrourological history: follow-up in Nephrology Consultation, since 2004 with CKD of unaffiliated aetiology (Creatinine 2mg/dl), usual urinary infections, left renal lithiasis, with nephritic colic (at least 5), expulsion of clear urine, no haematuria, not frothy, and hypercholesterolaemia. Concomitant medications included furosemide (FUROSEMIDA) taken for an unspecified indication from 16Mar2018 to an unspecified stop date; simvastatina taken for hypercholesterolaemia from 04May2007 to an unspecified stop date; lisinopril taken for hypertension from 20Dec2018 to an unspecified stop date; carvedilol taken for hypertension, start and stop date were not reported. On 03Apr2021 (also reported as 03Mar2021) on waking up she was found inert with signs of death (sudden death). It was also reported that the patient vomited on 03Apr2021 (also reported as 02Mar2021), no fever or dyspnoea. 112 was called who administered primperan and prescribed hydration with oral serum for the event vomited. It was explained that it will be self-limited to 24-48 hours as a reaction to the vaccine. The patient died on 03Apr2021. It was not reported if an autopsy was performed. The outcome of the event vomited was unknown and sudden death was fatal.  No follow-up attempts are possible. No further information is expected. Information on lot and batch numbers already obtained.; Reported Cause(s) of Death: Sudden death Cerebral venous thrombosis; This is a spontaneous report from a contactable physician downloaded from a regulatory authority-WEB, regulatory authority number ES-AEMPS-833579. A 45-year-old male patient received the second dose of bnt162b2 (COMIRNATY, lot number: ep2166), intramuscular on 04Mar2021 as a single dose for COVID-19 vaccination. The patient medical history included dyslipidaemia, obesity and paranoid schizophrenia; all from an unknown date. The patient previously received the first dose of bnt162b2 (COMIRNATY, lot number was not reported), intramuscular on 11Feb2021 for covid-19 immunisation. Concomitant medications included topiramate; alopurinol; paliperidona; simvastatin; and sertraline; all were taken for an unspecified indication, start and stop date were not reported. The patient experienced cerebral venous thrombosis on 14Apr2021. The outcome of the event was fatal. The patient underwent lab tests and procedures which included computerised tomogram head abnormal: extensive venous thrombosis and occlusion of DIC with obliteration of cisternae of the base on 14Apr2021. The patient died on an unspecified date. Cause of death was cerebral venous thrombosis. It was unknown if an autopsy was performed.  Case Summary and Reporter”s Comments Text; CEREBRAL VENOUS THROMBOSIS without THROMBOPENIA despite having passed more than 1 month since the last dose.  No follow-up attempts are possible. No further information is expected.; Reporter”s Comments: CEREBRAL VENOUS THROMBOSIS without THROMBOPENIA despite having passed more than 1 month since the last dose.; Reported Cause(s) of Death: Cerebral venous thrombosis CEREBRAL HEMORRHAGE; new-onset headaches and was very tired and exhausted; new-onset headaches and was very tired and exhausted; blood pressure systolic: 220 mmhg on 12Apr2021 (Measured by the GP), and 150 mmhg on 12Apr2021 (Blood pressure measured on arrival at hospital).; This is a spontaneous report from a contactable physician downloaded from the Agency Regulatory Authority-WEB, regulatory authority number NO-NOMAADVRE-FHI-2021-Uxz3gm. An 85-year-old female patient received the second dose of BNT162B2 (COMIRNATY, Lot Number: EP2166) intramuscularly on 25Feb2021 at single dose for COVID-19 immunisation. The patient”s medical history and concomitant medications were not reported. The patient had previously received the first dose of BNT162B2 (COMIRNATY, batch number unknown) on 04Feb2021 for COVID-19 vaccination. On 12Apr2021, the patient developed cerebral hemorrhage. Relevant laboratory findings and investigations included blood pressure systolic: 220 mmHg on 12Apr2021 (Measured by the GP), and 150 mmHg on 12Apr2021 (Blood pressure measured on arrival at hospital). The primary reporter stated that she was unsure of the causal link between vaccination and cerebral hemorrhage and pointed out that for this patient a hypertensive hemorrhage was also a possibility. The doctor further wrote that the patient after vaccination (2021) experienced new-onset headaches and was very tired and exhausted. The condition became acutely worse on 12Apr2021 and the patient was hospitalized on 12Apr2021. The patient died on 14Apr2021 for cerebral hemorrhage. It was not reported if an autopsy was performed. The outcome of other events was unknown. The case was considered to be Serious. The Regulatory Authority has assessed the causal relationship between the suspect product and the cerebral hemorrhage as Possible.   No follow-up attempts are possible. No further information is expected.; Reported Cause(s) of Death: CEREBRAL HEMORRHAGE Lung infection; Decreased appetite; This is a spontaneous report from a contactable consumer downloaded from the regulatory authority-WEB. The regulatory authority report number is FR-AFSSAPS-BX20213276 with safety report unique identifier FR-AFSSAPS-2021039850.   A 71-year-old male patient received the second dose of BNT162B2 (COMIRNATY, lot number EP2166), intramuscularly administered in the left arm on 26Feb2021 at a single dose for covid-19 immunization. Medical history included non-insulin-dependent diabetes mellitus and, cancer of lung – “treatment in progress, if any, not specified”. The patient has not had covid-19. The patient”s concomitant medications were not reported. The patient experienced decreased appetite on 27Feb2021 with outcome of not recovered. At 1 month of vaccination, on 26Mar2021, the patient had lung infection with aggravation and hospitalization for 15 days (from an unspecified date in 2021 to an unspecified date in 2021) – the outcome was fatal. It was also reported “death of the patient – cause unknown” (pending clarification). The patient died on an unspecified date in 2021. It was unknown if an autopsy was performed. The patient has not been tested for covid-19 since the vaccination.   Imputation made without prejudice to the elements of investigations which could be carried out within the framework of legal or amicable compensation procedures.; Reported Cause(s) of Death: lung infection Fever; Confusion; large intracranial haemorrhage; This is a spontaneous report from a contactable physician downloaded from the Agency Regulatory Authority-WEB, regulatory authority number SE-MPA-2021-025067 and Sender”s (Case) Safety Report Unique Identifier SE-VISMA-1617714989586.  A 75-year-old female patient received the second dose of BNT162B2 (COMIRNATY; lot number: EP2166), via an unspecified route of administration on Mar2021 at single dose for COVID-19 immunisation. The patient”s medical history included chronic atrial fibrillation, cardiac failure right, sleep apnoea syndrome, chronic obstructive pulmonary disease, all ongoing. The patient”s concomitant medications were not reported. The patient previously received the first dose of BNT162B2 (COMIRNATY) on an unspecified date for COVID-19 immunization. The patient experienced large intracranial haemorrhage on an unspecified date; fever and confusion on Mar2021 and was hospitalized. The patient underwent lab tests and procedures which included CT of the brain: extracranial haematoma on an unspecified date. The patient died on an unspecified date due to large intracranial haemorrhage. It was not reported if an autopsy was performed. The outcome of the events fever and confusion was unknown. Report was assessed as serious, hospitalization. The clinical course was reported as follows: Reported suspected adverse events were confusion and fever. Vaccination with dose 2 in Mar2021 and the next day the woman developed fever and confusion. She was hospitalised a day later, had fallen at home and a CT of the brain was performed, showing only extracranial haematoma. The woman was discharged after 4 days in the hospital but had a remaining tendency to fall. 19 days after the vaccination debut of expressive aphasia and paresis of the right arm and leg, arrived at emergency care. Had a large intracranial haemorrhage and died 2 days later. This was not reported as suspected adverse events.  No follow-up attempts are possible. No further information is expected.; Reported Cause(s) of Death: large intracranial haemorrhage Infarct myocardial; This is a spontaneous report from a contactable physician downloaded from the Agency Regulatory Authority FR-AFSSAPS-PO20211727 and received via Regulatory Authority.  An 84-year-old male patient received the second dose of BNT162B2 (COMIRNATY) via Intramuscular on 03Mar2021 left arm at single dose (Lot EP2166) for COVID-19 immunisation. Medical history included fitted sleep apnea syndrome, moderate arterial hypertension, glaucoma, onset of non-Alzheimer”s memory disorder, had a myocardial scintigraphy for chest pain on 18Jan2019 without specificity, has not seen the cardiologist since, had a Brain MRI: deficiency in the central nucleus which may correspond to an old TIA (Transient ischemic attack), did not have the Covid. Concomitant medications included long term with Atorvastatin 10 mg / day, indapamide, perindopril arginine (BIPRETERAX [INDAPAMIDE;PERINDOPRIL ARGININE]) 5, acetylsalicylic acid, ascorbic acid (ASPIRIN [ACETYLSALICYLIC ACID;ASCORBIC ACID]) 100, and acetylleucine (TANGANIL)100. The patient previously received the first dose of BNT162B2 (COMIRNATY) for COVID-19 immunisation, presented a small rash on the first injection that he did not want to report waiting for information from cardiology intensive care. On 04Mar2021 of a severe myocardial infarction supported by intensive cardio care death on 07Mar2021 at 5:45 a.m. No autopsy was done. Outcome of the event was fatal.  No follow-up attempts possible. No further information expected.; Reported Cause(s) of Death: Infarct myocardial severe form of COVID; vaccination failure; This is a spontaneous report from a contactable physician downloaded from the Agency Regulatory Authority-WEB, regulatory authority number FR-AFSSAPS-PA20210461. Safety Report Unique Identifier FR-AFSSAPS-2021036800.   A 93-years-old male patient (Husband of a resident) received bnt162b2 (COMIRNATY), dose 2 intramuscular on 05Mar2021 (Batch/Lot Number: EP2166) as 0.3 ml, single, dose 1 via an unspecified route of administration on 09Feb2021 (Batch/Lot Number: EJ6795) as single dose for covid-19 immunisation. Medical history included Chronic obstructive pulmonary disease, Cardiac insufficiency, Hypertension arterial. No previous history of covid. Concomitant medication included fluindione (PREVISCAN [FLUINDIONE]); rosuvastatin calcium (CRESTOR); atenolol (ATENOLOL), Izaar. The patient had good tolerance for the first dose. The patient experienced severe form of covid and vaccination failure on 23Mar2021, which required hospitalization in Mar2021 and death on 26Mar2021. Clinical detail was reported as: the patient had respiratory symptoms about 7/8 days after the second dose of vaccine which the patient neglected. Then he presented with asthenia, fever and respiratory discomfort around 15 March 2021. He was hospitalised following his visit to the emergency room and died on 26 March 2021 of a severe form of COVID (65% invasion on the thoracic scan). The PCR done on 23Mar2021 showed an variant. IN TOTAL, severe SARS COV2 infection variant B117 resulting in the death of an elderly man with a risk factor for developing a severe form of the disease. The patient underwent lab tests and procedures which included thoracic scan: severe form of COVID (65% invasion on the thoracic scan) on Mar2021, Covid-19 PCR test: positive on 23Mar2021 variant. The patient died on 26Mar2021. An autopsy was not performed.  NB: Imputation made “without prejudice to the elements of investigation which could be carried out within the framework of legal or amicable compensation procedures”. Reported Cause(s) of Death: SEVERE FORM OF COVID Death; found dead in bed; Fallen and hit his head; Fallen and hit his head; This is a spontaneous report downloaded from the regulatory authority (Regulatory Authority Report Number: SE-MPA-2021-023862).  A contactable physician reported that a 77-year-old male patient received BNT162B2 (COMIRNATY; Lot Number: EP2166) at the age of 77 years, intramuscular, in Mar2021, at a single dose, for COVID-19 immunization. The patient”s medical history included heart failure. The patient”s concomitant medications included furosemide (FURIX), atorvastatin, acetylsalicylic acid (TROMBYL), spironolactone, sertraline, enalapril, and metoprolol. The reported suspected adverse reaction was death. In Mar2021, the patient had fallen some day before he died and had hit his head. In Mar2021 the patient was found dead in bed 3 days after the vaccination (Mar2021). In conversations with the physician, he informs that an autopsy will not be performed. The outcome of event reported as “Death; found dead in bed”,  fatal, the outcome of the other events was unknown.   No follow-up attempts are possible. No further information is expected.; Reported Cause(s) of Death: Death; found dead in bed Death from natural causes; This is a spontaneous report from a contactable physician downloaded from the regulatory authority PT-INFARMED-B202103-2360. A 97-year-old male patient received (COVID-19 mRNA vaccine (with modified nucleoside) (Comirnaty), concentrate for dispersion for injection, 30 mcg/0.3 ml, batch EP2166, CAUL: 09621, dose of 0.3 ml) intramuscular as a single dose for COVID-19 immunization. Medical history included cardiac heart insufficiency; 1.5 L / min long duration supplementary oxygen for unknown respiratory condition with pulmonary hypertension. Concomitant medications were unknown. The patient died 15 days after the administration of the suspected vaccine. The reported cause of death was “death by natural causes”. The patient had emergency medical care and was hospitalized. Oxygen therapy (1.5 L / min) was required due to unknown respiratory disease with pulmonary hypertension. There is also reference to previous heart failure. The Reporter is unaware of the usual medication of the patient. Outcome of ADR: Death. Relatedness of drug to reaction(s)/event(s): Source of assessment: Reporter Method of assessment: unknown, Result of Assessment: improbable.  No follow-up attempts possible. No information expected.; Reporter”s Comments: Concomitant Medication-Unknown Did a Medication Error occur? -No Other information-Previous cardiac heart insufficiency; 1.5 L / min long duration supplementary oxygen for unknown respiratory condition with pulmonary hypertension; Reported Cause(s) of Death: Death from natural causes Bacterial infection/Sepsis shock; Fever; not feeling well; This is a spontaneous report from a contactable consumer. A 60-year-old male patient (father of the reporter) received the first dose of BNT162B2 (COMIRNATY) via an unspecified route of administration in the left arm on 05Mar2021 at 13:00 (at the age of 60-year-old) (Lot Number: EP2166) as single dose for COVID-19 immunisation. Relevant medical history included multiple blood infections and chronic blood infections, paralysis from 1997 (paralyzed for 23 years), bed sores, bacterial problems, general physical health deterioration (the patient was paralyzed and not in the best health shape) and iodine allergy. Concomitant medications were not reported. The patient died 3 days after receiving the vaccine. He had a blood infection and the doctor decided that it was ok to give him the vaccine. He had a fever and was not feeling well on 05Mar2021. The patient was hospitalized for the events. The patient died on 08Mar2021. An autopsy was not performed. The patient did not receive corrective treatments. The reporter commented that his dad was paralyzed and not in the best health shape and he was not sure why was he given the vaccine. The doctor told the reporter that he died from bacterial infection and the cause of death was septic shock (onset date 05Mar2021).; Reported Cause(s) of Death: Sepsis Shock Chest pain; ST-T segment elevation; This is a spontaneous report downloaded from the Agency Regulatory Authority-WEB (Regulatory Authority report number: SE-MPA-2021-024468). A contactable physician (contactable through Regulatory Authority only) reported that an 84-year-old female patient received BNT162B2 (COMIRNATY, Lot number: EP2166; Expiration date was not reported), intramuscular in Mar2021 as a single dose for COVID-19 immunization. Medical history included essential hypertension and hypothyroidism; both were unknown if ongoing. The patient”s concomitant medications were not reported. In Mar2021, 8 days after the vaccination, the patient had chest pain. The patient did not seek medical attention, then called the health center a week later, and was referred to the emergency room. The patient”s electrocardiogram (ECG) in Mar2021 ST-T segment elevation. The patient had underwent percutaneous coronary intervention for the reported events. The patient had died on an unspecified date in 2021 after two days of hospitalization. It was unknown if an autopsy was performed.  No follow-up attempts are possible. No further information is expected.; Reported Cause(s) of Death: Chest pain; ST-T segment elevation sudden death; This is a spontaneous report from a contactable physician downloaded from the Agency Regulatory Authority-WEB, regulatory authority number FR-AFSSAPS-NT20210907.  A 65-year-old male patient received first dose of bnt162b2 (COMIRNATY, solution for injection, lot: EP2166), intramuscular on 10Mar2021 as single dose for covid-19 immunisation. Medical history included chronic kidney disease stage V (with hemodialysis), chronic hemodialysis, peripheral arterial occlusive disease (multi-stented PAD), ischaemic heart disease (triple coronary bypass grafting with complications) and valvular heart disease (calcified aortic stenosis tight). Concomitant medications included atorvastatin; bisoprolol; clopidogrel; sodium polystyrene sulfonate (KAYEXALATE); levothyroxine; calcium carbonate (OROCAL); pantoprazole; paracetamol; sevelamer carbonate (RENVELA); folic acid (SPECIAFOLDINE); glyceryl trinitrate (TRINITRIN); alfacalcidol (UN ALFA) and warfarin. The patient did not have Sars-CoV2 infection. The physician reported sudden death of the patient in a few minutes while preparing to come to his dialysis session on 24Mar2021. He was 14 days after a first dose of bnt162b2 and had a significant cardiovascular history. The patient died on 24Mar2021. It was unknown if autopsy was performed.  No follow-up attempts are possible. No further information is expected.; Reported Cause(s) of Death: sudden death cardiac arrest; COVID-19 infection; fever (39 degrees Celsius); This is a spontaneous report from a contactable physician downloaded from a regulatory authority-WEB, regulatory authority number GR-GREOF-20211826. A 75-year-old male patient received bnt162b2 (COMIRNATY), dose 1 intramuscularly on 09Mar2021 (Batch/Lot Number: EP2166) at 75-years-old as 0.3 mL, single for COVID-19 immunization. Medical history included chronic dyslipidaemia from an unknown date and unknown if ongoing, unregulated arterial hypertension from an unknown date and unknown if ongoing, very high Body Mass Index (BMI) increased from an unknown date and unknown if ongoing, mild symptoms of infection of the upper respiratory tract from 05Mar2021 to an unknown date. Concomitant medications included rosuvastatin (MANUFACTURER UNKNOWN) taken for dyslipidaemia, start and stop date were not reported. On 09Mar2021, the patient experienced: fever (39 degrees Celsius) (non-serious), cardiac arrest (death, medically significant), COVID-19 infection (death, medically significant), death (as reported) (death, medically significant). The clinical course was reported as follows: According to the reporter, the patient on the day of the vaccination did not report any acute symptoms while he was providing his medical history, neither any allergies. The patient just reported the chronic dyslipidaemia treatment. It was the first dose of the vaccine COMIRNATY and the patient remained in the vaccination center for 15 minutes according to the guidelines; without presenting any symptoms. On 16Mar2021, the patient”s son, called the reporter to declare the death of his father. The patient”s son stated that the patient had a fever the same day of the vaccination and passed away approximately six hours later. A close relative was found positive with SARS-CoV-2 on 13Mar2021; and on the day of the report was still hospitalized. The patient was “buried after the death certificate from a private physician.” On 18Mar2021, the patient”s son was contacted, who was also a physician. According to the patient”s son, his father had unregulated arterial hypertension, dyslipidaemia and very high Body Mass Index (BMI) (weighed 110 kilograms for over 40 years with 170 cm height). The patient, four days before his vaccination, had mild symptoms of infection of the upper respiratory tract (mild cough, sniffle and sore throat). On 09Mar2021, the patient was vaccinated and three hours later presented high fever (39 degrees Celsius). The patient three hours later died. The patient”s son stated that the physician who examined his father told him that he found representative data of cardiac arrest and the cause of death was cardiac arrest. Three days later, the patient”s wife was found positive with COVID-19 infection and was hospitalized.  According to the patient”s son”s opinion, his father died from COVID-19 infection, even though the patient had not tested positive. The patient underwent lab tests and procedures which included body temperature: 39 Centigrade on 09Mar2021.  The clinical outcome of the events: cardiac arrest, COVID-19 infection, death, was fatal. The clinical outcome of the event fever (39 degrees Celsius), was unknown. The patient died on 09Mar2021 due to cardiac arrest, death, COVID-19 infection (according to the patient”s son).  It was unknown if an autopsy was performed.   The causality assessment from the a regulatory authority for vaccines was unlikely; Method of assessment: a regulatory authority causality criteria.  No follow-up attempts are possible. No further information is expected. ; Reported Cause(s) of Death: COVID-19 infection; Cardiac arrest Death unexplained; This is a spontaneous report from a contactable physician downloaded from the Agency Regulatory Authority -WEB, regulatory authority number FR-AFSSAPS-RN20210986.  A 93-year-old male patient received the first dose of BNT162B2 (COMIRNATY, Lot Number: EP2166), intramuscular, administered in left arm on 03Mar2021 as single dose for COVID-19 immunization. Medical history included hypertension, mild cognitive impairment and, prostate cancer from an unknown date. Long-term treatment not reported. No history of allergy was reported. No history of COVID-19 was reported. Concomitant medications were not reported. On 24Mar2021 during the night, unexpected sudden death without prodrome, nocturnal, suggestive of embolism or cardiac accident without further information. Given the time of death and the uncertainty of the diagnosis and age, no examination was carried out and no autopsy was requested. The patient underwent lab tests and procedures which included COVID-19 virus test: unknown results on an unknow date. The patient died on 24Mar2021. An autopsy was not performed.  No follow-up attempts is possible. No further information is expected.; Reported Cause(s) of Death: Death unexplained Cardio-respiratory arrest; Difficulty breathing and speaking; Extreme tiredness; Appetite loss; Difficulty breathing and speaking; Swollen legs; This is a spontaneous report from a contactable consumer. An 86-year-old female patient received first dose of bnt162b2 (COMIRNATY), via an unspecified route of administration on 24Feb2021 (Lot Number: EP2166) at 0.3 mL, single for covid-19 immunisation. The vaccine was administered at a Clinic. The patient”s medical history and concomitant medications were not reported. According to the reporting consumer, the patient was healthy without any known diagnosed pathologies. It was unknown if the patient had an allergies to medications, food, or other products. The patient didn”t receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. On 25Feb2021, the patient experienced extreme tiredness, appetite loss, difficulty breathing and speaking and swollen legs. No treatment was received for the adverse events. On 25Mar2021, the patient was deceased. The reported cause of death was cardio-respiratory arrest, tiredness, appetite loss, difficulty breathing and speaking and swollen legs. The patient died on 25Mar2021. An autopsy was not performed.; Reported Cause(s) of Death: Difficulty breathing and speaking; Cardio-respiratory arrest; Extreme tiredness; Appetite loss; Difficulty breathing and speaking; Swollen legs SUDDEN DEATH; collapsed outdoors due to cardiac arrest; collapsed outdoors due to cardiac arrest; This is a spontaneous report from a contactable physician downloaded from the regulatory authority, regulatory authority number SE-MPA-2021-021651.  An 86-year-old male patient received bnt162b2 (COMIRNATY), intramuscular on Mar2021 (Batch/Lot Number: EP2166) as single dose for covid-19 immunisation. Medical history included hypertension, ulcerative colitis, chronic ischemic heart disease, unspecified, and hyperlipidaemia. Concomitant medications included acetylsalicylic acid (TROMBYL), prednisolone for ulcerative colitis, metoprolol, and candesartan. The patient experienced sudden death on Mar2021. The patient was at the outpatient care center for dressing a wound, good healing after light trauma and he was unaffected and well during the visit. Later, a relative reported that the day after the vaccination (Mar2021), the patient had collapsed outdoors due to cardiac arrest. An ambulance was called but the man”s life could not be saved. The patient died on Mar2021 due to sudden death. The outcome of the other events was unknown. No autopsy will be performed.   No follow-up attempts possible. No further information expected.; Reported Cause(s) of Death: Sudden death unknown cause of death; Intraventricular haemorrhage; Vertiginous disorder; Vomiting; This is a spontaneous report from a contactable  Physician downloaded from the regulatory authority-WEB  IT-MINISAL02-701252 This is a report received from the Regulatory Authority.    This 83-year-old male patient received BNT162B2 (COMIRNATY, lot number: EP2166, lot expiry (31May2021)), single dose, dose 1 via intramuscular route of administration in the right arm on 06Jan2021 at 10:00 AM at the age of 83 years-old) for COVID-19 vaccination. Medical history included nephrectomy. Concomitant medications were not reported. On 12Mar2021, the patient experienced vertigo, vertiginous disorder and vomiting occurring within minutes after administration of COVID-19 vaccine. On 12Mar2021, acute tetraventricular haemorrhage is documented following cerebral computerized tomography (without DCS). The patient was hospitalized for vertigo, vertiginous disorder, intraventricular haemorrhage and vomiting. The outcome of vertigo, vertiginous disorder, intraventricular haemorrhage and vomiting was reported as fatal. The patient died of an unknown cause on 16Mar2021. The stop date of vertigo, vertiginous disorder, intraventricular haemorrhage, unknown cause of death and vomiting It was unknown if an autopsy was performed.   Reporter”s comments: Reported episode of malaise with mild dizziness and alimentary vomiting occurring a few minutes after the administration of vaccine for COVID-19 (PFIZER-BIONTECH). Acute tetraventricular haemorrhage is documented.  Sender”s comments: Asked for follow-up from the referring doctor, he reports that the patient on 16Mar2021 was still hospitalized in intensive care in a pharmacological coma.  Reporter”s comment: Died on 16Mar2021. Autopsy reports not yet available.  Sender”s comment: Following a new request for follow-up, the reporter, together with reporting the patient”s death on 16Mar2021, provides clinical documentation, which is attached.  No follow-up attempts possible. No further information expected.  Follow-up (29Mar2021): This is a follow-up report received from a contactable physician downloaded from the regulatory authority-WEB  IT-MINISAL02-701252 This is a report received from the Regulatory Authority. New information included: autopsy information(unknown), the new outcome of the all events: fatal with newseriousness criterium: death.   Follow-up (01Apr2021): This is a follow-up report received from contactable physician downloaded from the regulatory authority-WEB  IT-MINISAL02-701252. This is a report received from the Regulatory Authority. New information includes: The day of death (16Mar2021) and the stop date for all events (16Mar201).; Reporter”s Comments: Reported episode of malaise with mild dizziness and alimentary vomiting occurring a few minutes after the administration of vaccine for covid-19 (pfizer-biontech). Acute tetraventricular haemorrhage is documented. Died on 16Mar2021. Autopsy reports not yet available.; Reported Cause(s) of Death: Intraventricular haemorrhage; Vertiginous disorder; Vomiting; unknown cause of death Pulmonary embolism; This is a spontaneous report from two contactable physicians downloaded from the regulatory authority-WEB, regulatory authority numberSE-MPA-2021-019669. Other Case identifier number: SE-MPA-1615871445349. An 82-years-old male patient received bnt162b2 (COMIRNATY), via an unspecified route of administration on Mar2021 (Batch/Lot Number: EP2166) as single dose for covid-19 immunisation. Medical history included widespread prostate cancer, heart failure, hypertension, diabetes. The patient”s concomitant medications were not reported. It can be deduced from the reports that the man was vaccinated 4-5 days before the diagnosis of pulmonary embolism. The man dies shortly after the pulmonary embolism is discovered. Cause of death is not specified in the report. It was not reported if an autopsy was performed.  No follow-up attempts possible. No further information expected.; Reported Cause(s) of Death: unknown cause of death two cerebral hemorrhages; fell unconscious; This is a spontaneous report received from a contactable consumer downloaded from the Agency Regulatory Authority-WEB, regulatory authority report number is SE-MPA-2021-022425.  A 75-year-old male patient received BNT162B2 (COMIRNATY, solution for injection), dose 2 via an unspecified route of administration on Feb2021 (Batch/Lot Number: EP2166) as single dose for COVID-19 immunisation.  Medical history included dementia alzheimer”s type and atrial fibrillation. The patient”s concomitant medications was anticoagulant, unspecified which. The patient previously took BNT162B2 (COMIRNATY, solution for injection, lot number: EJ6134), dose 1 in Jan2021 for COVID-19 immunisation. The patient experienced two cerebral heamorrhages one day after dose 2 which conflicts with submitted onset date of four days before dose 2. The man was found outside his home and transported to hospital, upon arrival he was conscious and able to state his date of birth/social security number but then fell unconscious. He remained unconscious until his death a few days later. The reporter writes that the man was in good health and walked every day. The patient died on an unspecified date in 2021.  It was not reported if an autopsy was performed.  No follow-up attempts are possible. No further information is expected.; Reported Cause(s) of Death: two cerebral hemorrhages; fell unconscious possible cause of possible arrhythmia; possible cause of deteriorating general condition; she collapsed; felt a little bad; felt tired; This is a spontaneous report from a contactable physician downloaded from the Agency Regulatory Authority-WEB, regulatory authority number SE-MPA-1615363791551.     An 84-year-old female patient received bnt162b2 (COMIRNATY), intramuscular on Mar2021 (Batch/Lot Number: EP2166) as SINGLE DOSE for covid-19 immunisation. Medical history included cardiac failure. The patient”s concomitant medications were not reported. In Mar2021, Possible cause of deteriorating general condition and possible arrhythmia was reported. After the vaccination, the patient felt a little bad and felt tired. The next day at 15:00, she collapsed. RLS 8 CPR started, narrow QRS complexes and ROSC (return of spontaneous circulation) are detected after 6min. DT (Diffusion tensor imagining) brain and angio as well as MRI only show age insults/infarcts. Shows a general slowdown. Neurological status improved, at best RLS 4. Echocardiography shows similar picture as before, possibly increased hypokinesia septally. Doubled NTproBNP and Troponin release. Extubated but hypercapne, inability to keep airways clear. The woman passing away about a week after arrival at hospital. It does not appear from the report whether the woman had any other contemporary medicines. The patient underwent lab tests and procedures which included angiogram: age insults/infarcts, echocardiogram: hypokinesia, possibly increased hypokinesia septally, magnetic resonance imaging: age insults/infarcts, n-terminal prohormone brain natriuretic peptide: doubled release, troponin: doubled release. It was not reported if an autopsy was performed. The patient died on an unspecified date. The outcome of the events felt a little bad, felt tired, and collapsed was not unknown. The events possible cause of possible arrhythmia, and possible cause of deteriorating general condition were fatal.   No follow-up attempts possible. No further information expected. Information on lot and batch numbers already obtained.; Reported Cause(s) of Death: possible cause of deteriorating general condition; possible cause of possible arrhythmia death; This is as spontaneous report received from a contactable physician downloaded from the Agency Regulatory Authority-WEB. The regulatory authority report number is PT-INFARMED-T202103-936.  A 91-year-old male patient received the first dose of BNT162B2 (COMIRNATY), intramuscular on 01Mar2021 (lot number: EP2166) at 0.3 mL, single for COVID-19 immunisation. The patient”s medical history and concomitant medications were not reported. The patient died on 10Mar2021 (9 days after the vaccine administration). The event was reported to have lasted about 1 minute, but the circumstance of death was not known. No drug-drug interaction or medication error was suspected. It was not reported if an autopsy was performed.  Relatedness of drug to reaction(s)/event(s): Death: Source of assessment: Notifier, Method of assessment: Unknown, Result of Assessment: Unlikely.  No follow-up attempts are possible. No further information is expected.; Reported Cause(s) of Death: death Other unspecified not fully defined and not complete cause of death; Sick of fever 39 degrees Celsius a day later; Decreased general condition; wheezing; rising blood pressure; decreased saturation; This is a spontaneous report from a contactable physician regulatory authority number SE-MPA-2021-019693. A 77-year-old male patient received bnt162b2 (COMIRNATY, lot number: EP2166), intramuscular on Mar2021 as 0.3 mL, single for covid-19 immunisation. The patient medical history included multiple system atrophy, Parkinson”s type MSA-P; hypertension and previous myocardial infarction; all from an unknown date and unknown if ongoing. On March 2020, the patient had a Covid-19 infection and unknown if ongoing. The patient”s concomitant medications were not reported. The reported events were other incompletely defined and unspecified causes of death on Mar2021. Clinical course reported as the patient was vaccinated with Comirnaty on March 2021. Sick of fever 39 degrees Celsius a day later. Decreased general condition, wheezing, rising blood pressure and decreased saturation. Died at night between days 4 and 5 after the vaccine was given. The outcome of sick of fever 39 degrees Celsius a day later, decreased general condition, wheezing, rising blood pressure and decreased saturation was unknown. Outcome of the unknown cause of death was fatal. Cause of death was unknown. The patient died on Mar2021. Autopsy will not be performed.  No follow-up attempts possible. No further information expected.; Reported Cause(s) of Death: Unknown cause of death Intracerebral haemorrhage; Subarachnoid haemorrhage; This is a spontaneous report from contactable physicians downloaded from the Agency Regulatory Authority, regulatory authority number SE-MPA-2021-019656. Other unique identifier SE-MPA-1615884879618.  A 74-year-old female patient received the first dose of bnt162b2 (COMIRNATY), intramuscular on Mar2021 (Batch/Lot Number: EP2166) as single dose for COVID-19 immunization. Medical history included hypertension, lung sarcoid, sleep apnea, asthma, and middle cerebral artery aneurysm from an unknown date. Concomitant medication included paracetamol (ALVEDON) from 20Mar2018 to an unspecified date; urea (CANODERM) from 09Oct2019 to an unspecified date; candesartan cilexetil (CANDESARSTAD) from 06Jun2020 to an unspecified date; fluticasone propionate (FLUTIDE) from 19Mar2018 to an unspecified date; sterculia urens gum (INOLAXOL N) from 20Mar2018 to an unspecified date; metoprolol from 29May2020 to an unspecified date; bendroflumethiazide (SALURES) from 27Feb2021 to an unspecified date; mucopolysaccharide polysulfuric acid ester (HIRUDOID) from 19Mar2018 to an unspecified date; and salbutamol sulfate (VENTOLINE) from 19Mar2018 to an unspecified stop date. The patient previously took doxazocin and experienced unspecified previous drug reaction. In Mar2021, it was reported that three days after the vaccination with Comirnaty the patient arrived at the emergency room with RLS 8, no spontaneous breathing, had a laryngeal mask and weak peripherals pulses. The patient was found unconscious in her home after an alert from a friend. She had stable vital parameters but RLS 8 and did not respond to pain stimulation, large dilated pupils that did not respond to light. High suspicion of cerebral event why the patient went directly to the CT brain scan which confirmed a large parenchymal hemorrhage frontotemporal left side and large amounts of subarachnoid hemorrhage and significant mass effect with midline excess. Not considered to be in question for neurosurgical evacuation due to the large intracerebral hemorrhage, already signs of entrapment and poor prognosis. The patient was taken to the Intensive care unit to investigate whether she was possibly a candidate for organ donation, but it appeared later that she had declined this. Relatives were informed of the patient”s condition. Renewed clinical examination showed that the patient had no cerebral activity and was pronounced dead at midnight and the respirator was turned off. The reporter had no/very low suspicion of connection with the vaccination. It was assessed as a large intracerebral bleeding, probable rupture of previously known aneurysm. The patient died on an unspecified date. It was not reported if an autopsy was performed.  No follow-up attempts are possible. No further information is expected.; Reported Cause(s) of Death: Intracerebral haemorrhage; Subarachnoid haemorrhage fever of 38.5 ? C; Edema upper limb; edema of vaccination arm; Oedema face; Hypotension; Tachycardia; Death unexplained; This is a spontaneous report from a contactable physician downloaded from the regulatory authority. The Regulatory Authority report number is FR-AFSSAPS-NT20210622.  A 92-year-old male patient received bnt162b2 (COMIRNATY), dose 2 intramuscular, administered in Arm Right on 04Mar2021 14:00 (Batch/Lot Number: EP2166) as single dose for Covid-19 immunization. The patient received the first dose of Comirnaty on an unspecified date for Covid-19 immunization (unremarkable). Medical history included Covid-19 infection confirmed with positive PCR on 04Oct2020; ischaemic stroke, and type 2 diabetes mellitus: both from an unknown date and unknown if ongoing; No allergic history. Concomitant medications included bisoprolol, furosemide, acetylsalicylate lysine (KARDEGIC), metformin, alfuzosin hydrochloride (ALFUSIN), silodosin, finasteride, pantoprazole, ropinirole, alprazolam, oxazepam, zopiclone, mirtazapine, and olanzapine; all taken for an unspecified indication, start and stop date were not reported. It was reported that the patient was living in an institution (GIR score 3) and vaccinated with a second dose of Comirnaty on 04Mar2021 at 2 pm. There was a post-vaccination surveillance for 20/30 minutes which was unremarkable. The next morning “around 8 a.m.” (05Mar2021) when waking up (H + 19), the patient was found with a fever of 38.5 ?C, edema of the face and of the vaccinated arm, “hypotension of 9/5″ and tachycardia. It was decided to hospitalize the patient, but the latter dies before the ambulance arrives, that is to say in less than an hour after the discovery of the first symptoms. The outcome of events was fatal. The patient died on 05Mar2021. It was unknown if an autopsy was performed.   No follow-up attempts are possible. No further information is expected.; Reported Cause(s) of Death: Death unexplained; Edema upper limb; Fever; Oedema face; Hypotension; Death unexplained; Tachycardia SEPSIS; EMBOLISM MESENTERIC; MESENTERIC ISCHEMIA/acute on chronic mesenteric ischemia with necrosis of the small intestine; MESENTERIC ISCHEMIA/acute on chronic mesenteric ischemia with necrosis of the small intestine; acute on chronic mesenteric ischemia with necrosis of the small intestine; DIARRHEA; REDUCED GENERAL CONDITION; FALLING DOWN; This is a spontaneous report from a contactable physician downloaded from the Regulatory Authority. Regulatory authority report number NO-NOMAADVRE-FHI-2021-Uj3g9z, Safety Report Unique Identifier NO-NOMAADVRE-E2B_00022624.  An 86-years-old female patient received the second dose of BNT162B2 (COMIRNATY; lot number: EP2166), via unspecified route of administration on 26Feb2021 at a single dose for COVID-19 immunization. Medical history included Chronic Mesenteric Ischemia. The patient”s concomitant medications were not reported. On 27Feb2021, the patient experienced diarrhea, reduced general condition, and ”falling down”. On 01Mar2021, the patient developed sepsis, embolism mesenteric, mesenteric ischemia. On the same day, abdominal CT confirmed acute on chronic mesenteric ischemia with necrosis of the small intestine. The patient was admitted to hospital from 01Mar2021 to an unspecified date due to sepsis, embolism mesenteric, mesenteric ischemia/acute on chronic mesenteric ischemia with necrosis of the small intestine. On an unspecified date in Mar2021, gastrointestinal surgery was performed and only 40 cm of viable intestines were found and this was not compatible with life. The patient died in Mar2021 due to sepsis, embolism mesenteric, and mesenteric ischemia/acute on chronic mesenteric ischemia with necrosis of the small intestine. The outcome of the other events was unknown. It was not reported if an autopsy was performed.  Sender Comment: The report applies to a patient who got diarrhea, reduced general condition and fell at home the day after the second dose of COMIRNATY. On 01Mar2021, the patient was hospitalized due to sepsis, embolism mesenteric, mesenteric ischemia/acute on chronic mesenteric ischemia with necrosis of the small intestine. Abdominal CT showed acute on chronic mesenteric ischemia with necrosis of the small intestine. The reported reactions are not among the known side effects of this vaccine. As of today, we know a lot about side effects that occur in the days and weeks after vaccination, but we cannot rule out rare side effects or whether there should be side effects that only appear long after the vaccination. In each case, it is difficult to know whether the symptoms are due to the vaccine or another, random simultaneous cause that has nothing to do with the vaccine in question. However, it cannot be ruled out that the vaccine has contributed to the worsening of the patient”s underlying disease and / or habitual condition and thus is disposed of in the relevant case. On the basis of the information in the report and in accordance with international criteria, the causal link with vaccination is assessed as possible. A possible causal relationship is defined as a reaction, including pathological laboratory tests, which occurs in a temporal relation to the use of a drug, but which may also be due to an underlying disease, other drugs or chemicals.  No follow-up attempts are possible. No further information is expected.; Reported Cause(s) of Death: Sepsis; Embolism mesenteric; mesenteric ischemia/acute on chronic mesenteric ischemia with necrosis of the small intestine; mesenteric ischemia/acute on chronic mesenteric ischemia with necrosis of the small intestine; mesenteric ischemia/acute on ch bridging ischaemic stroke; This is a spontaneous report received from a contactable physician downloaded from the Agency Regulatory Authority-WEB. The regulatory authority report number is IT-MINISAL02-701388. An 82-year-old female patient received BNT162B2 (COMIRNATY, solution for injection, batch/lot number: EP2166), intramuscular on 05Mar2021 at 11:41 at 0.3 mL, single for SARS-CoV-2 vaccination.  The patient”s medical history included thyroidectomy, ischaemic heart disease, and cognitive deterioration; all from an unknown date and unknown if ongoing. Concomitant medications included donepezil, bisoprolol fumarate (CARDICOR), acetylsalicylic acid, and levothyroxine sodium (EUTIROX); all taken for an unspecified indication, start and stop date were not reported. The patient experienced bridging ischaemic stroke on 06Mar2021, reported as the patient arrived at the emergency department on 06Mar2021 in a sleepy state. She was admitted to the emergency medicine ward on 11Mar2021 for coma in acute cerebral ischaemia. Her family reported that the patient had undergone the Pfizer vaccine on 05Mar2021. The patient died on 14Mar2021 due to the bridging ischaemic stroke.  It was not reported if an autopsy was performed. Sender”s comment: Comirnaty vaccine batch EP2166 carried out on 05Mar2021 at 11.41. The report of the referring physician and the vaccination card always sent by the referring physician are attached. Requested additional data on previous pathologies or drugs taken by the patient and awaiting a reply.   No follow-up attempts are possible. No further information is expected.; Reported Cause(s) of Death: bridging ischaemic stroke Hemorrhage of gastrointestinal tract, unspecified; This is a spontaneous report received from a contactable consumer or other non-HCP downloaded from the  Regulatory Authority-WEB. The regulatory authority report number is FR-AFSSAPS-LM20210562.  Verbatim: Not medically confirmed. Patient notification Lot no EP2166, 1st dose 03Mar2021, left arm. Medical History, current diseases, context : COVID-19 disease history: NO, diabetes and cardiovascular disease. Description of Adverse Effect: Death of digestive hemorrhage on D3 of vaccination. The patient who lost weight due to diarrhea for a few weeks before vaccination. Brief observation, no further information available. No follow-up attempts possible. No further information expected.; Reported Cause(s) of Death: Hemorrhage of gastrointestinal tract, unspecified suspected pulmonary embolism, during the diagnosis of a person who died in hospital, pending confirmation by histopathological examination; This is as spontaneous report received from a contactable physician downloaded from the WEB. The regulatory authority report number is IT-MINISAL02-703463. A 84-year-old female patient received the first dose of BNT162B2 (COMIRNATY, COVID 19 COMIRNATY VACCINE (PFIZER): Booster dose number 1, formulation: Solution for injection, lot number: EP2166; Expiration date: not reported), via intramuscular route on 06Mar2021 as a single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On 08Mar2021, The patient experienced suspected pulmonary embolism, during the diagnosis of a person who died in hospital, pending confirmation by histopathological examination. Reporter commented as, the patient died in hospital a few hours after admission two days after the first dose of the COMIRNATY vaccine. Diagnostic finding with suspicion of death due to pulmonary embolism (awaiting histological confirmation), Emergency department access documentation and autopsy report will be posted as soon as available. The patient underwent lab tests and procedures which included histological examination of the lungs: awaiting for the result on 11Mar2021. Outcome of the event was fatal.  No follow-up attempts possible. No further information expected ad information on lot# already obtained.; Reporter”s Comments: Patient died in hospital a few hours after admission two days after the first dose of the Comirnaty vaccine . Diagnostic finding with suspicion of death due to pulmonary embolism (awaiting histological confirmation); Reported Cause(s) of Death: suspected pulmonary embolism, during the diagnosis of a person who died in hospital, pending confirmation by histopathological examination Infarct myocardial; This is a spontaneous report from a contactable physician downloaded from the regulatory authority FR-AFSSAPS-TO20211616.  An 85-year-old female patient received bnt162b2 (COMIRNATY, Injection: D2), dose 2 intramuscular on 04Mar2021 (Lot Number: EP2166) as single dose (in “left”) for COVID-19 immunization. The patient”s medical history and concomitant medications were not reported. The patient previously received bnt162b2 (COMIRNATY), dose 1 on an unspecified date (Lot Number: unknown) as single dose for COVID-19 immunization. The patient experienced infarct myocardial on 04Mar2021 (fatal). HISTORY OF THE CASE: Sudden death the night following the injection by myocardial infarction. The patient had no known cardiological history. EVOLUTION: Not reinstated on declaration date // 2021). The patient died on an unspecified date. It was not reported if an autopsy was performed. “Covid test: unknown”  File in progress: request for additional information (atcd, other signs before death)  No follow-up attempts are possible.; Reported Cause(s) of Death: Infarct myocardial death; This is a spontaneous report from a contactable physician, downloaded from the WEB, regulatory authority number CZ-CZSUKL-21002656. A 91-year-old female patient received the first dose of bnt162b2 (COMIRNATY, Solution for injection; lot number: EP2166, expiration date was unknown), intramuscularly on 01Mar2021 at 0.3 mL, single for COVID-19 immunization. The patient”s medical history was not reported. The patient did not take any concomitant medicinal products. The patient experienced death on 05Mar2021. The patient died on 05Mar2021 after the first vaccination with COMIRNATY. An autopsy was not performed.  No follow-up attempts are possible. No further information is expected.; Reported Cause(s) of Death: death/ patient died Cardiac arrest; Shortness of breath/ dyspnoea; This is a spontaneous report from a contactable consumer or other non-HCP downloaded from the Regulatory Authority NL-LRB-00479712. An 81-year-old female patient received first dose of BNT162B2 (COMIRNATY, Lot Number: EP2166), via an unspecified route of administration on 10Mar2021 at age of 81-year-old at single dose for COVID-19 immunisation. The patient”s medical history was not reported. Concomitant medications included beclomethasone/ formoterol/ glycopyrronium, simvastatine, omeprazole, carbasalate calcium, alendronic acid, propranolol, calcium carbonate/ colecalciferol (CALCIUM CARBONATE W/ VITAMIN D). No diagnostic procedures. No previous COVID-19 infection. On 15Mar2021, 5 days after BNT162B2, the patient experienced cardiac arrest and Shortness of breath/ dyspnoea. The outcome of events cardiac arrest and shortness of breath/ dyspnoea was fatal. The patient died on Mar2021. It was not reported if an autopsy was performed.   No follow-up attempts are possible. No further information is expected.; Reported Cause(s) of Death: Cardiac arrest; Dyspnoea Sudden death (suspected cardiac); This is a spontaneous report received from a contactable physician downloaded from the Regulatory Authority-WEB. The regulatory authority report number is IT-MINISAL02-700615. An 88-year-old female patient received first dose of bnt162b2 (COMIRNATY, Solution for injection, Lot Number: EP2166), Intramuscularly on Left arm on 03Mar2021 18:54, at single dose for covid-19 immunisation. The patients medical history and concomitant medications were not reported. The physician reported for temporal correlation but, death not related to vaccination. The clinical report will be sent. The outcome of event was Fatal.  No follow-up attempts possible. No further information expected.; Reporter”s Comments: reported only for temporal correlation but in my opinion death not related to vaccination; Sender”s Comments: Based on the current available information and the plausible drug-event temporal association, a possible contributory role of the suspect product to the event cannot be totally excluded. Additional information is needed to better assess the case, including complete medical history, diagnostics, counteractive treatment measures and concomitant medications. This case will be reassessed once additional information is available.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.; Reported Cause(s) of Death: Unknown cause of death fall with bleeding at the cranial and nasal level; fall with bleeding at the cranial and nasal level; fall with bleeding at the cranial and nasal level; fall; This is a spontaneous report from a contactable other healthcare professional downloaded from a regulatory authority-WEB ES-AEMPS-795102.  An 86-years-old female patient received first dose of bnt162b2 (COMIRNATY), via an unspecified route of administration, administered in left arm on 03Mar2021 (Lot Number: EP2166) at single dose for COVID-19 immunisation.  Medical history included hypothyroidism, Type 2 diabetes, Anxiodepressive syndrome, osteoporosis, chronic venous insufficiency. Independent for basic activities of daily living. She was seen in the Rehabilitation Service on 01Feb2021. Clinical judgement: Low back pain, spondyloarthrosis, degenerative scoliosis. Right greater trochanter syndrome. Right coxarthrosis. Treatment: alternate paracetamol with metamizole magnesium (NOLOTIL) every 8h if pain. No hypertension, no dyslipidemia. No known heart disease or bronchopathy. Concomitant medications included levothyroxine sodium (EUTIROX); pentoxifylline (PENTOXIFILLINE); calcium pidolate, colecalciferol (OSVICAL D).  The patient previously took calcium pidolate;colecalciferol (OSVICAL D), levothyroxine sodium (EUTIROX). It was reported that the first dose was administered and after 4 days, patient appeared deceased at her home without signs of violence. Four days after bnt162b2 administration, she was found dead on the bathroom floor. She showed signs of a fall with bleeding at the cranial and nasal level.  The patient died on 08Mar2021.  It was not reported if an autopsy was performed.  No follow-up attempts possible. No further information expected.; Reported Cause(s) of Death: Sudden death Vomiting; Chest pain; Cardiac arrest; Cardiogenic shock; Acute myocardial infarction; Weakness; Blood pressure decreased/blood pressure 90/60; This is a spontaneous report from a contactable physician downloaded from the Regulatory Authority. A 69-year-old female patient received bnt162b2 (COMIRNATY) at the age of 69-year-old, via an unspecified route of administration on 26Feb2021 08:29 (Lot Number: EP2166; Expiration Date: 31May2021) as single dose for COVID-19 immunisation. Medical history included STEMI from an unknown date and unknown if ongoing, ongoing hypothyroidism, ongoing hypertension, and coronary artery disease from an unknown date and unknown if ongoing. The patient”s concomitant medications were not reported. It was reported that the patient was hospitalized in the cardiology department from 28Feb2021, admitted with chest pain and vomiting. On 01Mar2021, the patient”s condition was stable, and her pulse was normal. On 02Mar2021 there was weakness, blood pressure decreased/blood pressure 90/60. On 04Mar2021, the patient”s health deteriorated, resuscitation was performed, then the patient was intubated and coronography (unknown results) was performed. On the same day (04Mar2021) at 05:50 there was a cardiac arrest, at 06:12 the patient died. The patient also experienced acute myocardial infarction, the secondary cause was cardiogenic shock on 04Mar2021. According to the death certificate, the initial cause was acute myocardial infarction, the secondary cause was cardiogenic shock, and the direct cardiac arrest. Chest pain and vomiting, weakness, blood pressure 90/60 were also reported as cause of death. It was unknown if an autopsy was performed. The reporting person classified them as serious. URPL (RA) also classified the application as a serious.   Sender comment: Taking into account the entire clinical picture, it should be concluded that the symptoms were related to coronary artery disease, which had been diagnosed earlier. It is difficult to say whether exacerbation of coronary heart disease, MI and death were related to vaccination. In the database, 2 cases of unstable angina and 35 cases of acute myocardial infarction after COMIRNATY vaccine have been reported. There is a time relationship between the administration of the vaccine and the occurrence of the reaction. The reporting person classified it as serious, URPL also classified the report as serious. Relatedness of drug to all events assessed by Regulatory Authority as Unclassifiable (WHO method of assessment). No follow-up attempts possible. No further information expected.; Reported Cause(s) of Death: Vomiting; Chest pain; Weakness; Blood pressure decreased/blood pressure 90/60; Acute myocardial infarction; Cardiac arrest; Cardiogenic shock. CEREBRAL INFARCTION; This is a spontaneous report from a contactable physician downloaded from the Regulatory Authority. An 88-year-old female patient received bnt162b2 (COMIRNATY), second dose intramuscular, administered in Arm Left on 24Feb2021 15:20 (Batch/Lot Number: EP2166) as single dose for covid-19 immunisation. The patient previously took the first dose of bnt162b2 (COMIRNATY) on an unspecified date for covid-19 immunisation. Medical history included (reported as Multimorbid patient) type 2 diabetes mellitus, hypertension and heart failure, all from an unknown date and unknown if ongoing. Concomitant medication included candesartan cilexetil (ATACAND) taken for hypertension from 2016 to an unspecified stop date oral at 8 mg, 1x/day; acetylsalicylic acid, magnesium oxide (ALBYL-E) taken for type 2 diabetes mellitus from 2010 to an unspecified stop date oral at 75 mg, 1x/day; furosemide (FURIX [FUROSEMIDE]) taken for cardiac failure from 2018 to an unspecified stop date oral at 20 mg, 1x/day; lercanidipine hydrochloride (ZANIDIP) taken for hypertension from 2015 to an unspecified stop date oral at 10 mg, 1x/day; linagliptin (TRAJENTA) taken for type 2 diabetes mellitus from 2019 to an unspecified stop date oral at 5 mg, 1x/day. It was reported that the patient was admitted after being found by her son at 12:30 am on the day of admission, lying next to the bed. The son last observed her at 23:00 pm the night before, then she was in a habitual state. At hospitalization: neglect, left-sided hemiparesis, eye paresis, and clearly drooping corners of the mouth and dysarthria. No public assistance at home. It was reported that the patient with a large cerebral infarction six days (02Mar2021) after vaccination with covid-19 vaccine (Comirnaty). Rapid deterioration after hospitalization, and palliative treatment was started due to major irreversible brain damage, carotid stenoses bilaterally and age. She died nine days after the vaccination. The patient underwent lab tests and procedures which included computerised tomogram: ct caput (after hospitalization):  on Mar2021 Large cerebral infarction. Central, right hemisphere, including basal ganglia.  CT angio (after hospitalization):  – Significant stenosis of the carotid bifurcation bilaterally. And lack of contrast filling throughout the course of the external carotid artery. The patient died on 05Mar2021.  It was not reported if an autopsy was performed.  No follow-up attempts are needed. No further information is expected.; Reporter”s Comments: A 88 years old woman with a large cerebral infarction six days after vaccination with covid-19 vaccine (Comirnaty). Rapid deterioration after hospitalization, and palliative treatment was started due to major irreversible brain damage, carotid stenoses bilaterally and age. She died nine days after the vaccination. Multimorbid patient with hypertension, heart failure and type 2 diabetes mellitus.; Reported Cause(s) of Death: cerebral infarction Deterioration in general condition, worsening of general physical condition; This is a spontaneous report from a contactable healthcare professional downloaded from the Regulatory Authority-WEB, IT-MINISAL02-700476. A 95-year-old female patient received the first dose of bnt162b2 (COMIRNATY, solution for injection), via an unspecified route of administration, administered in left arm on 05Mar2021 (batch/lot number: EP2166; expiration date: 31May2021) as single dose for COVID-19 immunisation. The patient”s medical history and concomitant medications were not reported. The patient had deterioration in general condition, worsening of general physical condition on 13Mar2021. The patient died on 14Mar2021. It was unknown if an autopsy was performed.  No follow-up attempts are possible. No further information is expected.; Reporter”s Comments: Administration site: Left arm Sent from Agency; Reported Cause(s) of Death: Deterioration in general condition, worsening of general physical condition Eating disorder; acute renal failure; dehydration; natremia at 166 mmol/L; worsening of dementia; notion of mottling; This is a spontaneous report from a contactable physician downloaded from a regulatory authority-WEB FR-AFSSAPS-PO20211322. An 83-years-old female patient received second dose of bnt162b2 (COMIRNATY, solution for injection, Lot Number: EP2166, expiry date not reported), intramuscular, administered in left arm on 02Mar2021 as 0.3 mL, single dose for covid-19 immunisation. Medical history included Dementia Alzheimer”s type (Alzheimer-type dementia) history (in nursing home) and hypothyroidism, both from an unknown date and unknown if ongoing at the time of the events. The patient”s concomitant medications were not reported. The patient had the first IM injection (0.3mL, left arm) of the Comirnaty vaccine (lot EJ6795) on 09Feb2021 for COVID-19 immunisation. Patient had hospitalization on 05Mar2021 to an unknown date in 2021, for acute renal failure, and dehydration (natremia at 166 mmol/L) in a patient with eating disorder, reported as refusing to eat; all on 05Mar2021. On entry, patient G15, opponent, clinical examination impossible (notion of mottling since 04Mar2021). Biological assessment at entry (05Mar2021): serum creatinine at 190 umol/l, uremia at 29 mmol/L, and natremia at 170 mmol/L. Establishment of SC hydration, introduction of treatment with morphine electric syringe pump 0.5 mg / h, and collective decision to limit acute care before death on 11Mar2021. As conclusion, the reporter mentioned a worsening of dementia in the post-vaccination context. Therapeutic measures were taken as a result of the events reported. The outcome of the event notion of mottling was unknown. The patient died on 11Mar2021. The causes of death were reported as eating disorder, acute renal failure, dehydration, natremia at 166 mmol/L, and worsening of dementia. It was unknown if an autopsy was performed.  No follow-up attempts possible. No further information expected.; Reported Cause(s) of Death: Eating disorder; acute renal failure; natremia at 166 mmol/L; dehydration; worsening of dementia tired; Death unexplained; This is a spontaneous report from a contactable physician downloaded from the Regulatory Authority (RA), regulatory authority number FR-AFSSAPS-NT20210647.   A 87-years-old male patient received bnt162b2 (COMIRNATY), dose 1 intramuscular on 04Mar2021 (Batch/Lot Number: EP2166) as single dose on left arm for covid-19 immunisation.  Medical history included recent stroke.  The patient”s concomitant medications were not reported.  The patient experienced death unexplained on 12Mar2021. According to his wife, the patient had been tired in recent days. At around 6 a.m., the patient woke up screaming and died immediately. Intervention of the firefighters who ascertain the death. No COVID disease and no test performed.  The patient died on 12Mar2021.  It was not reported if an autopsy was performed.   No follow-up attempts are possible. No further information is expected.; Reported Cause(s) of Death: death unexplained Myocardial Infarction; Death unexplained; Pain in arm/pain in the injected arm; tingling; This is as spontaneous report received from a contactable consumer downloaded from the Regulatory authority-WEB. The regulatory authority report number is FR-AFSSAPS-LM20210503.  An 88-year-old female patient received the first dose of bnt162b2 (COMIRNATY, Batch/Lot Number: EP2166), intramuscular, administered in arm left on 02Mar2021 as a single dose for COVID-19 immunisation. Medical history included arthrosis, hypercholesterolemia and hypertension arterial from an unknown date and unknown if ongoing, aortic incompetence from 2007 to an unknown date. The patient”s concomitant medications were not reported. Clinical course was as follows: On 02Mar2021, the patient had the first injection of the pfizer vaccine in the afternoon. On 03Mar2021, complained of pain in the injected arm, tingling described to her daughter over the phone, took paracetamol. No tachycardia (palpitations) described by the patient to her daughter. On 04Mar2021, called her daughter at 7:00 a.m., still complained of pain in the arm without other complaints, prepared to go to her cardiac ultrasound appointment, around 9:45 a.m. activation of the Presence system, phone call for verification but no response, the taxi driver who came to pick her up entered the home and found the patient on the ground, called the fire brigade, patient in cardiopulmonary arrest. Doctor noting death talked to family with myocardial infarction. The patient experienced death unexplained on 04Mar2021, pain in arm/pain in the injected arm and tingling on 03Mar2021. Therapeutic measures were taken as a result of pain in arm/pain in the injected arm and tingling. The outcome of the events was fatal. The patient died on 04Mar2021. An autopsy was not performed.  No follow-up attempts are possible. No further information is expected.; Reported Cause(s) of Death: tingling; Pain in arm/pain in the injected arm; death unexplained; Infarct myocardial sudden death; This is a spontaneous report from a contactable physician downloaded from the Agency Regulatory Authority-WEB, regulatory authority number IT-MINISAL02-698035.     An 86-year-old male patient received the first dose of bnt162b2 (COMIRNATY) (Lot Number: EP2166), intramuscular 0.3 mL, single on 10Mar2021 for COVID-19 immunisation. Medical history included ongoing chronic ischemic heart disease, ongoing diabetes mellitus. Concomitant medications included insulin for diabetes mellitus, pantoprazole sodium sesquihydrate (PANTORC), acetylsalicylic acid (CARDIOASPIRIN), amlodipine besilate, olmesartan medoxomil (BIVIS), fluvastatin sodium (LESCOL), tamsulosin hydrochloride (OMNIC), dutasteride (AVODART).  The patient experienced sudden death on 12Mar2021. The patient died on 12Mar2021. It was not reported if an autopsy was performed.  No follow-up attempts possible. No further information expected.; Reported Cause(s) of Death: sudden death Septic shock; Cardiogenic shock; Fasciitis necrotising; This is a spontaneous report received from a contactable physician downloaded from the Regulatory Authority (RA). The regulatory authority report number is IT-MINISAL02-697871. An 81-year-old female patient received first dose of BNT162B2 (COMIRNATY, Solution for injection, lot number: EP2166, expiry date: May2021), via Intramuscular route, into Deltoid Right, on 05Mar2021 11:36 AM, at 0.3 ml single for SARS-CoV-2 vaccination. Medical history included Benign prostatic hyperplasia, Arterial hypertension and Dyslipidemia. Concomitant medications included oral amiodarone hydrochloride, at 200 mg, oral pantoprazole, at 40 mg and oral lercanidipine (LERCADIP, tablet), at 20 mg, oral allopurinol (ZYLORIC, 300 mg, tablet), at 300 mg, oral apixaban (ELIQUIS), at 5 mg, oral atenolol (ATENOLOLO EG, tablet, 50 mg), at 25 mg, oral ferrous sulfate (TARDYFER), at 80 mg, oral atorvastatin calcium (TOTALIP), at 20 mg; all for an unknown indication. On 06Mar2021, at 11:00, patient had Septic shock, Cardiogenic shock and Fasciitis necrotising. It was reported that on 06Mar2021, about 11 am, followed by progressive worsening and transferring to the ER of the hospital on 07Mar2021 at 00:26. The intake of Prostamol (1tabl) and Macular B forte (1tabl) supplements is reported. The reporter stated that patient sent by the ER of hospital for vascular surgery consultation in patient with suspected acute ischemia of the right upper limb, arrived at the triage of emergency and acceptance department at 05:16 on 07Mar2021, visited at 05: 26 in poor general condition, alert and collaborating, dyspnoic and at times agitated. The patient reported that had the first dose of anti-SARS-COV2 vaccine administered on 05Mar2021. The patient reported the appearance of edema, hyperemia and itching after about 24 hours from the first administration, he reported that he had been scratching and subsequently had blistering and pain in the whole right upper limb progressively worsening, thus he went to the ER of hospital after being first visited by the medical Service. At the ER of the hospital. He underwent blood tests, antigenic swab, cortisone therapy (urbason), antibiotics (merrem and vancomycin) and antihistamine, despite which the local clinical picture was progressively worsening. At our Emergency department the patient was subjected to molecular TNF, negative result, at 05:45 on 07Mar2021 he was taken to a CT section to perform chest and right upper limb CT in suspicion of acute ischemia; at 05:50 during the primary phase of the CT examination, before the administration of the contrast medium, the patient presented cardiocirculatory arrest for which resuscitation maneuvers began together with the anesthetists-resuscitators, according to the advanced cardiovascular life support (ACLS) protocol with an initial positive response. The patient was intubated, brain and chest CT scan was performed without Contrast medium and at 6:45 am on 07Mar2021 he was transferred to the red room of the emergency department, where the monitoring had been continued and at 6 :55 am presented a new episode of asystole. 5 cycles of cardiopulmonary resuscitation according to the ACLS protocol were performed without success; at 7:20 am on 07Mar2021 the death with diagnosis of necrotizing fasciitis, septic shock and cardiogenic shock was ascertained. The autopsy check of the body was requested, which was carried out on 09Mar2021. Seriousness of the events necrotizing fasciitis, septic shock and cardiogenic shock reported as fatal. Outcome of the events edema, Hyperemia and Itching was unknown. Outcome of events Septic shock, Cardiogenic shock and Fasciitis necrotising was fatal.; Sender”s Comments: The fatal events  is assessed as possibly related to the suspect drug _comirnaty_____ based on strong temporal association, but consider also possible contributory effects from patient”s medical history and/or concomitant medications The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.  ; Reported Cause(s) of Death: Septic shock; Cardiogenic shock; Fasciitis necrotising Sudden death; Chest pain; Collapsed; This is a spontaneous report from a contactable physician from the Regulatory Authority. Regulatory Authority number: SI-JAZMP-NCPHV-2021SI0309_0309.  An 81-year old male patient received his first dose of the BNT162B2 (COMIRNATY, batch EP2166, Expiration date 31May2021) intramuscularly on 05Mar2021 in the morning at single dose for COVID-19 immunization at home. Relevant medical history included dementia, ischemic heart disease, condition after STEMI, condition after prostate cancer, condition after large bowel volvulus, anemia and cachexia. Concomitant medications were not reported. On 05Mar2021 in the afternoon the patient collapsed in the bathroom. The patient was without signs of life when the physician arrived. The first EKG was asystole. An autopsy was ordered due to an unknown cause of death. The patient died unexpectedly at 5:58 p.m. On 5Mar2021, the patient complained of chest pain.  No follow-up attempts possible. No further information expected.; Reported Cause(s) of Death: unknown cause of death Death; This is a spontaneous report from a contactable physician downloaded from the regulatory authority AT-BASGAGES-2021-14937.  An 86-year-old male patient received bnt162b2 (COMIRNATY), intramuscular on 03Mar2021 (Lot Number: EP2166) as a single dose for COVID-19 immunization. Medical history included Multiple morbidities. The patient”s concomitant medications were not reported. On 09Mar2021 the patient experienced Death. The patient died on 09Mar2021. It was not reported if an autopsy was performed. Event assessed as serious.  Sender Comment:  Follow-up information has been requested.  No follow-up attempts possible. No further information expected. COMIRNATY batch already obtained.; Reported Cause(s) of Death: unknown cause of death dead; This is a spontaneous report from a contactable physician downloaded from the Regulatory Authority, regulatory authority number SE-MPA-2021-012965. Other Case identifier number: SE-MPA-1615191743107. A 77-year-old male patient received BNT162B2 (COMIRNATY, Batch/Lot Number: EP2166), intramuscularly on Mar2021 at 0.3 mL, single for covid-19 immunisation. The patient”s medical history and concomitant medications were not reported, no known underlying diseases. The patient received vaccine in Mar2021 in the afternoon, felt well at least until the next morning. Alone at home in the forenoon the next day. The patient was found dead early in the afternoon the day after the vaccination. Probably died before 12 o”clock. Report assessed as serious, death. The patient died in Mar2021. It was not reported if an autopsy was performed.  No follow-up attempts are possible. No further information is expected.; Reported Cause(s) of Death: death Heart attack; This is a spontaneous report from a contactable consumer (patient”s daughter). A 70-year-old male patient received first dose of BNT162B2 (COMIRNATY, PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, strength: 0.3 ml, Lot number: EP2166, expiration date: unknown) via an unspecified route of administration (location: Left arm) on 23Feb2021 at 10:00 AM at age of 70-year-old at 0.3 mL, single for COVID-19 immunisation. The patient”s medical history was not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. The vaccine was administered at other facility. The patient didn”t receive any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medications included atorvastatin, metformin, and indapamide/ perindopril arginine (PRETERAX). The patient experienced heart attack on 28Feb2021 at 09:00 AM, seriousness criteria was reported as resulting to death. The patient didn”t receive any treatment for the event. Since the vaccination, he was not tested for COVID-19. The patient died on 28Feb2021 at 9:00 AM. The cause of death was reported as heart attack. An autopsy was not performed.; Reported Cause(s) of Death: Heart attack

stock here, recreating July 2020 just before Google killed my blog.

• Americas Front Line Doctors Site Is Up Again, And …
• Silenced Frontline Doctors Hold Capitol Hill Press…
• Bill Gates Is Further Outed As a Psychopathic Narc…
• Fauci and Birx Pushing The Envelope On How Much Ab…
• Who do you trust more: 1) Mark Zuckerberg 2) Dr. …
• This is Not A Civil War, This Is An Attempted Over…
• Are We MKUltra Lab Mice, a Yugoslavian Explains Ho…
• DC Doctors Describe Realities of COVID, Need To Ge…
• Automated Speech to Text Transcription — With a F…
• Man Driving On Road, Arrested For Driving On Road,…
• Transcript of The Now Highly Censored “Front Line …
• Guest Post, SARS-2 COVID CON-fusion and Mastery of…
• Ghislaine Maxwell Is Reddit’s Infamous maxwellhill?
• In Milwaukee, Speaking Highly Of Trump Will Now Ge…
• Celebrities Who Went to Epstein Island are 800% Mo…
• How Much Did It Cost Them to Buy Our Government an…
• 3 types of People, Sheep, Sheep Dog, and Wolves
• Wealth of Members of Congress, Senate Average $20M!
• List of 282 Companies Supporting BLM — Boycott Them
• WUWT Is Moving, A Great Climate Site Full Of Reali…
• How to Maintain Multiple Twitter Accounts — Q Urg…
• Britian Is Driving The Push To Degrade and Enslave…
• Joe Biden, Continued Cognitive Decline, Only a Con…
• Amazing Polly — We Are Now Dependent On A System …
• Why Do Our “Leaders” Just Look Like Freaks, Adreno…
• Tucker and Hannity, Combined hit Jobs, Kavanaugh M…
• Bill Gates Is a Smirking Gloating Psychopath, Want…
• COVID IS JUST a step on the ladder to complete tak…
• Daily Death Charts, All 50 States, 28 Have 5 or Fe…
• St Louis “Karen” Kim Gardner Indicted Under Depriv…
• I Went To A Throat Specialist, and ENT, To Get In …
• Awesome Meme — Explains Why It Is Not “Just About…
• Strzok Testimony Shoots Down Many NYT Lies
• St. Louis Couple Viciously Attacked for Effectivel…
• More Proof That Obama Foundation Was Using Floyd I…
• You never Even Heard: White Postal Lady Assassinat…
• Remember When Obama Said “NO Danger from Fukushima…
• Let’s Not Throw Pedophilia Around Too Easily, It R…
• 311 Is A Number From Devils Triangle
• Positive News Stories About Trump (Of Course They …
• Glitch in the Matrix!
• Epstein Island, Killing Fields, Tennis Courts, Goo…
• If you Subtract the Senior-Cide Murders It’s Just …
• Mouthy Buddha: A Great Reporter, With Video Skills…
• The Letters From The Governors That Murdered 60,00…
• Recycling, Batteries, Tires, Hazardous: Great Webs…
• Entertaining Cartoon On Bill Gates, Sums It All Up…
• Chrissy Teigen — Examples of Her Degeneracy
• Good Things About Trump
• Ricky Gervais at the Golden Globes 2020 – All of h…
• Disney — 33 Ways That Disney Is Evil
• Marxism Already Here: 3 Executions Related to Mask…
• Bill Gates and Melinda Gates Giggle and Smirk Over…
• (10) Minutes, Tips To Set Up For Browsing Security…
• Wins of the Day
• A History of Taxation in the USA Anna von Reitz et al
• Idaho Plane Crash — Children of Top Nike Executiv…
• Nicole Junkermann, Epstein Confidante, MOSSAD, And…
• Pictures and Stories About Dozens On The Epstein F…
• Florida News Total Bullshit, Over 1200 ICU Beds Av…
• 8:12 / 9:10 Utah County Meeting – On Masks In Scho…
• Florida Busted, Totally Padding COVID Numbers by 1…
• Holy Planetary Alignments Batman!
• 33 YO Motorcycle Ride Share “Guru” Dismembered in …
• A Civil Disobedience To Boycott Walmart, Costco, M…
• Great News on SARS-CoV-2 – T-Cell “Memory” and 100…
• Data Discovery, (5) States Plotted, Hospitalizatio…
• Facist Fauci Fooled Followers — USA Today Indictment
• First They Murdered A Woman For Saying ‘All Lives …
• 10 Stages of Genocide — Prove Me Wrong — The Cab…
• Texas Total Scam, Pretending They Are Running Out …
• All 245 Names Extracted From Epstein LSJ Flight Lo…
• Wins Of The Day
• July 4th Eclipse Pictures Of The Moon
• Maxwell, Epstein, and the Control of Science — Am…
• A Great Speech about Communism (hiding behind weas…
• Cuomo Panders to Atlanta Black Female Mayor, And P…
• S. Marshals have been clashing with protesters in …
• Leftist Strategy For The Near Term — Murder Young…
• 12 Top Lies and Misdirections of Fauci And All Roa…
• Views From a 30 YO White Girl
• New Video Hosting Site, Kill YouTube, Japan BLM I …
• The Silenced Majority
• Media Mind Control: The News Cycle Has Been Domina…
• No Name McCain Praises Huma Abedin “Always At Clin…
• Most States Hospitalization Is Steadily Down, Some…
• COVID Death Trend In USA, Way Down. Other States…
• Interesting Site That Calculates R-Naught Values P…
• Rapid Response White House Account Created Today -…
• VPNs Do You Need One? Some Good Backgrounder
• Wayfair Names Their Furniture After Abused and Mis…
• COVID Abuse, How Does This Compare To A Narcissist…
• USA Increase in COVID Deaths 4 Days: but WAIT It’s…
• The Staircase of Disbelief — How Normies Cannot G…
• Start Stop Start Stop Start Stop Method of Killing…
• Documentary from 2014 Explaining How They Will Use…
• The Big Wobble — Is COVID A Scam?
• President of Ghana Reads Out The “Rockefeller Plan…
• Could Trump Initiate National Security Presidenti…
• Hawaii Goes Full Tilt Marxist — Gov Ige (Loves Ch…

stock here:

In a hilarious “debunk” of how athletes and entertainers ARE NOT dropping like flies because of the VXX, this tool lists many of the athletes and entertainers that are dropping like flies. His first debunk point that Jak Knight was not taken out by the Vax is that
“he died at home”

https://www.foxnews.com/entertainment/jak-knight-stand-up-comedian-writer-dead-28

The “debunk” LOL

https://www.techarp.com/facts/jak-knight-vaccine-death-facts/

Did Paul Ryder Die From Vaccine On Day Of Concert?!Marion Barber III : Cause Of Death Not Vaccine SADS!Tyler Sanders Reportedly Died From Drug OD, Not Vaccine!Did NHL Player Bryan Marchment Die From Vaccine SADS?James Caan Dies At 82, Antivaxxers Blame Vaccines!Carlos Santana Collapsed From Dehydration, Not Vaccine!Did Comedian Nick Nemeroff Die From Vaccine SADS?!Travis Barker Confirmed Pancreatitis Was From Colonoscopy!Jaylon Ferguson Autopsy : Cause Of Death Was Drug OD!Did Josh Gad’s Nephew, Marco, Die From Vaccine SADS?!Depeche Mode’s Andy Fletcher : Cause Of Death Not Vaccine!Did Sukma Athlete Stephanie Sim Die From Vaccine Stroke?!Did Ravens Linebacker Jaylon Ferguson Die From Vaccine?!Did NBA Star Caleb Swanigan Die From COVID-19 Vaccine?!Did Tom Mann’s Fiancee, Dani Hampson, Die From Vaccine?!Fact Check : Did Gwen Casten Die Of COVID-19 Vaccine?!Why Steve Kirsch Is 100% Wrong On Justin Bieber’s Paralysis!Did Justin Bieber Blame Pfizer Vaccine For His Paralysis?!Did Justin Bieber Get Ramsay Hunt Syndrome From Vaccine?!Did Indian Singer KK Die From Vaccine Heart Attack?!Fact Check : Did Ray Liotta Die From COVID-19 Vaccine?!Did Rapper Lil Keed Die From Pfizer COVID-19 Vaccine?!Did Gilbert Gottfried Die From COVID-19 Vaccine?!Why Steve Kirsch Is Wrong About Taylor Hawkins Dying From VaccineWas Bruce Willis Forced To Get COVID-19 Vaccine?!Did Bruce Willis Get Aphasia From COVID-19 Vaccine?!Did Taylor Hawkins Die From Vaccine-Induced Myocarditis?!Did Foo Fighters Drummer Taylor Hawkins Die From Vaccine?!Did Bob Saget Die From COVID-19 Vaccine Booster Dose?It’s Official – Bob Saget Died From Head Trauma, Not Vaccine!Fact Check : Did Louie Anderson Die From Booster Dose?!Fact Check : Did Meat Loaf Die From Booster Dose?!Did Shebby Singh Die From COVID-19 Vaccine Booster Dose?Did Betty White Die From COVID-19 Booster Dose?

I have been aware of this for I guess, years. But it was so absurd that I often wondered whether this was just made up, so that normies could point to “crazy conspiracy” theorists. 

But I found it, amazingly preserved on YouTube so I immediately copied it, stored on harddrive, and uploaded to Bitchute. 

Y’all need to do that stuff also! 

ON the bottom bottom is a cringe worthy interview posted on Jun 25, 2021 (just about the same time that the CDC started re-coding Vax injuries and deaths in the USA as happening in another country) —posted by the Global Shapers

At the end of these still images is the video that was generated by their Twitter Post.   The Twitter post has since been taken down, so it is great that someone preserved this.

———————————————————————

 

And poor Canada is so toast. They have been infiltrated. And they are not allowed to talk about him.

stock here, brand new on my radar. Brandon Smith lays it down.

By Brandon Smith

The idea that there is an agenda for global government among the financial and political elites of the world has long been called a “conspiracy theory” within the mainstream and the establishment media. And sadly, even when you can convince people to look at and accept the evidence that banking institutions and certain politicians work together for their own purposes, many folks will STILL not entertain the notion that the ultimate goal of these power mongers is one-world empire. They just can’t wrap their heads around such a thing.

People will say that the establishment is driven by greed alone and that their associations are fragile and based only on individual self interest. They will say that crisis events and shifts in social and political trends are random, not the product of deliberate engineering. They will say that elitists will never be able to work together because they are too narcissistic, etc.

All of these arguments are a coping mechanism for the public to deal with evidence they cannot otherwise refute. When the facts become concrete and the powers-that-be admit to their schemes openly, some people will revert to confused denial. They don’t want to believe that organized evil on such a scale could actually exist. If it did, then everything they thought they knew about the world might be wrong.

For many years the agenda for global governance was only whispered about within elitist circles, but every once in a while one of them would speak aloud in public about it. Perhaps out of arrogance or perhaps because they felt the time was right to ease the populace into accepting the possibility. Whenever they did mention it, they called it the “New World Order.” World leaders from George HW Bush to Barack Obama to Joe Biden to Gordon Brown to Tony Blair and beyond have all given speeches talking about the “New World Order.” Money and political elites like George Soros and Henry Kissinger have mentioned the NWO incessantly over the years.

---

What Is The “Council For Inclusive Capitalism?” It’s The New World Order

stock here. Of course, Q was part pys-op, and the best lies have an element of the truth.

Its kind of a shock to me to see the prevalence of creeps and full on pedos out there.

Pizzagate, promoted by Q, did result in many arrests and convictions.

Putting up an incomplete list of pizzagate related arrests that have happened over the past 3.5 years. Pulled up the archives. Consider this a morale boosting post to remind us that shit is happening.

The next time Robert Robinson and his pals show up shitting the place up, we can just link this thread to shit on his idiotic arguments.

https://voat.co/v/pizzagate/2853167 Robert Robinson. This one being on top is to spite PGIsDumb.

https://voat.co/v/pizzagate/3319196 Jeffery Epstein

https://voat.co/v/pizzagate/3518401 Field McConnel

https://voat.co/v/pizzagate/2913929 Stoney Westmoreland

https://voat.co/v/pizzagate/3629165 Jessica Yaniv

https://voat.co/v/pizzagate/3491846 Jim Farmer

https://voat.co/v/pizzagate/2991026 Perkins Coie (HRC campaign law firm)

https://voat.co/v/pizzagate/2989597 backpage.com

https://voat.co/v/pizzagate/2872773 H.L. Moody Jr.

https://voat.co/v/pizzagate/2608986 Carlos Castillo

https://voat.co/v/pizzagate/2151327 Eric Komar

https://voat.co/v/pizzagate/2085725 Jason Kessler

https://voat.co/v/pizzagate/1762864

https://voat.co/v/pizzagate/1729288 Ralph Shortley

https://voat.co/v/pizzagate/1699902 Ken Fenske

https://voat.co/v/pizzagate/1434496 Richard Harding

https://voat.co/v/pizzagate/3603540 Dr. Pizza

https://voat.co/v/pizzagate/3567087 Brian Smith

https://voat.co/v/pizzagate/3553130 Tomohiro Maki

https://voat.co/v/pizzagate/3504183 John Lunsford

https://voat.co/v/pizzagate/3496733 Saifullah Al-Mamun

https://voat.co/v/pizzagate/3432248 Mike Folmer

https://voat.co/v/pizzagate/3432234

https://voat.co/v/pizzagate/3363031 Guido Germano

https://voat.co/v/pizzagate/3333630 Mark Catley

https://voat.co/v/pizzagate/3329602 R. Kelly

https://voat.co/v/pizzagate/3265954 George Nader

https://voat.co/v/pizzagate/3262428 Joaquin Garcia

https://voat.co/v/pizzagate/3135241 Dan Green (judge)

https://voat.co/v/pizzagate/3120380 Michael Avenatii

https://voat.co/v/pizzagate/3055572 Fred Lenczychi

https://voat.co/v/pizzagate/2863573 Tekashi69

https://voat.co/v/pizzagate/2797280 Steve Penny

https://voat.co/v/pizzagate/2761648 Joel Davis

https://voat.co/v/pizzagate/2644946 Clare Bronfman and Salzman

https://voat.co/v/pizzagate/2601431 Jeffery Cooper

https://voat.co/v/pizzagate/2536345 Howard Rubin

https://voat.co/v/pizzagate/2511790 Allison Mack

https://voat.co/v/pizzagate/2472472 Keith Rainere

https://voat.co/v/pizzagate/2373068 Jess Cliffe

https://voat.co/v/pizzagate/2288617 Jonathan Heely

https://voat.co/v/pizzagate/3674596 Harvey Weinstein

• 5 comments
•   …  

sort by:

New Bottom Intensity Old

Sort: Top

[–]EricKaliberhall[M] 1 point (+1|-0) 5 hours ago 

Jacob Schwartz – https://voat.co/v/pizzagate/1892155

Sir Ron Brierley – https://voat.co/v/pizzagate/3567628

‘HELP’ flair is activated.

• link
• reply
•   …  

[–]flyingcuttlefish1.4 minutes ago 

some early stories at the start of the whole thing – https://flyingcuttlefish.wordpress.com/pizzagate/

stock here. This is a great list of Names that went to Epstein’s Island. Each name has a link to take you to the original scan of the page it came from.

And it is now searchable…..try Justice Roberts

1971 names

Abby

1 contact page 1

Joanna Abousleiman

1 contact page 1

Nick Adam

France1 contact page 1

Alejandro Agag

1 contact page 1

Marie Claire & John Agnew

UK1 contact page 1

Azzedine Alai

1 contact page 1

Rufus & Sally Albermarle

US1 contact page 1

Saffron Aldridge

UK1 contact page 1

Pam Alexander

1 contact page 1

Giacomo Aligranti

UK1 contact page 1

Paul Allan

1 contact page 1

Nick & Sarah Allan

1 contact page 1

Charlie Althorp

1 contact page 1

Carella Alun-Jones

UK1 contact page 2

Jeremy & Deborah Alun-Jones

UK2 contacts page 2

Vincente Alvarez

1 contact page 2

Philippe Amon

Switzerland2 contacts page 2

Roberta & Maurice Amon

US1 contact page 2

Lisa Anastos

US1 contact page 2

Lulu Anderson

1 contact page 2

Robert & Alex Appleby

UK1 contact page 2

Alex Appleby

1 contact page 2

Robert Appleby

1 contact page 2

Maite Arango

Spain1 contact page 2

Victor Arellano

UK1 contact page 3

Joaquin Fernandez de Arion

Spain1 contact page 3

Fernando Arion

US1 contact page 3

Arthur & Cathy Armstrong

1 contact page 3

Herve & Marine Aron

US1 contact page 3

Lorinda Ash

1 contact page 3

Ashley & Allegra Hicks

UK1 contact page 3

Nick & Ari Ashley

UK1 contact page 3

Charlotte & Vittorio Assal

US1 contact page 3

Mr Simon Astaire

UK1 contact page 3

William Astor Viscount

1 contact page 3

Helene Atkin

US1 contact page 3

Mike & Aml Atkin

US1 contact page 3

Jose Aznar

S&S Capital

US1 contact page 3

Jean Baddeley

Spain1 contact page 3

Peter Bahrke

1 contact page 3

Danny Baker

1 contact page 3

Shariar Bakhtiar

Church Palm Collage

1 contact page 3

Andre Balazs

US2 contacts page 4

Alec Baldwin

1 contact page 4

Balliol College, Oxford

England1 contact page 4

Alice Bamford

1 contact page 4

George Bamford

1 contact page 4

Sir Anthony & Lady C Bamford

1 contact page 4

Doug BandsVIP

Office of William J. Clinton

US3 contacts page 4

David Slade

Listed under Doug Bands

US1 contact page 4

Mike Lee

Listed under Doug Bands

US1 contact page 4

Sara Latham

Listed under Doug Bands

US1 contact page 4

Denise Diorio

Listed under Doug Bands

US1 contact page 4

Joe Cashion

Listed under Doug Bands

US1 contact page 4

Uma

Listed under Doug Bands

US1 contact page 4

Mark Galespie

Listed under Doug Bands

US1 contact page 4

Jim Morrison

Listed under Doug Bands

US1 contact page 4

Hanna Richert

Listed under Doug Bands

US1 contact page 4

Laura

Listed under Doug Bands

US1 contact page 4

Jim Kennedy

Listed under Doug Bands

US1 contact page 4

Bands, Doug (guy Doug friend)

Listed under Doug Bands

US1 contact page 4

Bands, Doug (no. 42 do not use)

Listed under Doug Bands

US1 contact page 4

Clive Bannister

HSBC Investment Bank plc

UK1 contact page 4

Javier Banon

IFB International Finance Bank

US1 contact page 4

Nicholas & Gretal Barham

UK2 contacts page 4

Andrews Helen

Listed under Nicholas & Gretal Barham

Australia1 contact page 4

Peter Barnes

1 contact page 4

Craig Barnett

1 contact page 4

Hillary Bastone

1 contact page 4

Hillary Batstone

UK2 contacts page 4

Tim Natasha Batstone

1 contact page 5

Lorenzo Baumer

1 contact page 5

Lord & Lady Beaumont

UK1 contact page 5

Tamara Beckwith

1 contact page 5

Lisa Beizberg

US2 contacts page 5

Erin Eagan

Listed under Lisa Beizberg

1 contact page 5

Steven Benson

1 contact page 5

Baron Bentinck

UK1 contact page 5

Nicolas Berggruen

Alpha Investment Managment

US2 contacts page 5

Bill Berkman

The Associated Group

US2 contacts page 5

Tara Bernard

1 contact page 5

Martyn Birchall

US1 contact page 5

Robin Birley

Birleys Limited

UK2 contacts page 5

Debbie & Bola Von Bismarck

UK1 contact page 5

Vanessa Von Bismarck

US2 contacts page 5

Jean Marc Bisson

1 contact page 5

Jean Paul Bjorlin

US1 contact page 5

Conrad & Barbara Black

US2 contacts page 6

Penny

1 contact page 6

Blacker (Blogs & Jill) Mr & M

1 contact page 6

David Blaine

1 contact page 6

Colin Hiss

Listed under David Blaine

1 contact page 6

Kay Katie

1 contact page 6

Mike Bloomberg

US2 contacts page 6

Samantha Boardman

1 contact page 6

Serena Boardman

1 contact page 6

Johnie & Sophie Boden

UK1 contact page 6

Daniel Bodini

US2 contacts page 6

Edward de Bolsgelin

UK1 contact page 6

Pierre Boisguilbert

1 contact page 6

Anabelle Bond

1 contact page 6

Andrea & Giola Bonomi

Italy1 contact page 6

Nicholas Bookis

1 contact page 6

Mark & Lauren Booth

NetJets

UK2 contacts page 6

Maria Bevan

Listed under Mark & Lauren Booth

1 contact page 6

Christina A Boothe

1 contact page 6

Paulo Borgese

1 contact page 6

Michael Borrico

Certified Contracting Inc.

New York1 contact page 6

Hon Bruce & Penelope Bossom

UK1 contact page 7

Sylvianne Boucherie

France1 contact page 7

Rick Bourke

US1 contact page 7

Hamish Bowles

1 contact page 7

ferdinando Brachetti Peretti

1 contact page 7

Hugo Brachetti

1 contact page 7

Caroline Braine

1 contact page 7

Katie & Serge Braine

UK1 contact page 7

Ben Bram

1 contact page 7

Tony Brand

1 contact page 7

d’Adda Brandolini

President-Exor

France1 contact page 7

Nuno & Muriel Brandolini

US2 contacts page 7

Peter Brandt

1 contact page 7

Richard Branson

1 contact page 7

Flavio Briatore

Renault Fl Ltd.

2 contacts page 7

Rosella

Listed under Flavio Briatore

1 contact page 7

Julia Broadhurst

South Africa1 contact page 7

Louis Albert de Broglie

France2 contacts page 8

Jr. Edgar Bronfman

Lexa Partners LLC

US1 contact page 8

Christopher & Amanda Brooks

US1 contact page 8

Miranda Brooks

US2 contacts page 8

Chris & Alison Brown

US1 contact page 8

James & Lucinda Bruce

UK1 contact page 8

Jean-Luc Brunel

Karin Models

France4 contacts page 8page 95

Pamela

Karin Models

Listed under Jean-Luc Brunel

US1 contact page 8

Karins

Karin Models

Listed under Jean-Luc Brunel

US1 contact page 8

Michael

Karin Models

Listed under Jean-Luc Brunel

US2 contacts page 8page 82

Eve

Karin Models

Listed under Jean-Luc Brunel

US1 contact page 8

Brazil

Karin Models

Listed under Jean-Luc Brunel

US1 contact page 8

Tania Bryer

UK1 contact page 8

Joan Juliet Buck

1 contact page 8

Jimmy & Jane Buffet

US1 contact page 8

Bartle Bull

US1 contact page 8

Hamish & Emma Bullough

UK1 contact page 8

Ron Burckle

US1 contact page 8

Jules Bumey

1 contact page 8

Martin Burtril

1 contact page 8

Candice Bushnell

1 contact page 8

Arki Busson

US1 contact page 9

Charlie Butter

UK1 contact page 9

Terri Button

Visa International

UK2 contacts page 9

Robert Byng

Belgravia Court

UK1 contact page 9

Alain Cadenet de

UK1 contact page 9

Jason Calacanis

1 contact page 9

Caledon Castle, Nr Armagh Co Tyrone, Northern Ireland

Caledon Castle, Nr Armagh Co Tyrone, Northern Ireland

UK1 contact page 9

Mario & Ariadne Calvo-Platero

US1 contact page 9

Roddy Cambell

1 contact page 9

Alistar Cambell

UK1 contact page 9

Giancario Camerana

1 contact page 9

Cammy

1 contact page 9

Naomi Campbell

UK2 contacts page 9

Arrel

Listed under Naomi Campbell

US1 contact page 9

Brooke & Emilio Campo del

UK1 contact page 9

Andrew Candole de

UK1 contact page 9

Nicholas Candy

Candy and Candy Ltd.

UK1 contact page 9

Caprice

1 contact page 10

Sara Massimo Carello

1 contact page 10

William & Carina Carey

1 contact page 10

Camila Carlbom

1 contact page 10

Carmine

1 contact page 10

Barbara Carrera

1 contact page 10

Sophie Caruth

1 contact page 10

Michel & Charlene Carvalho

UK1 contact page 10

Guido Casagrande

Italy1 contact page 10

Simon Case

1 contact page 10

George & Pauline Case

UK1 contact page 10

Debbie Castaneda

1 contact page 10

Alby & Victoria Cator

UK1 contact page 10

Mark & Mini Cecil

Kenya2 contacts page 10

Aurelia Cecil Stephenson

UK1 contact page 10

Dr. Mark Cecil

UK1 contact page 10

Fabrizio Cerina

Credit des Alphes

Switzerland1 contact page 10

Giancario Cammarata

Credit des Alphes

Listed under Fabrizio Cerina

1 contact page 10

Gian Carlo Carutti

Italy1 contact page 10

Vikram Chatwal

Hampshire Hotels & Resorts

US2 contacts page 11

John & Lucy Chenevix-Trench

UK1 contact page 11

Gianluca Cicogna

US1 contact page 11

Geoconda Cicogna

1 contact page 11

Gianfranco Cicogna

UK1 contact page 11

Marina Cicogna

1 contact page 11

Pietro & Alejandra Cicognani

US1 contact page 11

Linska Cierach

UK1 contact page 11

Guiseppi Cipriani

1 contact page 11

Gustavo & Patty Cisneros

US1 contact page 11

Amadeo Claverino

1 contact page 11

Isabel Claverino

1 contact page 11

John Alice Fay Cleese

1 contact page 11

Graham & Emma Clempson

UK1 contact page 11

Lucy Clive

1 contact page 11

Larry Coben

Sunrise Capital Partners

US2 contacts page 11

Ms Mandy Cochrane

UK1 contact page 11

Dalit Cohen

UK1 contact page 11

Peter Cohen

US1 contact page 12

Jo Coleman

US1 contact page 12

Nicholas & Georgia Coleridge

UK1 contact page 12

Jeffrey Colle

1 contact page 12

Phil & Orlanne Collins

1 contact page 12

Henrietta Conrad

UK1 contact page 12

Susannah Sten Ber Constantine

UK1 contact page 12

Clive Cooke

US2 contacts page 12

Ms Rachel Cordle

UK1 contact page 12

Rupert & Camilla Cordle

UK2 contacts page 12

Alise

Listed under Rupert & Camilla Cordle

1 contact page 12

Fernando de Cordova Hohenlohe

Spain2 contacts page 12

Harry Cotterell

Byford Court

UK1 contact page 12

Martine de Courcel

1 contact page 12

Marina Cowdray

The Viscounless Cowd

UK1 contact page 12

Colin Cowie

US1 contact page 12

Sophie Crabbe

UK1 contact page 13

Alaistar Cudro

1 contact page 13

R. Boykin Curry

Eagle Capital Management

US2 contacts page 13

Amanda Cutter

US1 contact page 13

Chrstopher Brooks

Chrstopher

US1 contact page 13

Henri & Tatiana d’abo

UK1 contact page 13

Carman D’Alessie

1 contact page 13

Prince Pierre d’Arenberg

US2 contacts page 13

Jacques de crussol d’Uzes

1 contact page 13

Amr A. Dabbagh

1 contact page 13

Sophie Dahl

1 contact page 13

Drake Darrin

US1 contact page 13

William Dartmouth

UK1 contact page 13

Jeff Davies

1 contact page 13

Robert Maron

Listed under Jeff Davies

1 contact page 13

David & Linda Davies

UK1 contact page 13

Nick & Heather Day

P&D Development Company

Kenya1 contact page 13

Marcelo de Andrade

Brazil2 contacts page 13

Patrick de Baecque

1 contact page 14

Milly de Cabrol

US1 contact page 14

Alen De Cadenet

1 contact page 14

Hermine de Clermont-Tonnerre

Princess

France1 contact page 14

Anouska De Georgiou

UK1 contact page 14

Fernando De Soto

Spain2 contacts page 51page 14

Jean & Paulette Dedijeu

France1 contact page 14

Luca Del Bono

Quintessentially

UK2 contacts page 14

Adam Dell

1 contact page 14

Dina & Fouard Chartuuni Deluca

US2 contacts page 14

Cass & Ted Derby

UK2 contacts page 14

Ros & Jonathan Derby

US1 contact page 14

Charlotte Di Vita

1 contact page 14

Debbie Dickenson

US1 contact page 14

Janice Dickenson

US1 contact page 14

Chris Royer

Listed under Janice Dickenson

US1 contact page 14

Marc Antoine & Cath Dietrich

France1 contact page 14

Paul Dietrich

President Meridian Emerging Markets Ltd.

US1 contact page 14

Laura Dietrich

US1 contact page 14

Johnathan Dimbelby

1 contact page 14

Pedro Diniz

PPD Sports

Brazil1 contact page 15

Alexandra Dixon

UK2 contacts page 15

Dale Djerassi

2 contacts page 36page 15

Alex & Suzie Dolbey

Short Hoo

UK2 contacts page 15

Alegra Donne

Alegra

UK1 contact page 15

Dori

1 contact page 15

Dorrit

1 contact page 15

David & Christy Prunier Doss

US1 contact page 15

Diandra Douglas

US2 contacts page 15

Eli Wiesel

1 contact page 15

Jeremy Drax

UK1 contact page 15

Bernhard Dreesmann

UK1 contact page 15

Minnie Driver

1 contact page 15

Anthony Dubb

US1 contact page 15

Peter Dubbens

1 contact page 15

Glen Dubin

Dubin & Swieca Capital Management

US3 contacts page 15

Louis & Tiffany Dubin

The Athena Group

2 contacts page 15

Peter Dubin

1 contact page 16

Duchess of York

UK2 contacts page 16

John O’Sullivan

Listed under Duchess of York

1 contact page 16

Kate Weddington

Listed under Duchess of York

1 contact page 16

Janine

Listed under Duchess of York

2 contacts page 16page 86

Francsco Ducrey-Giordano

Italy1 contact page 16

Paul Duesing

Leisure & Lifestyle Ventures

US1 contact page 16

Duke of York

UK2 contacts page 16

Robert Olney

Listed under Duke of York

1 contact page 16

Miranda & Steph Dunbar Johnson

UK1 contact page 16

Griffin Dunne

US1 contact page 16

Philip & Dominice Dunne

UK1 contact page 16

Anh Duong

1 contact page 16

Luigi Durso

Ines de la Fressange

France1 contact page 16

John & Charlotte Duthie

UK1 contact page 16

Umar Dzhabrallou

1 contact page 16

Bernie Ecclestone

UK2 contacts page 16

Paul Eckon

1 contact page 16

Lucinda Edsel

UK1 contact page 16

Andrew & Tracy Edwards

UK1 contact page 17

Johnathan Elian

US1 contact page 17

Brian Elias

1 contact page 17

Johan & Amanda Eliasch

UK2 contacts page 17

Elizabeth

1 contact page 17

Eric Ellenbogen

1 contact page 17

Mr & Mrs Ellingworth

UK1 contact page 17

Ben Elliot

Quintessentially

US2 contacts page 17

Gail Elliot

US1 contact page 17

Joe Coffey

US1 contact page 17

Mandy & Ralph Ellison

US1 contact page 17

Anabel Elwes

UK1 contact page 17

Ed Epstein

US1 contact page 17

Noona Erba

Tall Blonde Armanai

1 contact page 17

Manuel & Ros Espirito Santo

1 contact page 17

Jean-Marc Estlin

France1 contact page 17

Christina Estrada Juffali

Juffali, Walid

UK2 contacts page 17

Chris Evans

1 contact page 18

Angie Evehart

1 contact page 18

David Faber

1 contact page 18

Sally Faber

UK1 contact page 18

Johnson Brook

UK1 contact page 18

Charlotte Faibairn

UK1 contact page 18

Fraser Hamish

UK1 contact page 18

The Hon Rupert Fairfax

UK1 contact page 18

Natasha Fairweather

Russia1 contact page 18

Ms Catherine Fairweather

UK1 contact page 18

Patrick & Marla Fairweather

Ambassador & Lady

UK1 contact page 18

Arnado & Jasmine Fakhre

UK1 contact page 18

Danny & Christine Fakhre

UK1 contact page 18

Meredith Fall

France1 contact page 18

Mrs Fallah

UK1 contact page 18

Ms Christina Fallah

UK1 contact page 18

Jon Robe

UK1 contact page 18

Olivier de Falletans

UK1 contact page 18

Pepe Fajul

1 contact page 18

Terence & Cornelia Faulkner

1 contact page 18

Fiona Feeley

UK2 contacts page 18

Frederic Fekkal

Frederic Fekkal Beauty Center

US2 contacts page 18

Paige

Frederic Fekkal Beauty Center

Listed under Frederic Fekkal

1 contact page 18

Phillipe

Listed under Frederic Fekkal

1 contact page 18

Sebastian

Listed under Frederic Fekkal

1 contact page 18

Andrew Feldman

1 contact page 19

Helena Felix

UK1 contact page 19

David & Anne Fell

1 contact page 19

Leonardo & Beatrice Ferragamo

Italy1 contact page 19

Hugo Ferranti

UK1 contact page 19

Brian Ferry

Studio One

UK1 contact page 19

Martin Fiennes

UK2 contacts page 19

Ralph Fiennes

1 contact page 19

Suzzana Fiennes

1 contact page 19

Chuck Fifer

1 contact page 19

Christopher & Charlotte Figg

1 contact page 19

Charles Finch

1 contact page 19

Howard Finklestein

1 contact page 19

Princess Firyal

US4 contacts page 19page 45

Dan Fisher

US1 contact page 19

Mook Flick

UK1 contact page 20

Bobby & Jeanette Foman

1 contact page 20

Zandy Forbes

1 contact page 20

Chris (Kip) Astrid Forbes

Forbes Magazine Vice Chairman

US2 contacts page 20

Steve & Sabine Forbes

US1 contact page 20

Katie Ford

Ford Models

US2 contacts page 20

Tom Ford

Gucci

1 contact page 20

Richard Buckley

Gucci

1 contact page 20

John Forman

1 contact page 20

Johnathan Forman

1 contact page 20

Nicola Formby

UK1 contact page 20

Rocco & Aliai Forte

UK1 contact page 20

Andrew Fox

1 contact page 20

William & Lucinda Fox

UK1 contact page 20

Violet Fraiser

1 contact page 20

Francesco Garde de la

Italy1 contact page 20

Kathy Francey

1 contact page 20

Isabel Fraysse

France1 contact page 20

Mathew Freud

1 contact page 20

David & Carina Frost

1 contact page 21

Mariella Frostrup

1 contact page 21

Cosmo & Amanda Fry

1 contact page 21

Teresa Fulhurst

1 contact page 21

Heinrich & Milana Furstenberg

Germany1 contact page 21

Alex, Alexandra V. Furstenbug

1 contact page 21

Nina Furstenburg Buravelli

Italy1 contact page 21

Edwina Fyson

UK1 contact page 21

Gelasio Gaetani

Italy1 contact page 21

Rufreido Gaetani

1 contact page 21

Kuki Gallman

Kenya1 contact page 21

Mario Jr. Ganero

1 contact page 21

Esteban Juan Ganoza

Peru2 contacts page 21

Ludmila Garcia

Spain2 contacts page 21

Adam Gardner

1 contact page 21

Michael Garland

1 contact page 21

Jeremy Garson

1 contact page 21

Nacho Gaspar

Spain1 contact page 21

Harriett Gaul

UK1 contact page 21

Tim Gaery

1 contact page 21

Jack Gelardin

UK1 contact page 21

Catriona German-Ribon

1 contact page 21

Eric Gertler

Privista

US1 contact page 22

Mark Getty

1 contact page 22

Pia & Chris Getty

1 contact page 22

Emma Gibbs

UK1 contact page 22

Caroline Gibson

UK1 contact page 22

Andrew Gilifilan

South Africa1 contact page 22

Lord & Lady Gillford

1 contact page 22

Andrew & Emma Gillmour

1 contact page 22

Gary Ginsberg

1 contact page 22

Howard Gittis

MacAndrews

1 contact page 22

Luca Giussani

1 contact page 22

Mary Glanville

1 contact page 22

Charlie Glass

1 contact page 22

Edmund & Emily Glentworth

1 contact page 22

Pilar Goess

1 contact page 22

Ellen Goldberg

Sante Fe Institute

1 contact page 22

Isabel Goldsmith

US2 contacts page 22

Sandy Golinkin

US1 contact page 22

Thomas Gomez

1 contact page 22

William & Emma Gomme

UK1 contact page 23

Gordon Jacobo

CG Investments

Spain1 contact page 23

Jullet Gore

1 contact page 23

Steve Gottlieb

1 contact page 23

Dimitri Goulandris

1 contact page 23

Lorenzo Grabau

1 contact page 23

Francois Graff

Graff Managing Director

US2 contacts page 23

David Granby

UK1 contact page 23

Jacques Grange

France1 contact page 23

Jamie Grant

1 contact page 23

Princess Olga Greece

1 contact page 23

MC & Pavlos Greece

hrh Prince Pavlos

1 contact page 23

Deborah Green

1 contact page 23

Jeremy Green

South Africa2 contacts page 23

Judy Green

US1 contact page 23

Geordie & Katherine Gregg

1 contact page 23

Natasha Grenfell

UK1 contact page 23

Ted Griffen

1 contact page 23

Nina Griscom

US1 contact page 23

Pamela Gross

US2 contacts page 23

Jimmy Finkelst

US2 contacts page 23

Lloyd Grossman

1 contact page 24

Marjorie Gubelmann

US1 contact page 24

Tony Guccioni

1 contact page 24

Christian Gudefin

Deutsche Bank

1 contact page 24

Solina & Nicolas Guedroitz

Sally & Rufus’ bestfreinds

UK1 contact page 24

Alessandro Guerini Maraldi

UK1 contact page 24

Valesca Guerrand-Hermes

Mathias

US1 contact page 24

Cornelia Guest

1 contact page 24

Barbara & Bert Fie Guggenheim

US2 contacts page 24

Sabrina Guiness

1 contact page 24

Mr Hugo Guinness

UK1 contact page 24

Luca Guissaini

1 contact page 24

Ira Gumberg

1 contact page 24

Susan & John Guttfreund

1 contact page 24

Dr.& Mrs Hahn

Germany1 contact page 24

Pippa Hall

1 contact page 24

Jen Halpern

Halpern Associates

UK2 contacts page 24

Clementine Hambro

1 contact page 24

George Hamilton

UK2 contacts page 24

Dana Hammond

1 contact page 25

Sharon Handler

US1 contact page 25

Ernst & Chantal Hanover

UK1 contact page 25

Brook Hanson

UK1 contact page 25

Lord & Lady Hanson

1 contact page 25

The Hon Robert Hanson

UK2 contacts page 25

Marie Hapsburg

UK1 contact page 25

Victoria Harvey

1 contact page 25

Isabella Harvie-Watt

1 contact page 25

Nick Haslam

1 contact page 25

Craig & Jane Hatkoff

Victor Capital Group

US1 contact page 25

Marc de Hauteville

1 contact page 25

Henry & Patricia Hay

US1 contact page 25

Reggie Hayworth

1 contact page 25

Clare Hazeli-Iveagh

Elveden Farms Limited

UK1 contact page 25

Barry & Susan Hearn

Matchroom

1 contact page 25

Bob Hefner III

1 contact page 26

Lisa Heiden

US2 contacts page 26

Mr Fredie Heineken

France1 contact page 26

Helen & Tim Shifter

US1 contact page 26

Marie Helvin

1 contact page 26

Jason Herbert

1 contact page 26

Olga & Olaf Hermes

US1 contact page 26

Juan & Helen Herrero

Spain1 contact page 26

Robert & Kim Hersov

UK1 contact page 26

Mr & Mrs Heseltine

UK2 contacts page 26

Ms Annabel Heseltine

Husband: Peter Butler

UK1 contact page 26

Rupert Heseltine

1 contact page 26

India Hicks

David Flintwood

Bahamas1 contact page 26

Anthony Hill

UK2 contacts page 26

Howard Himmelstein

Zyzzx

1 contact page 26

Jeff Hirsch

Photo Care

1 contact page 26

Robert & Andrea Hissom

UK1 contact page 26

Dustin Hoffman

1 contact page 26

Hetty Hoffman

UK1 contact page 26

Jessica Hoffman

US1 contact page 27

Ben Holland-Martin

UK1 contact page 27

Bea & James Hollond

European Financial Products Ltd

UK2 contacts page 27

Adam & Tierney Horne

UK2 contacts page 27

Ivana Bastiani

Listed under Adam & Tierney Horne

UK1 contact page 27

Nina Hovenian

1 contact page 27

Shaunt Hovnanian

Hovanian Group

US2 contacts page 27

Howard J. Kaplan

US2 contacts page 27

Lucy Howegego

1 contact page 27

Peter Hsu

1 contact page 27

Laura Hunt

2 contacts page 27

Gordon, Kit & Georgina Hunter

UK1 contact page 27

Carlyn & Laurie Hunter

UK1 contact page 27

Jon Huntsman

US1 contact page 27

Mary Kaye

US1 contact page 27

Nick & Kim Hurd

Hartley Court

UK2 contacts page 27

Liz Hurley

Simian Films

UK1 contact page 27

Anne Hurst

1 contact page 28

Robert J. Hurst

Goldman Sachs & Co. Vice Chairman

US2 contacts page 28

Ayla Hussain

Sundari

US1 contact page 28

Simon Hussey

UK1 contact page 28

Henry Hutley

UK1 contact page 28

Lulu & Edward Hutley

UK2 contacts page 28

Mr & Mrs Hutley

UK1 contact page 28

Lauren Hutton

1 contact page 28

Ivan Hymes

(Eddie’s Irv friend)

1 contact page 28

Inca

US1 contact page 28

Charlie Ind

UK1 contact page 28

Gerard J. Inzerillo

Kerzner International

US2 contacts page 28

Justine Carolie

Kerzner International

Listed under Gerard J. Inzerillo

US1 contact page 28

George Ireland

UK1 contact page 28

Eddie Irvine

1 contact page 28

Abdullah Isamel

1 contact page 28

Chris Isham

1 contact page 28

Samuel Gen

US1 contact page 28

Julian Jacobson

1 contact page 28

Mick Jagger

1 contact page 28

Hatti Jagger

Percy Lodge

UK2 contacts page 29

Jake

1 contact page 29

Mohammed Jameel

1 contact page 29

Susie James

UK1 contact page 29

Linda Janklow

Lincoln Center Theatre

US1 contact page 29

Nancy & Andrew Jarecki

Hit The Ground Running Films

US2 contacts page 29

Nick Jarecki

Falconwood

US1 contact page 29

Jason

1 contact page 29

Meites Javier

1 contact page 29

Tim Jeffries

UK2 contacts page 29

Richard & Nadine Johnson

US1 contact page 29

Lucy Johnson

UK1 contact page 29

Ann & Mick Jones

1 contact page 29

Barry & Jackie Josephson

(Barry W)

US2 contacts page 29

Kalliope Karella

US1 contact page 29

Michael Rena

US1 contact page 29

Ron Kastner

1 contact page 29

Anton Katz

1 contact page 29

Robin Plant

1 contact page 29

Mark Katzenellenbogen

South Africa1 contact page 30

Sarah Kelling

1 contact page 30

Rory Kegan

UK1 contact page 30

Amanda Keidan

Amanda Keidan Jewelry

US1 contact page 30

Jon Keidan

1 contact page 30

Georgie Keller

1 contact page 30

Caroline Kellet Fraysse

Jeanmarc Fraysse

UK1 contact page 30

Leo-Arthur & Gayl Kelmenson

Buzell, Jacobs, Neyann & Eckh

US1 contact page 30

Andrew & Kerry Kennedy Cuomo

US1 contact page 30

Ted Jr. Kennedy

US1 contact page 30

Bobby & Mary Kennedy

Pace Environmental Litigalion Clinic

2 contacts page 30

Ethel Kennedy

Hickory Hill

US1 contact page 30

Jo Kennedy

US1 contact page 30

Senator Edward Kennedy

US1 contact page 30

Sol Kersner

South Africa1 contact page 30

Antoine & Jana & George Khayat

UK1 contact page 30

Jemma Kidd

1 contact page 30

Abby King

UK2 contacts page 30

Taylor & Charlie & Helen Kirwin

UK1 contact page 31

Peter Kirwin Taylor

1 contact page 31

Henry Kissinger

US2 contacts page 31

Rupert & Charlotte de Klee

1 contact page 31

Johnathan Klesch

1 contact page 31

David Koch

1 contact page 31

Astrid Kohl

France1 contact page 31

Boby Kotic

Activision

1 contact page 31

Alex Von Kotze

UK1 contact page 31

Anna Kravetz

1 contact page 31

Caryn Krooth

1 contact page 31

Alistar Kudrow

1 contact page 31

Dalamal Lal

UK2 contacts page 31

Demetra Lalaunis

US1 contact page 31

Christopher Lambert

1 contact page 31

David Lambert

1 contact page 31

Edward Lambert

ESL Partners

US1 contact page 31

Duff & John Lambos

1 contact page 31

Caroline Lang

US1 contact page 31

Dieter Lange

1 contact page 31

Janet Larsen

UK1 contact page 32

Jonathan Laurie

UK1 contact page 32

Laura D.B. de Laviada

1 contact page 32

Christopher & Jean Lawford

US1 contact page 32

Paul Lawton

1 contact page 32

Christophe & Marie Lazar

L’Orongerie

France1 contact page 32

Simon & Jasmine Le Bon

1 contact page 32

Jean-Yves Le Fur

France1 contact page 32

Willie Le Marq

US1 contact page 32

Lea Piers

UK1 contact page 32

Jeffrey Leeds

US1 contact page 32

Jerry Lefcourt

1 contact page 32

Dominick Lester

US1 contact page 32

Philip Levine

Baron Corporation

US1 contact page 32

Doug Liman

1 contact page 32

Sloan & Roger Lindeman-Barnet

1 contact page 32

Adam & Elizabeth Lindemann

US1 contact page 33

George Sr. & Freida Lindemann

US1 contact page 33

Alex & Jaclyn Lindsay

Studio 5

UK1 contact page 33

Ludovic Lindsey

UK1 contact page 33

Blake Lindsley

US1 contact page 33

David Linley

1 contact page 33

Babis Liogos

1 contact page 33

Paul Lister

1 contact page 33

Arriette Livanos

1 contact page 33

Robert Lo Cascio

Live Wire CEO

US1 contact page 33

Alex Loeb

US1 contact page 33

Richard Lonsdale

1 contact page 33

Eva Vivre Lorenzoti

US1 contact page 33

John & Lottie Lorimer

UK1 contact page 33

Guy J Louthan

1 contact page 33

Courtney Love

US1 contact page 33

Ivana Lowell

US1 contact page 33

Mark Loyd

UK1 contact page 33

Colin Lucas

1 contact page 33

Carol & Earl Mack

The Mack Company

US2 contacts page 33

Dave & Bella Macmilan

UK1 contact page 34

Ira C Magaziner

1 contact page 34

Jennifer Maguire

US1 contact page 34

Elsa Hurley

Listed under Jennifer Maguire

US1 contact page 34

Giovanni Mahler

1 contact page 34

Sean Mahoney

US1 contact page 34

Michael Maller

US2 contacts page 34

Josh Mailman

1 contact page 34

Harry & Didi Malek

UK1 contact page 34

Machel Malenga

1 contact page 34

Marjorie Malina

1 contact page 34

Shelly & Tony Malkin

US1 contact page 34

Philip Mallinckrodt

UK1 contact page 34

John Manconi

1 contact page 34

Peter Mandelson

Member of Parliament, House of Commons, The Right Honorable Peter Mand

UK2 contacts page 34

Alessandro Manfredini

UK1 contact page 34

Eddie Mangope

Las Arcadas Leopard Park

1 contact page 34

Eddie Manners

UK1 contact page 34

Lucy Manners

UK1 contact page 34

Terssa Manners

UK1 contact page 35

Jose Luis & Alejandra Manzano

1 contact page 35

John Mappin

UK1 contact page 35

Eric Margolis

Jamieson Laboratories, Chairman

Canada2 contacts page 35

Grainne Jones

Listed under Eric Margolis

Canada1 contact page 35

Stephen & Alisa Marks

UK2 contacts page 35

Manilo & Pia Marocco

UK1 contact page 35

Jeremy Marsh

Swaltes Farm

UK2 contacts page 35

Tash Courage

Swaltes Farm

Listed under Jeremy Marsh

1 contact page 35

Astrid Merterier

US1 contact page 35

Peter Martins

NYC Ballet Director

1 contact page 35

Matteo Marzotto

Valentino

1 contact page 35

Christopher Mason

US1 contact page 35

Parisi Massimo

Baltic Models

1 contact page 35

Carolina Mattsson

Sweden1 contact page 35

Caitlin Mavroleon

1 contact page 35

Basil & Carina Mavroleon

1 contact page 35

Carlos Mavroleon

UK1 contact page 35

Manoll Mavroleon

UK1 contact page 36

Bluey Mavroleon

Switzerland1 contact page 36

Nicholas & Barbara Mavroleon

1 contact page 36

Anne Maxwell & Laurens

Holve

UK1 contact page 36

Christine Maxwell Malina

France2 contacts page 36

Debbie Maxwell

1 contact page 36

Philip Maxwell

UK1 contact page 36

E. Maxwell

UK2 contacts page 36

Ian & Tara Maxwell

Telemonde Networks Ltd

UK2 contacts page 36

Isabel Maxwell

US1 contact page 36

Alexander Djerassi

Listed under Isabel Maxwell

US1 contact page 36

Kevin & Pandora Maxwell

Telemonde Inc.

UK2 contacts page 36

Marcella Maxwell

UK1 contact page 37

John Mayhew

UK2 contacts page 37

Yassi Mazandi

UK1 contact page 37

Mateo Mazzoti

1 contact page 37

MC & Allenor

Lime close

UK2 contacts page 37

Alistair & Romilly McAlpine

Italy1 contact page 37

John McDonald

1 contact page 37

Anthony McFarland

1 contact page 37

Raymond McKenzie

Lazard Freres & Co.

US1 contact page 37

Cas Mclancy

1 contact page 37

Shannon Mclane

Cose Belle

1 contact page 37

Jock & Pru Mcleod

UK1 contact page 37

Todd Meister

US2 contacts page 37

Neil Mendoza

UK2 contacts page 37

Kate Menzies

UK1 contact page 37

Guy & Caroline Merison

1 contact page 37

Bruce Merivale-Austen

UK1 contact page 37

Jonathan Mermagon

UK1 contact page 38

Justin Metcalf

1 contact page 38

Melanie & Julian Metcalf

UK1 contact page 38

Julian & Melanie Metcalfe

2 contacts page 38

Justin & Joane Metcalfe

US1 contact page 38

Robin Metz

Nomi’s

1 contact page 38

Tony Meyer

US1 contact page 38

Fev & John Micklethwait

UK1 contact page 38

Gianluca Milani

Italy1 contact page 38

George & Clare Milford Haven

UK2 contacts page 38

Sarah Milford Haven

UK1 contact page 38

Nicole Miller

US2 contacts page 38

Cheryl Mills

1 contact page 38

Carie Minot

1 contact page 38

George Bell

1 contact page 38

Susan Minot

US1 contact page 38

Kevin Mischer

1 contact page 38

Daniela Modafferi

Italy1 contact page 38

Cico Moncada

1 contact page 38

Rosa Monckton

Asprey & Gerad Ltd.

UK1 contact page 39

Charlie & Kit Money Kryle

UK1 contact page 39

Cesar Montemayor

1 contact page 39

Riccardo Monti

1 contact page 39

Deborah Moore

UK1 contact page 39

Juliet & Chris Moore

US1 contact page 39

Geoffrey Moore

UK1 contact page 39

Stephen Morris

Capita Advisors Inc.

US1 contact page 39

Nick & Lucy Morris

UK1 contact page 39

Gigi & Averell Mortimer

Arden Asset Managment Inc., President

US2 contacts page 39

Peter Morton

1 contact page 39

Robert Morton

Producer Letterman s

1 contact page 39

Alan Mruvka

1 contact page 39

Donald Munro

US1 contact page 39

Rupert Murdoch

1 contact page 39

Kate Murray Philipson

1 contact page 39

Mr & Mrs Murray Philipson

UK1 contact page 39

Tertious & Cla Murray Threipland

1 contact page 39

Jean Pierre Murray

1 contact page 39

Emanuel Nadler

1 contact page 40

Adam Nagel

1 contact page 40

William Nagel

1 contact page 40

Dott M Jacope Nardi

1 contact page 40

Lile & Alex Nastasse

US1 contact page 40

Jelitza Negrete

US1 contact page 40

Andrew Nell

UK1 contact page 40

Andrew Neil

US1 contact page 40

Hetty Newman

UK1 contact page 40

John Newman

UK1 contact page 40

Clive Ng

US1 contact page 40

Constantine Niarchos

UK1 contact page 40

William & Jayne Nickerson

UK1 contact page 40

Yoshi Nishio

US1 contact page 40

Alix Noel

US1 contact page 40

Hon Thomas Noel

The Grange Farm

UK2 contacts page 40

Vanessa Noel

US1 contact page 40

Cecilia Noha

1 contact page 40

Tim Noonan

1 contact page 40

Harry Nuttall

RNR International Ltd., Chairman

UK2 contacts page 40

Carletto O’Donnell

UK2 contacts page 41

Louis O’Neill

US1 contact page 41

Simon Oates

1 contact page 41

Tom Oates

UK1 contact page 41

Yinka Ojora

1 contact page 41

Marella Oppenheim

1 contact page 41

Katie Orchard (Vaughn-Edward)

UK1 contact page 41

Alexander Mann

Global Markets

Listed under Orchard

UK2 contacts page 41page 83

Fabrice Orlando

1 contact page 41

Rachel Osbourne

UK1 contact page 41

William & Arabella Oswald

UK2 contacts page 41

Beo & Edvige Otto

1 contact page 41

Tom & Kate Owen Edmunds

The Coach House

UK1 contact page 41

Christina marc Yaggi Oxenberg

US1 contact page 42

Nicole Paini

UK1 contact page 42

Marcia Palau

UK1 contact page 42

Tara Palmer Tomkinson

1 contact page 42

James Palumbo

UK1 contact page 42

Peter Palumbo

UK1 contact page 42

Nader & Brigitte Panah-Izadi

France2 contacts page 42

Victoria & Alby Carto Pank

UK1 contact page 42

Jackie Parker

1 contact page 42

Carolina Parsons

1 contact page 42

Elise Paschen

1 contact page 42

Joel Pashcow

Atlantic Realty Trust

US4 contacts page 42

Stacey Pashcow

US1 contact page 42

Andres Pastrana

Ex President of Colu

Columbia2 contacts page 42

Hon Charles Pearson

UK1 contact page 43

Simon & Clem Pease

Underley Grange

UK1 contact page 43

Lorenzo Pedrini

Next Model agency

1 contact page 43

Tito Pedrini

1 contact page 43

Marcus Pekeler

1 contact page 43

Harlan Peltz

US1 contact page 43

Mark Pennell

1 contact page 43

Ronald Perelman

Revlon

US1 contact page 43

Helsius Petangi

1 contact page 43

John Peters

Peters Entertainment

US1 contact page 43

Holly Peterson

1 contact page 43

Riki Peterson

1 contact page 43

Pham & Andrew Linh-Dan

US1 contact page 43

Olivier & Alice Picasso

France1 contact page 43

Michael Picclotto

1 contact page 43

Jane & William Pickering

UK1 contact page 43

Frederico Pignatelli

US1 contact page 43

Jean Pigozzi

US1 contact page 43

Bob & Veronique Pittman

AOL Networks, President & CEO

US2 contacts page 43

Sandy Pittman

1 contact page 44

Richard Plepler

US2 contacts page 44

Diane & Denis Plouvier

France2 contacts page 44

Jeffrey Podolsky

New York Editor, Tatler

US1 contact page 44

George Polk

1 contact page 44

Edoardo Polli

Legler S.p.A.

Italy1 contact page 44

Emmanuelle Polu

1 contact page 44

Isabelle Polu

1 contact page 44

Clary Polu

France1 contact page 44

Ivanisevic Porrin

1 contact page 44

Pliny Porter

Fireworks Pictures

US1 contact page 44

Emmanuele Porthault

1 contact page 44

Porthault

France1 contact page 44

Pascal Porthault

France1 contact page 44

Remi & Isabel Forthault

France1 contact page 44

Meryl Poster

Miramax Films, Sr. V.P. Production

US2 contacts page 44

Muffie Potter

1 contact page 44

Electra Prestin

1 contact page 44

Catherine Prevost

1 contact page 44

Charles H. II Price

US1 contact page 45

Judy Price

Avenue

US1 contact page 45

Nick Pritzker

Hyatt Fevelopment Corp.

US2 contacts page 45

Thomas Pritzker

Numero Uno

US2 contacts page 45

Rodney Propp

Birkman friend

1 contact page 45

Christy Prunler

US1 contact page 45

David Doss

US1 contact page 45

Laudomia Pucci

Italy1 contact page 45

Marc Puig

Fashion Di, President

Spain1 contact page 45

Taria Puig

Spain1 contact page 45

Sonia Puopolo

1 contact page 45

David Puttnam

UK1 contact page 45

Chris Pymont

UK1 contact page 45

Alan Quartucci

1 contact page 45

Quinn Topper

1 contact page 45

Nicholas Rachline

1 contact page 46

Carole Radzlwill

US1 contact page 46

Gavin Rankln

UK1 contact page 46

Don Rappaport

1 contact page 46

Isabel Rattazzi

1 contact page 46

Patty Raynes

1 contact page 46

Kate Reardan

UK1 contact page 46

Michael Reynal

1 contact page 46

Miquel Reynal

Argentina1 contact page 46

Ali Reza

UK1 contact page 46

Nick Rebecca Willis Ritblat

1 contact page 46

Thomas Rupert Ritson

1 contact page 46

Joan Rivers

Melissa Rivers

US1 contact page 46

Joseph & Jill Robert

US1 contact page 46

Deb Roberts

1 contact page 46

Edmondo di Maya Robilant

UK1 contact page 46

Robin

1 contact page 46

Kasia / Pod Robinski

UK1 contact page 46

Jo Robinson

1 contact page 46

Lisa Shields

1 contact page 46

David Rocksavage

1 contact page 46

Bill Roaedy

MTV Europe

UK1 contact page 47

Gail Rolfe

UK1 contact page 47

Gerald Ronson

UK1 contact page 47

Wendy & Jo Rose

1 contact page 47

Charlie Rose

US1 contact page 47

Amanda Burder

US1 contact page 47

Andrew Rosen

1 contact page 47

Denis & Sylvia Rosen

UK1 contact page 47

Claudia Rosencrantz

UK1 contact page 47

Donald Rosenfeld

US1 contact page 47

Rob Rosenstein

1 contact page 47

Jane Rosenthal

Tribeca Productions

US1 contact page 47

Peter Thomas & Noreen Roth

Karbra Co.

US2 contacts page 47

Jessica Rothchild

1 contact page 47

Hannah Rothchild

UK1 contact page 47

Rich Rothenburg

1 contact page 47

Tania & Robin Rotherwick

Orc Software Ltd.

UK2 contacts page 47

Edouard De Rothschild

France1 contact page 48

Evelyn De Rothschild

UK1 contact page 48

Caroline Roumugere

1 contact page 48

Hon Lucinda Royle

UK1 contact page 48

Natalie Rucellai

Catherine’s friend

1 contact page 48

Della Rudnick

1 contact page 48

Michelle Russel

US1 contact page 48

Marina & Ian Rust

Ian-office

US2 contacts page 48

Tim Rustow

US1 contact page 48

Duke & Duchess Rutland

Belvoir Castle

UK1 contact page 48

Eric & Perri Ruttenberg

Tinicum Inc.

US2 contacts page 48

Nicholas Ryder

UK1 contact page 48

Amy Sacco

1 contact page 48

Jeffrey Sachs

1 contact page 48

Edmund Saffra

1 contact page 48

Wayne Safro

Cute S African (heide)

1 contact page 48

Wafic Said

1 contact page 48

Jamie Sainsbury

UK1 contact page 48

Eric Salama

1 contact page 48

Elizabeth Saltzman

UK1 contact page 49

Mia Samuels

ABC Prime Time

1 contact page 49

Jon & Corrie Sandelmar

US1 contact page 49

Guy & Fi Sangster

UK1 contact page 49

Ben Sangster

1 contact page 49

Julio Mario Santo Domingo

Switzerland1 contact page 49

M Espirito Santo

Portugal1 contact page 49

Solman

Saudi Prince

1 contact page 49

Randall Scerbo

US1 contact page 49

Gianmarco Schiatti

1 contact page 49

Helen & Tim Schifter

US1 contact page 49

Simon & Santa Sebag Montefiroe

1 contact page 49

Christine Seilern

US1 contact page 49

Isabel de Sejournet

UK1 contact page 49

Benny Shabtai

1 contact page 49

Brenda Shad

1 contact page 49

Andre & Angie Shearer

1 contact page 49

Chris & Maura Shore

US1 contact page 49

Bobby Shriver

Special Olympics Productions

US3 contacts page 49

Maria Shriver

1 contact page 49

Susie Shuster

1 contact page 50

Peggy Siegal

US2 contacts page 50

William / Bill Siegel

Chris-Craft Industries

US2 contacts page 50

William Sieghart

UK1 contact page 50

Ron Silver

1 contact page 50

Nancy & Henry Silverman

US2 contacts page 50

Bren Simon

MBS Associates, LLC

US2 contacts page 50

Sophie Simpson (Caruth)

1 contact page 50

Rena & Sami Sindi

US1 contact page 50

Bobby Slayton

1 contact page 50

Osborne Smith

US1 contact page 50

Noona Smith Peterson

1 contact page 50

James Smith

Aegis Trust

UK1 contact page 50

Maria Snyder

US1 contact page 50

Rupert & Milly Soames

Bank Misys Chief Executive

UK2 contacts page 50

Esperanza Sobrino

Acquavella Galleries

US2 contacts page 51

Andrew Solomon

The New York Times

US2 contacts page 51

Peter Soros

UK2 contacts page 51

Jaime & Marina de Soto

UK1 contact page 51

Hamilton South

1 contact page 51

Carlos Souza

Valentino

1 contact page 51

Kevin Spacey

Trigger Street Productions

US1 contact page 51

Hugo Squire

UK1 contact page 51

Edward St. Bris

France1 contact page 51

Caroline Stanburry

1 contact page 51

Rachael Hunter

Listed under Caroline Stanburry

1 contact page 51

Koo Stark

1 contact page 51

Thomas Starzewski

1 contact page 51

Chris Steenkamp

1 contact page 51

Jeffrey Steiner

1 contact page 51

Chris & Nina Steinkampf

South Africa1 contact page 51

Andrew Stengel

Miramax

US1 contact page 51

Rick & Mary Stengel

US1 contact page 51

Allison & Leonard Stern

US2 contacts page 52

Michael Stevens

1 contact page 52

Charlie Stopford-Sackville

UK1 contact page 52

Shona McKinney

UK1 contact page 52

Kate Stracher

1 contact page 52

Stuart Sundlun

US1 contact page 52

James & Amanda Sunley

UK1 contact page 52

Harry Sutherland

1 contact page 52

Peter Svenlinson

UK1 contact page 52

Sophie Swire

1 contact page 52

Hugo Swire

UK1 contact page 52

Jenny Swire

1 contact page 52

Mark Swire

Mark Swire Properties Ltd.

UK2 contacts page 52

Lucy Ewen Sykes

1 contact page 52

Paul Taaffe

Hill & Knowlton

1 contact page 52

Karim & Cristina Tabet

US1 contact page 52

Taki

UK1 contact page 52

Simon Talbot Williams

UK1 contact page 52

David Tang

DWC Tang Development Ltd

UK3 contacts page 52

Lucy Wastnag

DWC Tang Development Ltd

UK3 contacts page 52

Rupert Tate

UK1 contact page 53

Alfred Taubman

US2 contacts page 53

Bobby Taubman

1 contact page 53

Billy & Nicket Tavoulareas

UK1 contact page 53

Peter Tavoulareas

UK1 contact page 53

Emmy Tayler

2 contacts page 53

Felicia Taylor

US1 contact page 53

Pamela Taylor

1 contact page 53

Sebastian Taylor

UK1 contact page 53

Julie & Eliot Taymor

Loh Inc. & Zarathustra Music

US2 contacts page 53

Harry Tennenbaum

1 contact page 53

Eduardo Teodorani-Fabbri

CNH Global N.V.

US2 contacts page 53

Karen Bird

CNH Global N.V.

Listed under Eduardo Teodorani-Fabbri

1 contact page 53

Francesca Theilmann

1 contact page 53

Catherine Theodoli

1 contact page 54

Moegens Tholstrup

UK1 contact page 54

Paola Tholstrup

UK1 contact page 54

Barnaby Thompson

1 contact page 54

David Tisch

1 contact page 54

Merryl & Jimmy Tisch

US1 contact page 54

Anne & Andrew Tish

US2 contacts page 54

Sonia Titopupolo

1 contact page 54

Emily Olypitus Todhunter

UK1 contact page 54

Alvarez de Toledo Ignacio

1 contact page 54

Bea Tollman

1 contact page 54

Brett Tollman

US1 contact page 54

Mr & Mrs Tollman

US1 contact page 54

Syrie & Gavin Tollman

US1 contact page 54

Wyne Tollman

US1 contact page 54

Veronica Toub (Busson)

US2 contacts page 54

Philip Treacy

UK1 contact page 54

Blaine & Robert Trump

US1 contact page 54

Ivana Trump

1 contact page 54

Ivanka Trump

1 contact page 54

Robert & Blaine Trump

Trump Management Inc.

US2 contacts page 55

Chris Tucker

1 contact page 55

Christy Turlington

US1 contact page 55

Charles Turnbull

Governor of USVI

1 contact page 55

Jenny Turner

UK1 contact page 55

Miles Creswell Turner

UK1 contact page 55

Francesca Tyssen

1 contact page 55

Jorge Urbiola

1 contact page 55

Iraj & Linda Vahabzadeh

US1 contact page 55

Sophie Van Hauen

Charlotte Morgan

UK1 contact page 55

William Van Straubenzee

UK1 contact page 55

Martin Varsavsky

1 contact page 55

Patricia Velasquez

1 contact page 55

Julia Verdin

1 contact page 55

Annie & JP Verdin-Mulot

France2 contacts page 55

Jane Veronis

US1 contact page 55

Carmine S. Villani

Milestone Capital Ltd. President

1 contact page 55

Jacques Villeneuve

1 contact page 55

Emanuele Vittadini

France1 contact page 55

Dott. Merco Vittoreill

Italy1 contact page 56

Martine Vittoz

1 contact page 56

Patrick Vittoz

London1 contact page 56

Vonnic Vittoz

1 contact page 56

Charles Vivian Smith

UK1 contact page 56

Francesca Von Habsburg

1 contact page 56

Bettina Von Hase

Nine AM Limited

UK1 contact page 56

Eric Wachtmeister

Viking Internet

US2 contacts page 56

David Wagner

1 contact page 56

Rupert Wainright

1 contact page 56

Sam Waksal

US1 contact page 56

Mike Wallace

CBS 60 Minutes

US1 contact page 56

Barbara Walters

US1 contact page 56

Kevin Ward

1 contact page 56

Ozzie Warner

1 contact page 56

Mandy Warnford-Davis

UK1 contact page 56

Casey & Laura Wasserman

US1 contact page 56

David Wassong

Soros Private Equity Partners

US1 contact page 56

Lisa Wassong

Soros Private Equity Partners

Listed under David Wassong

US1 contact page 56

Lucy Wastnage

Hong Kong2 contacts page 57

Felicity Waterman

US1 contact page 57

Victoria Watson

UK1 contact page 57

Veronica Webb

1 contact page 57

Lord Weidenfeld

UK1 contact page 57

Jason Weimberg

Untitled Entertainment

US2 contacts page 57

Bob Weinstein

1 contact page 57

Harriet Weintraub

US1 contact page 57

Ruth Dr. Westheimer

1 contact page 57

Lally Weymouth

1 contact page 57

Somers White

US1 contact page 57

Victoria White

1 contact page 57

Michael White

1 contact page 57

Victoria White O’Gara

US1 contact page 57

Alan & Wendy Whitworth

UK1 contact page 57

Jim Wlal

William Morission Agency

1 contact page 57

Anouska & Mark Wienberg

1 contact page 57

Eli & Marion Wiesel

1 contact page 57

Liionel & Lydia Wigram

1 contact page 57

Lionel Wigram

US1 contact page 57

Alexandra & Nick Williams

UK1 contact page 57

David & Serena Williams-Ellis

UK1 contact page 58

Rebecca Willis

UK1 contact page 58

Alex & Fi Wilmot-Sitwell

UK1 contact page 58

Carter Wilson

US1 contact page 58

Manfred Windisch Grazot

1 contact page 58

Tim & Helen Windsor-Taylor

UK1 contact page 58

Steve Winn

1 contact page 58

Elizabeth Winston

US1 contact page 58

George Wippie

Fox Journalist

1 contact page 58

Carol Wolper

US1 contact page 58

Andy Wong

1 contact page 58

Theodore Wong

UK1 contact page 58

Trinny Woodall

UK1 contact page 58

Emily & Carrie Woods

1 contact page 58

Alexa Woodward

1 contact page 58

Shaun & Camilla Woodward

UK1 contact page 58

Marq & Marc of Worcester

Bunter & Tracey

UK1 contact page 58

Jim Wyatt

1 contact page 58

Steve & Cate Wyatt

US1 contact page 58

Mai Yamani

UK1 contact page 58

Yariv Zghoul

1 contact page 59

Andrew Yates

1 contact page 59

Toby Young

UK1 contact page 59

Tracy Younger

1 contact page 59

Greg Lee

1 contact page 59

Dimitri Yugoslavia

Philipps

US2 contacts page 59

Prince Michel of Yugoslavia

Access International Advisors

US1 contact page 59

Serge de Yugoslavia

1 contact page 59

Gordon Zacks

R G Barry Corp

1 contact page 59

Alexi Zaies

1 contact page 59

Paige & Bob Zangrillo

US1 contact page 59

Waleed Zawauri

UK2 contacts page 59

Bibi & Adrian Zecher

1 contact page 59

Julia Walters

Listed under Bibi & Adrian Zecher

1 contact page 59

Mark Zeff

1 contact page 59

John Zeiler

US1 contact page 59

Dino & Rosi Zevi

US1 contact page 59

Bettina Zilkha

US1 contact page 59

Brian Zipp

US1 contact page 59

Ryan Dionne

The Chef

US1 contact page 59

Scott Geffert

US2 contacts page 59

Joseph & Florina Rueda

1 contact page 60

Sarah Kellen

US1 contact page 60

Brian Kelly

US1 contact page 60

Ghislaine Maxwell

LSJ

US9 contacts page 67page 71page 82page 83page 85page 86page 60page 95

Scott

Listed under Ghislaine Maxwell

US1 contact page 60

GM

Listed under Ghislaine Maxwell

US1 contact page 60

JE

Listed under Ghislaine Maxwell

US1 contact page 60

Tahoe

Listed under Ghislaine Maxwell

US1 contact page 60

PB

Listed under Ghislaine Maxwell

US1 contact page 60

Etrieve

Etrieve

Listed under Ghislaine Maxwell

US1 contact page 60

Rich’s Security

Rich’s Security

Listed under Ghislaine Maxwell

US1 contact page 60

Mitrovich Andrea

Ballerina

US1 contact page 60

Robert Goldberg

Police Serg

1 contact page 60

Joseph & Florena Rueda

US1 contact page 60

Kinney Tahoe

Garage

1 contact page 60

Antiques – Resale Number

Antiques – Resale Number

1 contact page 60

Arizona

Arizona

US1 contact page 60

Aspen Club

Aspen Club

1 contact page 60

Au Bar

Au Bar

US1 contact page 60

Avis International

Avis International

1 contact page 60

Frank Bowling

Bel Air Hotel, General Manager

US1 contact page 60

Beverly Hills Hotel

Beverly Hills Hotel

US1 contact page 60

Beverly Wilshire

US1 contact page 61

Bice

US1 contact page 61

Bilboquet

US1 contact page 61

America – Bond Street

US1 contact page 61

Carlyle

US1 contact page 61

Christies

US1 contact page 61

Kim Sharon

Listed under Christies

US1 contact page 61

Patrick Cooney

Listed under Christies

US1 contact page 61

Ken S.

Listed under Christies

US1 contact page 61

St. James

Listed under Christies

US1 contact page 61

Franka Mercati

Listed under Christies

US1 contact page 61

Carol Magill

Listed under Christies

US1 contact page 61

Maria Loss

Listed under Christies

US1 contact page 61

Kim Solow

Listed under Christies

US1 contact page 61

Sarah Charnon

Listed under Christies

US1 contact page 61

Cipriani

US1 contact page 61

Coffee Shop

Coffee Shop

US1 contact page 61

Gibby Cohen

Polly Gym

US1 contact page 61

Henry Meer

US1 contact page 61

Dawat Haute Cuisine of India

Dawat Haute Cuisine of India

US1 contact page 61

Delmonico’s

Delmonico’s

US1 contact page 61

Doyle’s

Doyle’s

US1 contact page 61

Elaine

US1 contact page 61

Electrolysis

Electrolysis

1 contact page 61

Elio’s Restaurant

Elio’s Restaurant

US1 contact page 61

Essex House

Essex House

US1 contact page 61

Estia

Estia

US1 contact page 61

Kristin Mcgee

Exercise – New York

US1 contact page 61

Magali

Exercise – New York

Listed under Kristin Mcgee

US2 contacts page 82page 61

Jessica Benton

Exercise – New York

Listed under Kristin Mcgee

US1 contact page 61

Jennifer

Exercise – New York

Listed under Kristin Mcgee

US4 contacts page 93page 61page 86

Four Seasons

Four Seasons

US1 contact page 61

Four Seasons Hotel

Four Seasons Hotel

US1 contact page 61

Four Seasons Restaurant

Four Seasons Restaurant

US1 contact page 61

Pork Pies, Pork Sauages

Pork Pies, Pork Sauages

US1 contact page 62

Nicolas

LSJ

US2 contacts page 67page 62

Antoine Blech

Opia

US1 contact page 62

Mathew

Bartle

US1 contact page 62

Peninsulla Hotel

Peninsulla Hotel

US1 contact page 62

Pierre Hotel

Pierre Hotel

US1 contact page 62

Plaza

Plaza

US1 contact page 62

Athenee Hotel

Athenee Hotel

US1 contact page 62

Province Restaurant

Province Restaurant

1 contact page 62

Ritz Carlton

Ritz Carlton

1 contact page 62

Royalton

Royalton

US1 contact page 62

Sette Mezzo

Sette Mezzo

US1 contact page 62

Shoes – Repair, Shoe Service Plus

Shoes – Repair, Shoe Service Plus

US1 contact page 62

Shutters on the Beach

Shutters on the Beach

US1 contact page 62

Sotheby’s

Sotheby’s

US2 contacts page 62

Steve Mcguire

Sotheby’s

Listed under Sotheby’s

US1 contact page 62

St Regis Hotel

St Regis Hotel

US1 contact page 62

Stanhope Hotel

Stanhope Hotel

US1 contact page 62

Sunset Marquee

Sunset Marquee

US1 contact page 62

Tao Restaurant

Tao Restaurant

US1 contact page 62

Taylor, The

Taylor, The

US1 contact page 62

The Great American Health Bar

The Great American Health Bar

US1 contact page 62

The Lowell

The Lowell

US1 contact page 62

The Westbury

The Westbury

US1 contact page 62

Premiere Tickets

Premiere Tickets

US1 contact page 63

London London

Listed under Premiere Tickets

US1 contact page 63

Tribeca Grill

Tribeca Grill

US1 contact page 63

Two Bunch Palm

Two Bunch Palm

US1 contact page 63

Waldorf

Waldorf Astoria Hotel

US1 contact page 63

Westbury Hotel

Westbury Hotel

US1 contact page 63

Cecilia Szajman

Brazil1 contact page 63

Brasilinvest

Brasilinvest

Brazil1 contact page 63

Riccardo

1 contact page 63

Annabels

Annabels

1 contact page 63

Aspinals

Aspinals

1 contact page 63

Bibendum

Bibendum

1 contact page 63

Clermont Club

Clermont Club

1 contact page 63

Daphne

Daphne

2 contacts page 67page 63

Foxtrot Oscar

Foxtrot Oscar

1 contact page 63

Harrys Bar

Harrys Bar

1 contact page 63

Marks Club

Marks Club

1 contact page 63

Nam long

Nam long

1 contact page 63

Nikitas

Nikitas

1 contact page 63

Patisserie Valerie

Patisserie Valerie

1 contact page 63

San Lorezo

San Lorezo

1 contact page 63

Scalinis

Scalinis

1 contact page 63

Tramp

Tramp

1 contact page 63

Ira Zicherman

Bear Stearns

US1 contact page 63

Centurion

Centurion

1 contact page 63

James A. Growney

Chemical Bank Vice President

US1 contact page 63

Barbara Parsley

Chemical Bank

Listed under Finance – Chemical Bank

1 contact page 63

Cristina Bello

Colonial Bank (handwritten: Leonor)

1 contact page 64

Rob Bowran

Nat West

UK2 contacts page 64

Sharon Mulvany

Nat West

Listed under Finance – Nat West

UK2 contacts page 64

Finance – Natwest Bank

1 contact page 64

Dottle Wilson

1 contact page 64

Alaia Azzedine

France1 contact page 64

France – ATT Acess

France1 contact page 64

France – Bristol Hotel

France1 contact page 64

France – Cab Blue

France1 contact page 64

France – Cabaret (night club) (contact Frank)

France1 contact page 64

Baccart

Avis/St Tropez

France1 contact page 64

Chateau de la Messardler

Chateau de la Messardler

France1 contact page 64

Chez Denise

Chez Denise

France1 contact page 64

Chez L’Ami Louis

Chez L’Ami Louis

France1 contact page 64

Epstein Jeffrey

France2 contacts page 64

Marie Jean

Listed under France – Epstein, Jeffrey

France1 contact page 64

Cotrin Valdson

Listed under France – Epstein, Jeffrey

France1 contact page 64

Everlyn

Listed under France – Epstein, Jeffrey

France1 contact page 64

Ms. Peres

Listed under France – Epstein, Jeffrey

France1 contact page 64

Ms. Roule

Listed under France – Epstein, Jeffrey

France1 contact page 64

Mr. Pascal

Listed under France – Epstein, Jeffrey

France1 contact page 64

Mr. Karim/Karin?

Listed under France – Epstein, Jeffrey

France1 contact page 64

Mr. Lazno

Listed under France – Epstein, Jeffrey

France1 contact page 64

Mr. Tourteau

Listed under France – Epstein, Jeffrey

France1 contact page 64

Mr. Belstan/Belistan?

Listed under France – Epstein, Jeffrey

France1 contact page 64

Mr. Domenichini

Listed under France – Epstein, Jeffrey

France1 contact page 64

Mr. Lafond

Listed under France – Epstein, Jeffrey

France1 contact page 64

Mr. Pasquer

Listed under France – Epstein, Jeffrey

France1 contact page 64

Mr. Santos

Listed under France – Epstein, Jeffrey

France1 contact page 64

Marie Joseph Experton

Berfloz & Co.

Belgium1 contact page 65

Gerard

France1 contact page 65

Hotel Crillon

Hotel Crillon

France1 contact page 65

Hotel Raffael

Hotel Raffael

France1 contact page 65

Philippe Junot

US2 contacts page 65

L’Amijean

L’Amijean

France1 contact page 65

L’Arc

L’Arc

France1 contact page 65

L’Arpege

L’Arpege

France1 contact page 65

La Meriot

La Meriot

France1 contact page 65

La Poste

La Poste

France1 contact page 65

Betty Lagardere

France1 contact page 65

Stephane Coulaux

France1 contact page 65

Geraldine Talavera

Listed under Stephane Coulaux

France1 contact page 65

Le Telegraphe

Le Telegraphe

France1 contact page 65

Madame Lemercier

France1 contact page 65

Faiza

France1 contact page 65

Anne

Listed under Anne

France1 contact page 65

Claudia Hadida

France1 contact page 65

Debbie

Listed under Claudia Hadida

France1 contact page 65

Marie Francois

Listed under Claudia Hadida

France1 contact page 65

Rosemary

Listed under Claudia Hadida

France1 contact page 65

Alexandria

Listed under Claudia Hadida

France1 contact page 65

Carolina

Listed under Claudia Hadida

France1 contact page 65

Caroline

Listed under Claudia Hadida

France2 contacts page 65page 94

Debra Wakshai

Listed under Claudia Hadida

France1 contact page 65

Isabelle

Listed under Claudia Hadida

France1 contact page 65

Stephan

Listed under Claudia Hadida

France1 contact page 65

Bastien

Listed under Claudia Hadida

France1 contact page 65

Deborah

Listed under Claudia Hadida

France3 contacts page 65

Francois

Listed under Claudia Hadida

France2 contacts page 65

Suzanne

Listed under Claudia Hadida

France1 contact page 65

Corine – thai

Listed under Claudia Hadida

France1 contact page 65

Karine

Listed under Claudia Hadida

France1 contact page 65

Laetitfa

Listed under Claudia Hadida

France1 contact page 65

Magdall

Listed under Claudia Hadida

France1 contact page 65

Donna

Listed under Claudia Hadida

France1 contact page 65

Yelena

Listed under Claudia Hadida

France1 contact page 65

Nadja

Listed under Claudia Hadida

France1 contact page 65

Nadia

Listed under Claudia Hadida

France2 contacts page 65

Sonya

Listed under Claudia Hadida

France1 contact page 65

Tanya

Massage – California

Listed under Claudia Hadida

France2 contacts page 65page 92

Mr & Mrs Miele

France1 contact page 66

Cynthia & Claude Ott

France1 contact page 66

Alberto Pinto

France2 contacts page 66

Linda Pinto

Listed under Alberto Pinto

France1 contact page 66

Serge Boquet

Listed under Alberto Pinto

France1 contact page 66

Delphine Rateau

Listed under Alberto Pinto

France1 contact page 66

Jean Guguen

Listed under Alberto Pinto

France1 contact page 66

Danielle

Listed under Alberto Pinto

France1 contact page 66

Yves

Listed under Alberto Pinto

France1 contact page 66

Chantal

Listed under Alberto Pinto

France1 contact page 66

Pascal Laparra

Listed under Alberto Pinto

France1 contact page 66

Plaza Athensee

Plaza Athensee

France1 contact page 66

Sushi

Sushi

France1 contact page 66

Restaurant Enlecote

Restaurant Enlecote

France1 contact page 66

Ritz

Ritz

France1 contact page 66

France – River Cafe

France1 contact page 66

Tante Louise

Tante Louise

France1 contact page 66

Taxi Bleus

Taxi Bleus

1 contact page 66

France – Taxis

1 contact page 66

France – Taxis Bleus

1 contact page 66

Valdson Vleira Cotrin

France2 contacts page 66

Maria

Listed under Valdson Vleira Cotrin

France1 contact page 66

Berkeley Hotel

Berkeley Hotel

1 contact page 66

Blakes

Blakes

1 contact page 67

Carlton Tower

Carlton Tower

1 contact page 67

Claridges Hotel

Claridges Hotel

UK1 contact page 67

Cliveden House

Cliveden House

UK1 contact page 67

Connaught Hotel

Connaught Hotel

1 contact page 67

Dorchester Hotel

Dorchester Hotel

1 contact page 67

Geoffrey Gelardi

Lanesborough Hotel General Manager

UK1 contact page 67

Hotel Ritz

Hotel Ritz

1 contact page 67

Hotel Savoy

Hotel Savoy

1 contact page 67

The Barcley Hotel

The Barcley Hotel

UK1 contact page 67

Waterside Inn

Waterside Inn

1 contact page 67

Nicholas & Tina

Air Center Helicopter

1 contact page 67

Christopher

1 contact page 67

Madison Cox

Madison Cox Design, Inc.

US1 contact page 67

Jeffrey Epstein

LSJ

US20 contacts page 67page 71page 82page 85page 91page 95

Gretchen

LSJ

Listed under Jeffrey Epstein

US1 contact page 67

Miles

LSJ

Listed under Jeffrey Epstein

US1 contact page 67

Cathy

LSJ

Listed under Jeffrey Epstein

US1 contact page 67

Bascoe Hague

LSJ

Listed under Jeffrey Epstein

US1 contact page 67

Bruce White

LSJ

Listed under Jeffrey Epstein

US1 contact page 67

Tim Cook

LSJ

Listed under Jeffrey Epstein

US1 contact page 67

LSJ

LSJ

Listed under Jeffrey Epstein

US6 contacts page 67page 68

Leon

LSJ – Financial Trust Company

Listed under Jeffrey Epstein

US1 contact page 67

Dale

LSJ – Financial Trust Company

Listed under Jeffrey Epstein

US1 contact page 67

Cecile

LSJ – Financial Trust Company

Listed under Jeffrey Epstein

US1 contact page 67

Jeanne

LSJ – Financial Trust Company

Listed under Jeffrey Epstein

US1 contact page 67

Lorette

LSJ – Financial Trust Company

Listed under Jeffrey Epstein

US1 contact page 67

Jermaine

LSJ – Financial Trust Company

Listed under Jeffrey Epstein

US1 contact page 67

Jamie

LSJ – Financial Trust Company

Listed under Jeffrey Epstein

US1 contact page 67

Kim

LSJ – Financial Trust Company

Listed under Jeffrey Epstein

US1 contact page 67

Paul Hoffman

Paul Hoffman, P.C.

US2 contacts page 67

Lynn & Karen Gray

LSJ

1 contact page 68

Muffie Landt

LSJ

Listed under Lynn & Karen Gray

1 contact page 68

Zeno

LSJ

Listed under Lynn & Karen Gray

1 contact page 68

Kevin Raynold

LSJ

Listed under Lynn & Karen Gray

1 contact page 68

Gretchen Rhodes

LSJ

Listed under Lynn & Karen Gray

1 contact page 68

Brian Moseley

LSJ

1 contact page 68

Theresa Roberts

LSJ

US1 contact page 68

Elisa Eshed

Israel1 contact page 68

Efrat Evani Duud

Israel1 contact page 68

Avi Gil

Israel1 contact page 68

Arik Gutman

Israel1 contact page 68

Israel – Jerusalem Hyatt

Israel1 contact page 68

Neima Yakhof

Israel1 contact page 68

Ehud Olmert

1 contact page 68

Italy – Torne di Pisa

1 contact page 68

Italy – Train Info

1 contact page 68

Jeffrey – Apt. for Models

US1 contact page 68

Caba Yokosta

Listed under Jeffrey – Apt. for Models

1 contact page 68

Morrison

Listed under Jeffrey – Apt. for Models

1 contact page 68

Anna Macedo

Listed under Jeffrey – Apt. for Models

1 contact page 68

Jeffrey – Apt. for Models (4M) (Guest)

Listed under Jeffrey – Apt. for Models

1 contact page 68

Jeffrey – Apt. for Models (5P) (L&J)

Listed under Jeffrey – Apt. for Models

1 contact page 68

Jean-Luc

Listed under Jeffrey – Apt. for Models

1 contact page 68

Brent

Listed under Jeffrey – Apt. for Models

1 contact page 68

Jeffrey – Apt. for Models (8C)

Listed under Jeffrey – Apt. for Models

1 contact page 68

Sarah

Listed under Jeffrey – Apt. for Models

1 contact page 68

Dave

Listed under Jeffrey – Apt. for Models

1 contact page 68

Jeffrey – Apt. for Models (11P)

Listed under Jeffrey – Apt. for Models

1 contact page 68

Larry V

Listed under Jeffrey – Apt. for Models

1 contact page 68

Jeffrey – Apt. for Models (14G)

Listed under Jeffrey – Apt. for Models

1 contact page 68

Natty

Listed under Jeffrey – Apt. for Models

1 contact page 68

Frederick & Cath Adler

Fulbright & Jawokski

US2 contacts page 69

Jeffrey – Ali

1 contact page 69

Eva Andersson

NBC

US2 contacts page 69

Lulu

NBC

Listed under Eva Andersson

Sweden1 contact page 69

Glenn

NBC

Listed under Eva Andersson

Sweden1 contact page 69

Bill Archer

Protective Operation, R.L. Oatman & Associates Inc.

US3 contacts page 77page 69

Sherry Castle

Protective Operation, R.L. Oatman & Associates Inc.

Listed under Bill Archer

US2 contacts page 77page 69

Linda Aslanian

Four Seasons Hotel

US2 contacts page 69

Bandar Prince

US1 contact page 69

Elliot Cas

Listed under Bandar Prince

US1 contact page 69

Jon Bannenberg

Jon Bannenberg Limited

UK1 contact page 69

Ehud BarakVIP

Barak & Associates, LLC Chairman

2 contacts page 69page 95

Tom Barrack

Colony Capital Inc.

US1 contact page 69

Jodie Pitts

Colony Capital Inc.

Listed under Tom Barrack

US1 contact page 69

Tracey

Colony Capital Inc.

Listed under Tom Barrack

US2 contacts page 92page 69

David Monahan

Colony Capital Inc.

Listed under Tom Barrack

US1 contact page 69

Anthony Barrett

Ossa Properties

US2 contacts page 70

Donna Landa

Ossa Properties

Listed under Anthony Barrett

US1 contact page 70

Jonathan Barrett

Luminus Management

US2 contacts page 70

Jerry Beck

The Limited Inc.

US2 contacts page 70

Albert Benamou

France2 contacts page 70

Sophie Biddle-Hakim

US2 contacts page 70

Gilbert Hakim

US1 contact page 70

Nadia Bjorlin

US1 contact page 70

Leon Black

Apollo Management, L.P.

US2 contacts page 70

David Keidan

Buckingham Research

US1 contact page 70

Bob Crowley

Buckingham Research

Listed under David Keidan

US1 contact page 70

Butler Aviation, Signature Flight Support

Butler Aviation, Signature Flight Support

US1 contact page 70

Michelle Campos

US1 contact page 70

Jimmy Cayne

Bear Stearns, President & CEO

US2 contacts page 71

Silas Chou

A&G UK LTD

UK2 contacts page 71

Daniel

1 contact page 71

Dayle Davison

Citibank

US1 contact page 71

Geoff Von Kuhn

Citibank

Listed under Dayle Davison

US1 contact page 71

George Delson

George Delson & Associates

US2 contacts page 71

Catherine Derby

US1 contact page 71

Alan Dershowitz

US2 contacts page 71

Carolyn Cohen

Listed under Alan Dershowitz

US1 contact page 71

Gerald Edelman

Neurosciences Research Foundation

US2 contacts page 71

Don Engle

US1 contact page 71

Yuni

Epstein Interests

Listed under Jeffrey Epstein

1 contact page 71

Eric

Epstein Interests

Listed under Jeffrey Epstein

1 contact page 71

Jeff S

Epstein Interests

Listed under Jeffrey Epstein

1 contact page 71

Darren

Epstein Interests

Listed under Jeffrey Epstein

1 contact page 71

Lauren

Epstein Interests

Listed under Jeffrey Epstein

1 contact page 71

Cimberly

Epstein Interests

Listed under Jeffrey Epstein

1 contact page 71

Lesley

Epstein Interests

Listed under Jeffrey Epstein

1 contact page 71

Helen

Epstein Interests

Listed under Jeffrey Epstein

1 contact page 71

Al Castricone

Epstein Interests

Listed under Jeffrey Epstein

1 contact page 71

Michigan Home

Michigan Home

US1 contact page 72

Mark Epstein

Izmo Family of Companies, Inc.

US3 contacts page 72

Paula Epstein

US1 contact page 72

Joyce Michayluk

Listed under Paula Epstein

1 contact page 72

Andrew Farkas

Island Capital

US1 contact page 72

Jonathan D. Farkas

Live Oak Realty Corp.

US2 contacts page 72

Federal Express

Federal Express

2 contacts page 72

Taylor Foster

US1 contact page 72

Eric Gany

US1 contact page 72

Murray Gell-man

Sante Fe Institute

US1 contact page 72

Kenneth Gilman

The Limited, Inc., Vice Chairman/CFO

US2 contacts page 72

Howard Glick

Adam’s Book Store

US1 contact page 73

Bob Gold

US1 contact page 73

Bob Goodman

US2 contacts page 73

Vicki Gray

US1 contact page 73

Svetlana Griaznove

US1 contact page 73

Eileen Guggenheim

US1 contact page 73

Harold Mollin

1 contact page 73

Jalila Hashemi

UK1 contact page 73

Gregory & Margaret Hedberg

Hirschel & Adler Art Gallery

US2 contacts page 73

Paula Heil

Millennial Arts

US2 contacts page 73

Joey Hunter

Modelwire, Director

US2 contacts page 73

Darren K. Indyke

US2 contacts page 73

Michelle

Listed under Darren K. Indyke

US1 contact page 73

Herb Walman

Insurance Office of Central Oh

US1 contact page 74

Dan Cahill

Insurance Office of Central Oh

Listed under Herb Walman

US1 contact page 74

Janice Lichtenstein

Insurance Office of Central Oh

Listed under Herb Walman

US1 contact page 74

Walter Isaacson

Time Magazine

1 contact page 74

James Randy

1 contact page 74

Mylene Jampanol

France1 contact page 74

Gioria Jarecki

US1 contact page 74

Henry Jarecki

Falconwood Corporation

US2 contacts page 74

Pamela Johananoff

France2 contacts page 74

Lily Johnson

1 contact page 74

Elizabeth Johnson

US2 contacts page 74

John Kerry

Senator

US1 contact page 74

Jamie Whitehead

Listed under John Kerry

1 contact page 74

Jack Kessler

New Albany Company

US2 contacts page 74

Kristina Kincaid

Victoria’s Secret

US2 contacts page 74

Steve Kosslyn

Harvard University

US2 contacts page 74

Henry Kravis

Kohlberg Kravis & Roberts

US1 contact page 75

Adam Perry Lang

US1 contact page 75

Robin Leach

Leach Entertainment Enterprise

US2 contacts page 75

Nick Leese

House of Orient PTE Ltd.

Singapore2 contacts page 75

Cindy Lopez (Buklarewicz)

Karin Models

US2 contacts page 75

Marc Lundberg

N.A. Property Inc.

US2 contacts page 75

Melinda Luntz

Clarkeson Research Group

US2 contacts page 75

Denise Read

Clarkeson Research Group

Listed under Melinda Luntz

US1 contact page 75

John Welch

Mast Industries President

Hong Kong1 contact page 75

Ron Shulman

Mast Industries President

Listed under John Welch

Hong Kong1 contact page 75

Karen Fedorko

Mast Industries

Italy1 contact page 75

C. Thomas McMillen

The Risk Group Chairman

US2 contacts page 75

Thomas C. McMillen

The Risk Group Chairman, CEO

US1 contact page 75

Robert Meister

Aon-Rollins Hudig Hall, Vice Chairman

US3 contacts page 76

Kelly

Aon-Rollins Hudig Hall, Vice Chairman

Listed under Robert Meister

US3 contacts page 94page 76page 86

Jeffrey – Merrit, Jerry

1 contact page 76

Mark Middleton

US2 contacts page 76

Marvin Minsky

MIT

2 contacts page 76

Gloria Rudish

MIT

Listed under Marvin Minsky

US1 contact page 76

Gloria Minsky

MIT

Listed under Marvin Minsky

US1 contact page 76

David Mitchell

US2 contacts page 76

George Mitchell

Senator, Piper Rudnick

US2 contacts page 76

Larry Morrison

US2 contacts page 76

Nathan Myhrvold

Intellectual Ventures

US2 contacts page 76

Sharleen

Intellectual Ventures

Listed under Nathan Myhrvold

US1 contact page 76

Serena

Intellectual Ventures

Listed under Nathan Myhrvold

US1 contact page 76

Gerry Heinan

Intellectual Ventures

Listed under Nathan Myhrvold

US1 contact page 76

Joan Waters

Intellectual Ventures

Listed under Nathan Myhrvold

US1 contact page 76

Claudia Leschuck

Intellectual Ventures

Listed under Nathan Myhrvold

US1 contact page 76

N.A. Property, Inc.

N.A. Property, Inc.

US2 contacts page 76

Paul Burkhardt

N.A. Property, Inc.

Listed under Jeffrey – N.A. Property, Inc.

US1 contact page 76

Kathy Kahn

N.A. Property, Inc.

Listed under Jeffrey – N.A. Property, Inc.

US1 contact page 76

Carol Snyder

N.A. Property, Inc.

Listed under Jeffrey – N.A. Property, Inc.

US1 contact page 76

Peggy Ugland

N.A. Property, Inc.

Listed under Jeffrey – N.A. Property, Inc.

US1 contact page 76

Jim Weitthoff

N.A. Property, Inc.

Listed under Jeffrey – N.A. Property, Inc.

US1 contact page 76

Marc

N.A. Property, Inc.

Listed under Jeffrey – N.A. Property, Inc.

US1 contact page 76

New Albany Country Club

New Albany Country Club

US1 contact page 77

Timothy W. Newcombe

Newcombe Electronic Systems

US2 contacts page 77

Larry Esq. & Adelman Newman

US2 contacts page 77

Martin Nowak

US1 contact page 77

Bob Oatman

Protective Operation, R.L. Oatman & Associates Inc.

US2 contacts page 77

Janice Oatman

Protective Operation, R.L. Oatman & Associates Inc.

Listed under Bob Oatman

US1 contact page 77

Selma Ouertani

France1 contact page 77

Michael Ovitz

Artist Management Group

US2 contacts page 77

Mark Packer

Canastel’s

US2 contacts page 77

Joe Pagano

Chef Aspen CO

US2 contacts page 77page 95

Jeanie

Listed under Joe Pagano

US1 contact page 77

Itzhak Perlman

US1 contact page 77

Karin Palmer

Listed under Itzhak Perlman

US1 contact page 77

Pete

1 contact page 77

Lisa Phillips

US2 contacts page 77

Anne Fisher

Listed under Meredith

US1 contact page 77

Meredith

Listed under Meredith

US1 contact page 77

Anna

Listed under Meredith

US1 contact page 77

Genaveve

Listed under Meredith

US1 contact page 77

Hyperion Air or JEGE

Hyperion Air or JEGE

US1 contact page 77

International Aviation

International Aviation

Listed under Jeffrey – Pilot Information

US1 contact page 77

Aspen Base Operations

Aspen Base Operations

Listed under Jeffrey – Pilot Information

1 contact page 77

LA Garrett Aviation

LA Garrett Aviation

Listed under Jeffrey – Pilot Information

1 contact page 77

PB Jet Aviation

PB Jet Aviation

Listed under Jeffrey – Pilot Information

1 contact page 77

Boston Signature Flight

Boston Signature Flight

Listed under Jeffrey – Pilot Information

1 contact page 77

Santa Fe Capital Aviation

Santa Fe Capital Aviation

Listed under Jeffrey – Pilot Information

1 contact page 77

Columbus Pilot Office

Columbus Pilot Office

Listed under Jeffrey – Pilot Information

1 contact page 77

FBO Lane Aviation

FBO Lane Aviation

Listed under Jeffrey – Pilot Information

1 contact page 77

Bohlke International Airways

Bohlke International Airways

Listed under Jeffrey – Pilot Information

1 contact page 77

Atlantic Aviation Teterboro

Atlantic Aviation Teterboro

Listed under Jeffrey – Pilot Information

1 contact page 77

Million air

Million air

Listed under Jeffrey – Pilot Information

1 contact page 77

Galaxy

Galaxy

Listed under Jeffrey – Pilot Information

1 contact page 77

LAX Garrett Aviation

LAX Garrett Aviation

Listed under Jeffrey – Pilot Information

1 contact page 77

Santa Monica – Super Marine

Santa Monica – Super Marine

Listed under Jeffrey – Pilot Information

1 contact page 77

Van Nuys – Million Air

Van Nuys – Million Air

Listed under Jeffrey – Pilot Information

1 contact page 77

Jet West (Van Nyes)

Jet West (Van Nyes)

Listed under Jeffrey – Pilot Information

1 contact page 77

Sky Trails

Sky Trails

Listed under Jeffrey – Pilot Information

1 contact page 77

LGA Signature Flight Support

LGA Signature Flight Support

Listed under Jeffrey – Pilot Information

1 contact page 77

White Plains Westchester Airport

White Plains Westchester Airport

Listed under Jeffrey – Pilot Information

1 contact page 77

JFK General Aviation

JFK General Aviation

Listed under Jeffrey – Pilot Information

1 contact page 77

Stuart Pivar

US1 contact page 78

Dara Preece

US3 contacts page 86page 78

Thomas H. Quinn

Venable Law firm

US1 contact page 78

Lewis S. Ranieri

Ranieri & Co. Inc.

US2 contacts page 78

Ed Razek

US3 contacts page 78

David Rockefeller

Rockefeller Financial Service

US1 contact page 78

Dave Rodgers

US1 contact page 78

David Rigg

Listed under Dave Rodgers

US2 contacts page 80page 78

Henry Dean Rosovsky

Harvard University

US2 contacts page 78

Maureen McCarthy

Listed under Henry Dean Rosovsky

US1 contact page 78

David Ross

San Francisco Museum of Modern Art

US2 contacts page 78

Daniel Reynolds

Roxton Sporting

1 contact page 78

Oliver Sacks

US1 contact page 78

Stan Schaeffer

1 contact page 78

Jeffrey Schantz

US1 contact page 79

Douglas A Schoettle

US1 contact page 79

Monty Shadow

Italy1 contact page 79

David Shaeffer

US1 contact page 79

Richard Snyder

Golden Books Family Entertainment

US3 contacts page 79

Laura Yorke

Golden Books Family Entertainment

Listed under Richard Snyder

US3 contacts page 79

Melissa Solomon

US2 contacts page 79

Dottie Sowell

US1 contact page 79

Warren Spector

Bear, Steams & Co., President

US2 contacts page 79

Jes Staley

JP Morgan

US2 contacts page 79

Linda Toscano

JP Morgan

Listed under Jes Staley

US1 contact page 79

Tamara

JP Morgan

Listed under Jes Staley

US1 contact page 79

Kelly Bovino

JP Morgan

Listed under Jes Staley

US1 contact page 79

Lawrence S. Stroll

AIHL Investment Group, Chairman

US2 contacts page 79

Claire Ann

AIHL Investment Group, Chairman

Listed under Lawrence S. Stroll

1 contact page 79

Craig Tofoya

Fraser Yachts

US2 contacts page 80

Larry Tobiason

Lawrence F. Tobiason Assoc.

US2 contacts page 80

Bob Trossle

Miller and Raved

1 contact page 80

Donald TrumpVIP

The Trump Organization

US2 contacts page 80

Howard Wilson

The Trump Organization

Listed under Donald Trump

US1 contact page 80

Milania

The Trump Organization

Listed under Donald Trump

US1 contact page 80

Marty Trust

MastIndustries, Inc.

US2 contacts page 80

Steve Tuckerman

Trickerman Optical Co.

US1 contact page 80

Peg Ugland

US2 contacts page 80

Richard Ugland

Listed under Peg Ugland

US1 contact page 80

Jeffrey – UPS

1 contact page 80

Tony Valukas

Jenner & Block

US1 contact page 80

Larry Visoski

US1 contact page 80

Linda Wachner

Warnaco Inc.

US2 contacts page 80

Clauda

Listed under Linda Wachner

1 contact page 80

Francis Wahl

Bernhelm Halperian Ming Ducret

Switzerland2 contacts page 80

Alexia Wallaert

France2 contacts page 81

Vera Wang

Vera Wang Bridal House Ltd.

US3 contacts page 81

Cristalle Wasche

1 contact page 81

Wexner – Abigail Plantation

Wexner – Abigail Plantation

US1 contact page 81

Darrell Halstead

Wexner – Abigail Plantation

Listed under Wexner – Abigail Plantation

US1 contact page 81

Wexner – Flight Dept.

Wexner – Flight Dept.

US1 contact page 81

Tim Stehly

Wexner – Flight Dept.

Listed under Wexner – Flight Dept.

US1 contact page 81

Les WexnerVIP

The Limited Inc.

UK2 contacts page 81

David Byrne

Listed under Les Wexner

UK1 contact page 81

Curt Ufkes

Listed under Les Wexner

US1 contact page 81

Jeffrey – Wexner, Les

Listed under Les Wexner

US1 contact page 81

Abigail House

Abigail House

Listed under Les Wexner

US1 contact page 81

Karl Koon

Abigail House

Listed under Les Wexner

US1 contact page 81

Ryan Daina

The Limited Inc.

Listed under Les Wexner

US1 contact page 81

Main Line (information)

Main Line (information)

US1 contact page 81

Jim Whitehead

1 contact page 81

Herb Wolman

Insurance Office Central Ohio

US2 contacts page 81

Mort Zuckerman

Boston Properties

US1 contact page 82

Boston Properties

Boston Properties

Listed under Mort Zuckerman

US1 contact page 82

Clare

Boston Properties

Listed under Mort Zuckerman

US1 contact page 82

Bill Wedge

Boston Properties

Listed under Mort Zuckerman

US1 contact page 82

Richard Barnett

2 contacts page 82

Patricia Hughs

Listed under Richard Barnett

1 contact page 82

Magali Blachon

France1 contact page 82

Dennis – Flowers

Merc Garage

Listed under Jeffrey Epstein

US1 contact page 82

Rich

Merc Garage

Listed under Jeffrey Epstein

US1 contact page 82

Richie

Merc Garage

Listed under Jeffrey Epstein

US1 contact page 82

Ryan

Merc Garage

Listed under Jeffrey Epstein

US1 contact page 82

Lynn

Merc Garage

Listed under Jeffrey Epstein

US1 contact page 82

Lyn & Jojo

Merc Garage

Listed under Jeffrey Epstein

US1 contact page 82

Jojo

Merc Garage

Listed under Jeffrey Epstein

US1 contact page 82

Lyn

Merc Garage

Listed under Jeffrey Epstein

US1 contact page 82

Gary Baura

Flowers

1 contact page 82

Lynn Fontanilla

US1 contact page 82

Jojo Fontanilla

Listed under Jeffrey 71st – Fontanilla, Lynn & Jojo

US1 contact page 82

Steve Gaston

1 contact page 82

Graces Marketplace

Graces Marketplace

US1 contact page 82

Sue Hamblin

South Africa1 contact page 82

Charles Miller

Miller & Raved Inc.

US2 contacts page 82

Bob

Listed under Charles Miller

US1 contact page 82

Tom Sawyers

US1 contact page 82

Pat Sawyers

Listed under Jeffrey 71st – Sawyers Tom/Pat

US1 contact page 82

Brent Tindall

US1 contact page 82

Muthaiga Club

Muthaiga Club

1 contact page 83

Airport Transfers

Airport Transfers

1 contact page 83

Charlie

1st & Busi.

2 contacts page 89page 83

Kinnerton – Chelsea Police Station

1 contact page 83

Alan Coles

The Brompton Health Clinic, Registered Osteopath

UK3 contacts page 83

Les Wallace

UK1 contact page 83

Ray Perkins

Listed under Les Wallace

1 contact page 83

Walter

Listed under Les Wallace

1 contact page 83

Isi Entwistle

1 contact page 83

Denise

Hair Assocs

UK1 contact page 83

Kinnerton – Harrods Limited

UK1 contact page 83

Harvey Nichols

1 contact page 83

Holland & Holland

Holland & Holland

1 contact page 83

Jackson Stops, Jolyn & Benson

Jackson Stops, Jolyn & Benson

UK1 contact page 83

John Hobbs

John Hobbs Ltd.

UK1 contact page 83

La Famiglia

La Famiglia

1 contact page 83

Martin Tim

Grosvenor Estate

UK1 contact page 83

Debbie Stewart

Grosvenor Estate

Listed under Martin Tim

UK1 contact page 83

Kinnerton – Martine

UK1 contact page 83

Massage – UK (a)

Massage – UK (a)

UK1 contact page 83

Liz

Massage – UK (a)

Listed under Kinnerton – Massage – UK

UK1 contact page 83

Annabel

Massage – UK (a)

Listed under Kinnerton – Massage – UK

UK1 contact page 83

Barry

Massage – UK (a)

Listed under Kinnerton – Massage – UK

UK1 contact page 83

Joanne Brunt

Massage – UK (a)

Listed under Kinnerton – Massage – UK

UK1 contact page 83

Maxine

Massage – UK (a)

Listed under Kinnerton – Massage – UK

UK1 contact page 83

Lisa

Massage – UK (a)

Listed under Kinnerton – Massage – UK

UK1 contact page 83

Bernice Palazo

Massage – UK (a)

Listed under Kinnerton – Massage – UK

UK1 contact page 83

Felicity

Massage – UK (a)

Listed under Kinnerton – Massage – UK

UK1 contact page 83

Cherie Elling

Massage – UK (a)

Listed under Kinnerton – Massage – UK

UK1 contact page 83

Simon Edwards

Listed under Ghislaine Maxwell

1 contact page 83

Minicabs

Minicabs

1 contact page 83

Kevin & Valerie

Kevin & Valerie

1 contact page 83

Nessa O’Neil

1 contact page 83

Oping

Oping

1 contact page 83

Anthony Outred

UK1 contact page 83

Police

Police

UK1 contact page 83

Range Rover

Range Rover

1 contact page 83

John Ray

1 contact page 83

Stichcraft

Stichcraft

1 contact page 84

Maxine Tobias

Yoga – UK

1 contact page 84

Debbie Nichols

Unlisted London

1 contact page 84

Yara

Yara

1 contact page 84

Birnbaum

US1 contact page 84

John

Scobell

Listed under Birnbaum

US2 contacts page 89page 84

Burman

Vet for Max

US1 contact page 84

Dean

Chiropractor

US1 contact page 84

Dean Calakos

Chiropractor

Listed under Medical – Chiropractor

US2 contacts page 84

Bruce Cope

GM Dentist

US1 contact page 84

Bruno

US1 contact page 84

Farkus

US1 contact page 84

Ray

Paula’s Dr.’s

US2 contacts page 84page 85

Kashel

Paula’s Dr.’s

Listed under Ray

US1 contact page 84

Schimoni

US1 contact page 84

Ear Conning

Ear Conning

US1 contact page 84

J R Gaynor

US1 contact page 84

Hirshfield

US1 contact page 84

Ishmail

US1 contact page 84

Susan Kent

Park East Animal Hospital

US1 contact page 84

Michael Krumholtz

US1 contact page 84

Lee

US1 contact page 84

Lister Hospital

Lister Hospital

1 contact page 84

Magnani

US1 contact page 84

Medical

Medical

1 contact page 84

MedLink Emergency

MedLink Emergency

1 contact page 84

Meltzer

US1 contact page 84

Bruce Moskowitz

US1 contact page 84

Oxford Health Plans

Oxford Health Plans

1 contact page 85

Prudential

Prudential

1 contact page 85

Steinburg

NY Hospital

US1 contact page 85

Esther Sternberg

1 contact page 85

Maggie Tom

1 contact page 85

Steve Victor

US2 contacts page 85

Wayne Wyntik

Chiropractor

1 contact page 85

Babor

Babor

1 contact page 85

Perry Bard

US2 contacts page 85

The Breakers

The Breakers

1 contact page 85

Bard

Chiropractor

1 contact page 85

Francis Peadon

1 contact page 85

Creative Custom Swimwear

Creative Custom Swimwear

US1 contact page 85

Dawn Devito

US2 contacts page 85

Mike

Listed under Jeffrey Epstein

US2 contacts page 91page 85

Sally

Listed under Jeffrey Epstein

US1 contact page 85

Jerome Pierre

Gardener

Listed under Jeffrey Epstein

US2 contacts page 85page 87

Christophe

French Driver

Listed under Jeffrey Epstein

US2 contacts page 85page 95

Paula

Listed under Jeffrey Epstein

US2 contacts page 93page 85

Fay Goodman

Listed under Jeffrey Epstein

US1 contact page 85

Ronnie Carey

Listed under Jeffrey Epstein

US1 contact page 85

Christophe Gaie

US1 contact page 85

Francis Goldman

US1 contact page 85

Gerald Goldsmith

Palm Beach National Bank

US2 contacts page 85

Bill Maronet

ETC

1 contact page 86

Dawn W-R

1 contact page 86

Dawn James (Devito)

Listed under PB – Massage – Florida

1 contact page 86

Cheri Lynch

Listed under PB – Massage – Florida

2 contacts page 93page 86

Alison Chambers

Listed under PB – Massage – Florida

2 contacts page 93page 86

Jodie

Listed under PB – Massage – Florida

2 contacts page 86

PB – Massage – Florida (a) (CLASSIFIED)

Listed under PB – Massage – Florida

4 contacts page 86

Johanne

Listed under PB – Massage – Florida

2 contacts page 93page 86

Alexandra

Listed under PB – Massage – Florida

2 contacts page 86

Johanna

Listed under PB – Massage – Florida

2 contacts page 93page 86

Tammy

Facialist

Listed under PB – Massage – Florida

2 contacts page 86

Amy Birse

Listed under PB – Massage – Florida

1 contact page 86

Melissa Hanes

Listed under PB – Massage – Florida

2 contacts page 86

Vicky

Listed under PB – Massage – Florida

1 contact page 86

Lisa Sturgil

Listed under PB – Massage – Florida

1 contact page 86

Amber

Massage – California

Listed under PB – Massage – Florida

4 contacts page 92page 86

Katja

Gypsy’s girl

Listed under PB – Massage – Florida

2 contacts page 86

Geri Kay

Listed under PB – Massage – Florida

1 contact page 86

Melanie

Listed under PB – Massage – Florida

1 contact page 86

Katie Brihingham

Listed under PB – Massage – Florida

1 contact page 86

C… (CLASSIFIED) (CLASSIFIED)

Listed under PB – Massage – Florida

1 contact page 86

Dominique

Listed under PB – Massage – Florida

1 contact page 86

Mary Southwell

Listed under PB – Massage – Florida

1 contact page 86

(CLASSIFIED) (CLASSIFIED)

Listed under PB – Massage – Florida

7 contacts page 86

Diane Cahill

Listed under PB – Massage – Florida

1 contact page 86

Andrea

Listed under PB – Massage – Florida

2 contacts page 94page 86

Heidi

Massage – New Mexico

Listed under PB – Massage – Florida

3 contacts page 94page 91page 86

Coleen

Listed under PB – Massage – Florida

2 contacts page 86

Cristale

Listed under PB – Massage – Florida

2 contacts page 86

Michelle Beil

Listed under PB – Massage – Florida

1 contact page 86

Hawthornes

Listed under PB – Massage – Florida

1 contact page 86

M??????? (CLASSIFIED)

Listed under PB – Massage – Florida

1 contact page 86

Beth

Listed under PB – Massage – Florida

1 contact page 86

Carolyn

Listed under PB – Massage – Florida

1 contact page 86

Carolyn Casey

Listed under PB – Massage – Florida

1 contact page 86

Charlotte

Listed under PB – Massage – Florida

1 contact page 86

Chelsea

Listed under PB – Massage – Florida

1 contact page 86

Dara

Listed under PB – Massage – Florida

1 contact page 86

Debra

Listed under PB – Massage – Florida

2 contacts page 94page 86

Dina Lombardi

Facialist

Listed under PB – Massage – Florida

1 contact page 86

Gwendolyn Beck

Listed under PB – Massage – Florida

1 contact page 86

Heidi Kublick

Listed under PB – Massage – Florida

1 contact page 86

Jessie

Listed under PB – Massage – Florida

1 contact page 86

Jill Spiria

Listed under PB – Massage – Florida

1 contact page 86

Karen Mesa

Listed under PB – Massage – Florida

1 contact page 86

Kiery

Lisa P’s friend

Listed under PB – Massage – Florida

1 contact page 86

Kristen

Carolyn’s friend

Listed under PB – Massage – Florida

2 contacts page 93page 86

Kyle

Listed under PB – Massage – Florida

1 contact page 86

Laura Kline

Listed under PB – Massage – Florida

1 contact page 86

Lina

Cosmo & Co

Listed under PB – Massage – Florida

1 contact page 86

Maura

Listed under PB – Massage – Florida

1 contact page 86

Maura Koons

Listed under PB – Massage – Florida

1 contact page 86

Melissa

Carolyn’s friend

Listed under PB – Massage – Florida

2 contacts page 94page 86

Nela Estonia

Listed under PB – Massage – Florida

1 contact page 86

Nicole

Listed under PB – Massage – Florida

2 contacts page 93page 86

Sheridon

Listed under PB – Massage – Florida

1 contact page 86

Symar

Listed under PB – Massage – Florida

1 contact page 86

Stephanie

Listed under PB – Massage – Florida

1 contact page 86

Ashley

Listed under PB – Massage – Florida

1 contact page 86

Michael & Saily

PB House Managers

1 contact page 86

Mike Pezulo

El Brillo neighbor

1 contact page 86

Larry Mogens

1 contact page 86

Bruno Jennifer

Police PB

1 contact page 86

Gudger

Police PB

Listed under Tom Melinchok

1 contact page 86

Joe Recarey

Police PB

Listed under Tom Melinchok

1 contact page 86

Tom Melinchok

Police PB

Listed under Tom Melinchok

1 contact page 86

Trilych

Police PB

Listed under Tom Melinchok

1 contact page 86

Pompano Helicopter

Pompano Helicopter

1 contact page 86

Alan Stepek

Xyle’phloem

US1 contact page 86

Jack Liggett

Vet

1 contact page 86

John Bodie

Plane rental StFe

1 contact page 86

Ellis Freedman

Listed under Ranch

1 contact page 87

Malcolm Grumbridge

The Hogarth Group, Solicitor

Listed under Ranch

UK2 contacts page 87

Pierre Lemaine

Listed under Ranch

1 contact page 87

Scott & Sarah Marden

Nurse

Listed under Ranch

1 contact page 87

Bob Miranda

Listed under Ranch

1 contact page 87

Brian Moss

Listed under Ranch

1 contact page 87

Carolin Coleman

Listed under Ranch

1 contact page 87

Mauri Nesson

Listed under Ranch

1 contact page 87

Keith Oliver

Peters & Peters

Listed under Ranch

UK3 contacts page 87

Rodolph Onakewe

Listed under Ranch

France1 contact page 87

Robert Ord

Listed under Ranch

1 contact page 87

Paul Cox

Listed under Ranch

1 contact page 87

Helen Mcdowell

Peters & Peters

Listed under Ranch

UK1 contact page 87

Samuel Pisar

Listed under Ranch

1 contact page 87

Caroline Gravisse

Listed under Ranch

1 contact page 87

Leah Pisar

Listed under Ranch

1 contact page 87

Felix Posen

Listed under Ranch

UK1 contact page 87

Shaw Derek

Listed under Ranch

1 contact page 87

Shelly Aboff

Listed under Ranch

1 contact page 87

Tony Busby

Listed under Ranch

1 contact page 87

Paul Travis

Listed under Ranch

1 contact page 87

Jim Tutle

Listed under Ranch

1 contact page 87

Justin White

Listed under Ranch

1 contact page 87

Scotland Yard

Scotland Yard

1 contact page 87

Ken South

Listed under Security

1 contact page 88

The Home Office

The Home Office

Listed under Security

1 contact page 88

Bristol Hotel

Bristol Hotel

Switzerland1 contact page 88

The Corveglia Club

The Corveglia Club

Listed under Switzerland

1 contact page 88

The Steffani

The Steffani

Listed under Switzerland

1 contact page 88

Aero Leasing

Aero Leasing

Switzerland1 contact page 88

Air France

Air France

Listed under Travel

1 contact page 88

Air Hansen, Helicopter

Air Hansen, Helicopter

Listed under Travel

1 contact page 88

Leonard Kay

Listed under Travel

1 contact page 88

Val Cushing

Listed under Travel

1 contact page 88

Brenda Boone

Listed under Travel

1 contact page 88

Susan Michado

Listed under Travel

1 contact page 88

American Express

American Express

Listed under Travel

1 contact page 88

Abdullah Amad

American Express, Cent. Travel

Listed under Travel

1 contact page 88

Ian Roche

Listed under Travel

1 contact page 88

AT&T

AT&T

Listed under Travel

1 contact page 88

British Airways

British Airways

Listed under Travel

1 contact page 88

Claire McArdle

British Airways

Listed under Travel

1 contact page 88

Jilly Rutherford

British Airways

Listed under Travel

1 contact page 88

Olivier Roz

British Airways (Special Services)

Listed under Travel

1 contact page 88

Alan Jacobson

British Airways (Special Services)

Listed under Travel

1 contact page 88

Penelope Foy

British Airways (Special Services)

Listed under Travel

1 contact page 88

Berry Bernette

British Airways (Special Services)

Listed under Travel

1 contact page 88

Citicar

Citicar

Listed under Travel

US1 contact page 88

David Gladwin

Concord Tickets

Listed under Travel

UK1 contact page 88

Susie Simon

Concord Tickets

Listed under Travel

UK1 contact page 88

Michael Holtz

Concord Tickets

Listed under Travel

UK1 contact page 88

Continental Airlines

Continental Airlines

Listed under Travel

1 contact page 88

Delta Airlines

Delta Airlines

Listed under Travel

1 contact page 88

Delta Dash

Delta Dash

Listed under Travel

1 contact page 88

DHL Courier

DHL Courier

Listed under Travel

1 contact page 88

Flight Options

Flight Options

Listed under Travel

US1 contact page 88

Flyaway

Flyaway

Listed under Travel

1 contact page 88

Frequent Flyer Clubs, Delta One Pass

Frequent Flyer Clubs, Delta One Pass

Listed under Travel

1 contact page 88

Mario B. Jr. Garnero

Listed under Travel

1 contact page 88

Jean-Jacques Moinet

Helicopters, Nice Helicopteres

Listed under Travel

France1 contact page 88

Eileen Hickery

Special Services, NY

Listed under Travel

US1 contact page 89

Immunisation

Immunisation

Listed under Travel

1 contact page 89

Geoffrey Kent

Abercromble & Kent

Listed under Travel

US1 contact page 89

London Airways

London Airways

Listed under Travel

1 contact page 89

Karen

Lonsdale

Listed under Travel

2 contacts page 89page 91

Richard Santulli

Net Jets

Listed under Travel

1 contact page 89

Carol

Listed under Travel

1 contact page 89

Peggy Culver Feign

Net Jets

Listed under Travel

1 contact page 89

Erin

Net Jets

Listed under Travel

1 contact page 89

Nite & Day

Nite & Day

Listed under Travel

US1 contact page 89

Travel (T) – Northwest Airlines

Listed under Travel

1 contact page 89

Omar

Alto Travel, Travel Agent

Listed under Travel

US1 contact page 89

Travel (T) – Phone

Listed under Travel

1 contact page 89

Pisa Brothers

Pisa Brothers

Listed under Travel

US1 contact page 89

Plane Charter, Chauffair

Plane Charter, Chauffair

Listed under Travel

1 contact page 89

Platinum Travel

Platinum Travel

Listed under Travel

1 contact page 89

George Kocher

Raytheon Travel Air

Listed under Travel

US1 contact page 89

Karen Jenkins

Raytheon Travel Air

Listed under Travel

US1 contact page 89

Red Carpet Limousine Company

Red Carpet Limousine Company

Listed under Travel

1 contact page 89

Saphire Travel

Saphire Travel

Listed under Travel

1 contact page 89

Shopper’s Travel

Shopper’s Travel

Listed under Travel

US1 contact page 89

Sprint

Sprint

Listed under Travel

1 contact page 89

SR Reservations

SR Reservations

Listed under Travel

1 contact page 89

Marc Bullough

Steppes East

Listed under Travel

1 contact page 89

Mick Lany

Steppes East

Listed under Travel

1 contact page 89

Travel Consolidator Europe, Kevins Travel Contact

Travel Consolidator Europe, Kevins Travel Contact

Listed under Travel

1 contact page 89

Pascaline

Travel Consolidator Europe, Succes Voyage

Listed under Travel

1 contact page 89

CHEAP

CHEAP

Listed under Travel

1 contact page 89

Laker Airlines

Laker Airlines

Listed under Travel

1 contact page 89

Ragoo

Ragoo

Listed under Travel

1 contact page 89

Very Cheap Tickets (coach)

Very Cheap Tickets (coach)

Listed under Travel

1 contact page 89

Cheap Seats

Cheap Seats

Listed under Travel

1 contact page 89

Peter Koukoularides

Lonsdale

Listed under Travel

1 contact page 89

Connie

Listed under Travel

1 contact page 89

Capellini

Concorde Paris

Listed under Travel

1 contact page 89

Saphire / charters Gatewick-SLT

Saphire / charters Gatewick-SLT

Listed under Travel

1 contact page 89

Jet Blue

Jet Blue

Listed under Travel

1 contact page 89

Sabatian

Traveling Traveter

Listed under Travel

1 contact page 89

Ticket Planet

Ticket Planet

Listed under Travel

1 contact page 89

Homeric Tours

Homeric Tours

Listed under Travel

1 contact page 89

Stacy

Go Trips

Listed under Travel

1 contact page 89

24 hr. hotline code #E5516

24 hr. hotline code #E5516

Listed under Travel

1 contact page 89

Raghu cell

Raghu cell

Listed under Travel

1 contact page 89

cheapflights.co.uk

cheapflights.co.uk

Listed under Travel

1 contact page 89

Lucy

France Travel – airfrancediscount

Listed under Travel

1 contact page 89

cheap concorde tickets

cheap concorde tickets

Listed under Travel

1 contact page 89

Tashi

FlyTime Travel

Listed under Travel

1 contact page 89

Navigant

Navigant

Listed under Travel

1 contact page 89

Amex. Centurian Travel

Amex. Centurian Travel

Listed under Travel

1 contact page 89

Amex Plat. Travel

Amex Plat. Travel

Listed under Travel

1 contact page 89

Heather

Platinum

Listed under Travel

1 contact page 89

Global Travel

Global Travel

Listed under Travel

1 contact page 89

UN Travels and Tours

UN Travels and Tours

Listed under Travel

1 contact page 89

Virgin specialist

Virgin specialist

Listed under Travel

1 contact page 89

TWA

TWA

Listed under Travel

1 contact page 90

United Airlines

United Airlines

Listed under Travel

US1 contact page 90

US Air, Frequent Traveler Center

US Air, Frequent Traveler Center

Listed under Travel

US1 contact page 90

USA International

USA International

Listed under Travel

US1 contact page 90

Virgin Atlantic Airways

Virgin Atlantic Airways

Listed under Travel

1 contact page 90

Brice & Karen

Listed under Jeffrey Epstein

US1 contact page 91

Kate & Mike

Listed under Jeffrey Epstein

US1 contact page 91

Deidre & Floyd

Listed under Jeffrey Epstein

US1 contact page 91

Larry

Listed under Jeffrey Epstein

US1 contact page 91

HVAC – MH

HVAC – MH

Listed under Jeffrey Epstein

US1 contact page 91

Deldre

Listed under Jeffrey Epstein

US1 contact page 91

Floyd

Listed under Jeffrey Epstein

US1 contact page 91

Manolito

Listed under Jeffrey Epstein

US1 contact page 91

Kate

Listed under Jeffrey Epstein

US1 contact page 91

Bradbury Stamm

Bradbury Stamm

Listed under Jeffrey Epstein

US1 contact page 91

Tom Pascuzzi

Doctor

Listed under Jeffrey Epstein

US1 contact page 91

Shannon Healy

Zorro Ranch

US1 contact page 91

John Kelly

Attorney General

US2 contacts page 91

Gary Kerney

Landmark National

US2 contacts page 91

Bruce King

Governor – New Max

US1 contact page 91

Rhonda King

Rhonda King Realty

US1 contact page 91

Diana

Massage – New Mexico

US1 contact page 91

Laura Christianson

Massage – New Mexico

Listed under Diana

US1 contact page 91

Daniella Urbassek

Massage – New Mexico

Listed under Diana

US1 contact page 91

Sabrina

Massage – New Mexico

Listed under Diana

US1 contact page 91

Rachel

Massage – New Mexico

Listed under Diana

US2 contacts page 91page 92

Linda Spankman

Massage – New Mexico

Listed under Diana

US1 contact page 91

Melinda Walker

Massage – New Mexico

Listed under Diana

US1 contact page 91

Maureen

Massage – New Mexico

Listed under Diana

US1 contact page 91

Stina

Massage – New Mexico

Listed under Diana

US1 contact page 91

Nicki

Massage – New Mexico

Listed under Diana

US1 contact page 91

Bill Richardson

US1 contact page 91

Tony

Listed under Bill Richardson

US1 contact page 91

Santa Fe Institute

Santa Fe Institute

US1 contact page 91

Singleton

San Cristobal Ranch

US1 contact page 91

Shelley Aboff

US1 contact page 91

Dick Cowley

UK1 contact page 91

Sam Domb

US1 contact page 91

Hatsuhana

US1 contact page 92

Helmsley Palace

Helmsley Palace

US1 contact page 92

Il Cantinori

Il Cantinori

US1 contact page 92

Il Tre Merli

Il Tre Merli

US1 contact page 92

Isabelle’s

Isabelle’s

US1 contact page 92

Jour et Nuit

Jour et Nuit

US1 contact page 92

Karen Pets

Karen Pets

US1 contact page 92

Georgetta Klinger

US1 contact page 92

Le Club

Le Club

US1 contact page 92

Le Comptoir

Le Comptoir

US1 contact page 92

Lowell Hotel

Lowell Hotel

US1 contact page 92

Madison Gourmet

Madison Gourmet

US1 contact page 92

Madison Towers

Madison Towers

US1 contact page 92

Le Madre

Le Madre

US1 contact page 92

Mark Hotel

Mark Hotel

US1 contact page 92

Anastasia

Massage – California

Listed under Tracey

US1 contact page 92

Danielle Schwitzer

Massage – California

Listed under Tracey

US1 contact page 92

Lydia

Massage – California

Listed under Tracey

US1 contact page 92

Scott Connelly

Massage – California

Listed under Tracey

US1 contact page 92

Jackie Iverson

Massage – California

Listed under Tracey

US1 contact page 92

Lisa Versaci

Massage – California

Listed under Tracey

US1 contact page 92

RM – Massage – California , Gypsy

RM – Massage – California , Gypsy

Listed under Tracey

US1 contact page 92

Lori Bregman

Massage – California

Listed under Tracey

US1 contact page 92

Jen

Massage – California

Listed under Tracey

US1 contact page 92

Sophie Biddle

Massage – California

Listed under Tracey

US1 contact page 92

Gramza Tiffany

Massage – California

Listed under Tracey

US1 contact page 92

Scott Hobbs

Massage – California

Listed under Tracey

US1 contact page 92

Marie Sabe

Massage – California

Listed under Tracey

US1 contact page 92

Crissy

Massage – California

Listed under Tracey

US1 contact page 92

Davis Cauntae

Massage – California

Listed under Tracey

US1 contact page 92

Marianna

Massage – California

Listed under Tracey

US1 contact page 92

Chauntae

Massage – California

Listed under Tracey

US1 contact page 92

Alex Zosman

Massage – California

Listed under Tracey

US1 contact page 92

Elizabeth Zosman

Massage – California

Listed under Tracey

US1 contact page 92

Christy Tharpe

RM – Massage – California

Listed under Tracey

US1 contact page 92

Mayfair Regent

Mayfair Regent

US1 contact page 92

Patrick McMullan

Photographer

US1 contact page 92

Mercer Kitchen

Mercer Kitchen

US1 contact page 92

Morgan Hotel

Morgan Hotel

US1 contact page 92

Chow

US2 contacts page 92

Ardriano Carolyn

Listed under Visitors Massage

US1 contact page 93

Alicia

Listed under Visitors Massage

US3 contacts page 93page 94

Dawn

Listed under Visitors Massage

US1 contact page 93

Cache

Listed under Visitors Massage

Brazil2 contacts page 93

Manuele

Listed under Visitors Massage

US1 contact page 93

Marie

Listed under Visitors Massage

US1 contact page 93

Courtney Wild

Listed under Visitors Massage

US1 contact page 93

Teala

Listed under Visitors Massage

US1 contact page 93

Natalie

Listed under Visitors Massage

US1 contact page 93

Svetlana

Listed under Visitors Massage

US1 contact page 93

Britney

Listed under Visitors Massage

US1 contact page 93

Brittany

Listed under Visitors Massage

US1 contact page 93

Jenny

Listed under Visitors Massage

US1 contact page 93

Katye

Listed under Visitors Massage

US1 contact page 93

Emmy

Listed under Visitors Massage

US1 contact page 93

Nina

Listed under Visitors Massage

US1 contact page 93

Allison

Listed under Visitors Massage

US1 contact page 93

Katya

Listed under Visitors Massage

US1 contact page 94

Tim Newcombe

Citrix Systems Programmer

Listed under Important e-mail / addresses

US1 contact page 95

Charley Palmer

Aureole Restaurant, Chef

Listed under Important e-mail / addresses

US1 contact page 95

David Copperfield

Magician

Listed under Important e-mail / addresses

US1 contact page 95

Eve Andersson

Former model & mother of naked pic. (Dubin)

Listed under Important e-mail / addresses

US1 contact page 95

David Cook

(2004-2005), interacted and chat daily w/ underage girls

1 contact page 95